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Summary
The isolation procedure for the pMMO complex has been optimised to obtain a high
specific activity enzyme from Methylococcus capsulatus (Bath). The enzyme is
comprised of the pMMO hydroxylase (pMMOH) consisting of polypeptides 47,26 and
23kDa molecular mass. In addition to this, a putative pMMO reductase (pMMOR) was
also found to be necessary to maintain propylene oxidising activity. This component
was found to consist of two polypeptides of approximately 63 and 8kDa. Preliminary N-
terminal sequence data of the large subunit ofpMMOR indicates that the sequence bears
70% similarity to the methanol dehydrogenase (MDH) from Methylococcus capsulatus
(Bath). Therefore, we tentatively propose that the" MDH can act as a reductase
component to the pMMOH.
The significance of this result prompted investigations into the previous published
proposals that electrons derived from the methanol oxidation reaction can be channelled
back into the methane oxidation reaction by the methanol dehydrogenase, independent
of NADH. Any effect of methanol to act as a reductant to pMMO in membrane
preparations was lost upon isolation of the pMMO complex, indicating the necessity to
maintain a fully functional methanol dehydrogenase (MDH) upon isolation. In addition
to this, the in vitro electron donors of pMMO, NADH and duroquinol were found to act
via distinct pathways of electron transfer (electron transport inhibitor studies).
Electron paramagnetic resonance (EPR) spectroscopy data provided evidence that the
copper in the active site of pMMO existed as a mononuclear copper (II) centre not a
trinuclear copper centre suggested by Chan and coworkers (Chan et al., 1993; Nguyen et
al., 1994, 1996a, 1996b, 1998). In addition to this preliminary data also indicates the
presence of an iron centre which is only EPR visible after reduction of the complex
suggesting the majority of iron in the complex is EPR invisible. The exact nature of this
iron centre is still unclear.
A structural study of the pMMO complex has also been undertaken using electron
microscopy studies in conjunction with single particle analysis. This allowed low
resolution projection maps of different views of the pMMO complex to be generated.
The complex appears to exist in a polymeric state of at least a dimer, possibly a tetramer
if the molecular weight analysis calculated by sedimentation equilibrium analysis is
taken into account.
This study has provided some insight into basic characteristics and the structure of a
duroquinol-driven pMMO complex and its interaction with other electron transfer
proteins.
xv
Scope of this thesis
Although there has been significant progress in the elucidation of the particulate
methane monooxygenase (pMMO) from Methylococcus capsulatus (Bath) the recent
reports by Zahn and DiSpirito (1996) and Nguyen et al. (1998) have given rise to some
confusion in this field. Therefore, the aims of this PhD project were:
1) To develop a reproducible method for the isolation of the pMMO to obtain a high
specific activity enzyme.
2) To undertake basic characterisation of the pMMO.
3) To conclusively establish the nature of the metals associated to the pMMO.
. 4) To investigate the structure of the membrane-bound and purified pMMO complex.
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1. Introduction
1.1 Methane and the environment
Scientific interest into methane utilisation has surged in the last thirty years or so. This
has been due largely to two factors.
Firstly, methane is present in -1.8 parts per million in the atmosphere. It is twenty-six
times more potent than carbon dioxide as a greenhouse gas and is a source of
stratospheric water vapour, which influences ozone depletion (Lelieveld et al., 1993;
Shrope, 2000). Increasing concentrations of methane contribute to global warming,
and therefore it follows that efforts to reduce atmospheric methane concentrations
will help alleviate this effect.
Secondly, the steady decline in crude oil stocks means that the need to find a
replacement energy source is imperative (Hogan et al., 1991; Crutzen, 1991).
Methane is currently under-utilised as an energy resource because of the difficulty in
storing and transporting methane.
Both these problems could be overcome by converting methane to methanol, an easily
transportable compound, without sacrificing energy content. This conversion can be
carried out synthetically but it is a costly and energy-intensive process (Burch and
Parkyns, 1992). The solution may lie in the exploitation of naturally occurring micro-
organisms that carry out the conversion of methane to methanol. Understanding how
these microbes convert methane to methanol and under what conditions this can be
done efficiently may allow us to better utilise methane either by the direct exploitation
of these micro-organisms or by learning lessons from the biochemical features of the
enzymes that perform this reaction in order to design robust catalysts.
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1.2 Methane utilising bacteria
Methylotrophs are a diverse group of micro-organisms that are "able to grow at the
expense of reduced carbon compounds containing one or more carbon atoms but no
carbon-carbon bonds" (Anthony, 1982). These include methane, methanol,
methylated amines, formate, formamide, carbon monoxide, dimethylsulphide and
trimethylsulphonium compounds. Obligate methylotrophs grow only on such
compounds, whereas facultative methylotrophs are also able to grow on a variety of
other organic multicarbon compounds (Zatman, 1981; Anthony, 1982; Hanson,
1992).
1.2.1 Methanotrophs
Methanotrophs are aerobic bacteria that are a subset of methylotrophs and can utilise
methane as a sole carbon and energy. In 1970, Whittenbury and co-workers isolated
and characterised over 100 new methane oxidising bacteria that have formed the basis
of the current classification scheme. The methanotrophs were classified into five
different groups based on morphology, the structure of intracytoplasmic membrane,
the types of resting stages formed and physiological characteristics. The 'genera' were
named Methylomonas, Methylobacter, Methylococcus, Methylocystis and
Methylosinus. The classification was recently revised so methanotrophs were
classified into three groups (Type I, e.g. Methylomonas, Type II, e.g. Methylosinus
and Type X e.g. Methylococcus) based on the pathways used for carbon assimilation,
DNA base composition and intracytoplasmic membrane structure. (Whittenbury and
Dalton, 1981; Anthony, 1982; Hanson, 19~2 and Hanson and Hanson, 1996)
2
1.3 Methaneoxidation
In methanotrophs, the pathway for methane oxidation (Figure 1.1) has been largely
accepted as a sequence of four successive oxidation reactions (Marison and Attwood,
1982).
!02 H20 Cyt e.... Cyt c, H20
CH.7~CILOH hHCHO! ,,\" HCOOII(" "'\ CO,
NADH + H+ NAD+ PQQ+ PQQH2j NAD+ . NADH +H+ NAD+ NADH +H+
(1) (2) (3) (4)
Assimilated into biomass
Figure 1.1 The pathway of methane oxidation in methanotrophs.
The four oxidation reactions are catalysed by (1) methane monooxygenase
(MMO), (2) methanol dehydrogenase (MOH), (3) formaldehyde
dehydrogenase (FOH) and (4) formate dehydrogenase (FAOH).
The four main enzymes involved in this pathway have been well characterised and are
discussed in more detail below.
1.4 MethaneMonooxygenase (MMO)
The first step in the methane oxidation pathway, the hydroxylation of methane to
methanol, is catalysed by the enzyme methane monooxygenase (MMO). There are
two distinct types of the MMO. These differ in cellular location and have been
identified in various methanotrophs as the cytoplasmic or soluble MMO (sMMO) and
the membrane-bound or particulate MMO (pMMO).
Virtually all methanotrophs possess the particulate MMO (pMMO) whereas the
soluble MMO (sMMO) is restricted to a limited number ofmethanotroph strains e.g.
Methylosinus, Methylocystis, Methylococcus species and some Methylomonas
(Shigematsu et al., 1999) and Methylomicrobium (Fuse et al., 1998) species. In
general, the sMMO is capable of oxidising a wide range of substrates including
alicyclic and aromatic substrates. However, the particulate enzyme can only oxidise a
narrow range of substrates that is restricted to alkanes and alkenes of up to five
carbons in length.
3
1.4.1 Soluble Methane Monooxygenase (sMMO)
The soluble methane monooxygenase (sMMO) has been well characterised from
Methylococcus capsulatus (Bath) (Colby and Dalton, 1978; Woodland and Dalton,
1984; Green and Dalton, 1985; Liu and Lippard, 1994) and Methylosinus
trichosporium OB3b (Fox et al., 1989; Lipscomb, 1993). The sMMO has also been
identified in other methanotrophs including Methylobacterium sp. Strain CRL-26
(Patel and Savas, 1987), Methylosinus sporium 5 (Pilkington and Dalton, 1991),
Methylomonas GYB (Liu et al., 1991) and Methylocystis sp. Strain M (Nakajima et
al., 1992). In general, the soluble MMO is a multi-component enzyme made up of
three distinct proteins (Figure 1.2) which include an hydroxylase (protein A), a
regulatory protein (protein B) and an NAD(P)H-dependent oxidoreductase (protein
C).
A
NADH+H+
Figure 1.2 Schematic model of sMMO from Methy/ococcus
capsu/atus (8ath) (adapted from Rosenweig et a/., 1993). Protein A,
Hydroxylase (green), oxidises methane at its hydroxo-bridged di-iron sites.
Protein B, Regulatory (purple), converts enzyme to oxygenase in presence
of substrate. Protein C, Reductase (blue), transfers reducing equivalents
from NADH to protein A.
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1.4.1.1 The hydroxylase component (Protein A)
The hydroxylase component (protein A) of sMMO from Methylococcus capsulatus
(Bath) is the site of substrate oxygenation and oxygen binding (Colby and Dalton,
1978) and contains a di-iron centre coupled via a u-oxo bridge structure (Wilkins,
1992). It exists as a dimer of molecular mass of ~250 kDa. Each monomer is
comprised of the three subunits, U (60 kDa), p (45 kDa), and y (20 kDa) in an U2P2Y2
configuration (Woodland and Dalton, 1989; Fox et al., 1989; Dalton et al., 1993).
1.4.1.2 The regulatory component (Protein B)
The precise role of the regulatory component (protein B) is still unclear although it is
now generally accepted that it plays several roles in regulating enzymatic activity,
converting sMMO from an oxidase to an oxygenase, altering the redox potential of
the di-iron site and promoting electron transfer between components of the sMMO
(Green and Dalton, 1985; Kazlauskaite et al., 1996; Liu and Lippard, 1991; Liu et al.,
1995). Protein B comprises of a single polypeptide of molecular mass 16kDa and
does not contain any prosthetic groups or metals (Green and Dalton, 1985; Liu and
Lippard, 1991). The protein undergoes multiple cleavage from the N-terminal to give
protein B derivatives and a loss of 12 amino acids results in the inactive protein B'
(Pilkington et al., 1990; Kazlauskaite et al., 1996; Lloyd et al., 1997; Shinohara et
al., 1998, Bhambra, 1996).
1.4.1.3 The NAD(P)H oxidoreductase (Protein C)
The role of the NAD(P)H-dependent oxidoreductase component (protein C) is to
accept electrons from NADH and transfer them to the di-iron site of the hydroxylase.
ProteinC is a single polypeptide of molecular mass ~39kDa, containing FAD and an
Fe2S2 centre which are essential for MMO activity (Colby and Dalton, 1978; Colby
and Dalton, 1979; Green and Dalton, 1985; Lund and Dalton, 1985; Lund et al.,
1985). The reductase component from Methylococcus capsulatus (Bath) was
inhibited by copper ions (Green et al., 1985) which may have important implications
in the regulation ofMMO activity by copper ions.
5
1.4.2 Particulate Methane Monooxygenase (pMMO)
The particulate methane mono oxygenase (pMMO) is not as well characterised as its
counterpart sMMO largely because of its lability in vitro. There has been recent
progress in the isolation of pMMO from various methanotrophs and this is discussed
in greater detail later on in this chapter (section 1.10)
1.5 Methanol dehydrogenase (MOH)
In Gram negative methylotrophs, the oxidation of. methanol to formaldehyde is
catalysed by the periplasmic enzyme, methanol dehydrogenase (MDH). MDH is a
quinoprotein containing pyrrolo-quinoline quinone (PQQ) as its prosthetic group. The
majority of methanol dehydrogenases have an approximate molecular mass of
.,
-140kDa and exist as an a2~2 heterotetramer (Nunn et al., 1989). The a subunit has
a molecular mass of ~60kDa and contains one molecule of non-covalently bound
PQQ and a calcium ion, both of which are essential for enzyme activity (Anthony et
al., 1994). The ~ subunit has a molecular mass of 8.5 kDa and is generally rich in
lysine residues (Patel and Felix, 1976; Anthony, 1986; Anthony et al., 1994; Anthony
and Ghosh, 1998).
Figure 1.3 Structure of methanol dehydrogenase prosthetic group,
pyrrolo-quinoline quinone (PQQ).
The physiological electron acceptor for MDH is the unique acidic cytochrome CL,
which subsequently interacts with the cytochrome aa, complex of the periplasmic
membrane (Nunn and Anthony, 1988). Although the location of the MDH is usually
associated with the periplasm, MDH activity has been observed in both the soluble
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and particulate fractions of type I and type X methanotrophs (Patel and Felix, 1976;
Grosse et al., 1997). Anthony (1986) proposed that MDH may be at least partially
bound to the membrane and could interact with electron transport chain components.
MDH can oxidise primary alcohols, short-chain aldehydes up to propionaldehyde but
not secondary alcohols and has the same rate of oxidation of methanol as
formaldehyde (Heptinstall and Quayle, 1970; Dunstan et al., 1972; Marison and
Attwood, 1982; Anthony, 1986).
1.6 Formaldehyde Dehydrogenase (FDH)
The oxidation of formaldehyde to formate is catalysed by the formaldehyde
dehydrogenase (FDH) enzyme. These enzymes are divided into two groups
depending on whether the electron acceptor is NAD+ or an artificial dye e.g. 2,6-
dichlorophenolindophenol.
Stirling and Dalton (1978) reported an NAD+-dependent FDH from Methylococcus
capsulatus (Bath) which required a protein cofactor for the oxidation of
formaldehyde. Tate and Dalton (1999) suggested that the protein cofactor known as
the 'modifier' was a small molecular mass protein (8kDa). In the presence of the
modifier, only the oxidation of formaldehyde was observed. However, the enzyme
was also able to oxidise several aldehydes and alcohols in the absence of the modifier.
The FDH was shown to exist as a homotetramer of 63kDa subunits in contrast to the
homodimeric structure suggested by Stirling and Dalton (1978). Preliminary N-
terminal sequence information obtained for the FDH and the modifier showed no
sequence similarities with other protein sequences available in the database (Tate and
Dalton, 1999).
However recent studies have shown that the FDH and modifier from Methylococcus
capsulatus (Bath) have great similarity to the large and small subunit of methanol
dehydrogenases from other methylotrophs (Adeosun, 2000). This study also suggests
that the source of NAD+-linked FDH activity was due to an enzyme similar to the
NADP-dependent methylene tetrahydromethanopterin dehydrogenase (I--4MPT-DH)
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which has been identified and purified from Methylobacterium extorquens AMI
(Chistoserdova et al., 1998; Vorholt et al., 1998).
The NADP-dependent methylene tetrahydromethanopterin dehydrogenase (RtMPT-
DH) enzyme catalyses the dehydrogenation of methylene RtMPT to methenyl
RtMPT. Unlike the enzyme from Methylobacterium extorquens AMI, the RtMPT-
DH from Methylococcus capsulatus (Bath) was able to catalyse the dehydrogenation
of methylene RtMPT using NAD+ as an electron acceptor. The enzyme is important
in the generation ofNADH from formaldehyde oxidation.
An alternate route for formaldehyde is for it to enter into the tetrahydrofolate (RtF)
pathway. The pathway for RtF-dependent and RtMPT -dependent formaldehyde
oxidation pathways are summarised in Figure 1.4.
1.7 FormateDehydrogenase(FADH)
Formate dehydrogenase catalyses the oxidation of formate from various metabolic
pathways. There have been two contradictory reports on the isolation of a
methanotrophic FADH from Methylosinus trichosporium OB3b (Yoch et al.; Jollie
and Lipscomb, 1991). The FADH was purified anaerobically by Yoch et al. (1990)
and existed in two different forms of molecular mass 315kDa and 155kDa although
both forms consisted of the same subunits a (~54kDa) and f3(~102kDa). The lower
molecular weight FADH existed as an af3 heterodimer and the higher molecular
weight FADH, as an a2f32 tetramer. The enzyme was found to require the flavin
mononucleotide FMN, for activity and contained nonhaem iron and acid-labile
sulphide.
These findings were in contrast to the FADH purified by Jollie and Lipscomb (1991),
which existed as 2 af3y8 protomers (a~98kDa, f3~56kDa, y~20kDa and ~12kDa)
containing iron, inorganic sulphide, molybdenum and a novel flavin cofactor.
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1.8 Background to methane monooxygenase (MMO)
The existence of the oxygenase was demonstrated in early studies concerning the
origin of the oxygen atom in methanol, which was believed to be derived from
molecular oxygen (Leadbetter and Foster, 1959). This was conclusively proven by the
incorporation of one atom from 1802 into methanol by Pseudomonas methanica and
Methanomonas methanooxidans cells confirming that the oxygen atom originated
from molecular oxygen not water (Higgins and Quayle, 1970).
The first report of methane-oxidising activity in a methanotroph was in cell-free
particulate preparations from Methylococcus capsulatus (Texas) cells by Ribbons and
Michalover (1970). The fraction was found to consist of extensive intracytoplasmic
membranes. The methane-stimulated NADH oxidising system gave a stoichiometric
relationship of oxygen and NADH consumption, that was proportional to the uptake
of methane supplied (Ribbons, 1975). This indicated that a monooxygenase enzyme
was involved in methane oxidation. Ribbons and Michalover (1970) also speculated
on the similarity of the methane-oxidising system with the ammonia-oxidising system
from Nitrobacter europaea and Nitrocystis oceanus.
Similar results were obtained by Ferenci using cell-free' particulate preparations of
Pseudomonas (now Methylomonas) methanica (Ferenci, 1974; Ferenci et al. 1975).
The particulate fraction was also found to catalyse the oxygen and NAD(P)H-
dependent disappearance of bromomethane in a stoichiometric relationship (Colby et
al., 1975). Comparisons with the inhibitorprofile obtained for the methane oxidising
system from Methylosinus trichosporium OB3b cells (Hubley et al. 1975), indicated
that the enzyme that catalysed bromo methane disappearance in vitro was also the
enzyme that catalysed methane oxidation in vivo.
The first report on methanol accumulation from methane was in particulate extracts
from Methylosinus trichosporium OB3b (Tonge et al., 1975). 150mM phosphate
buffer was use to inhibit methanol oxidase activity which could interfere in the
methanol production measurements. Values obtained for NADH and oxygen
consumption were high compared to the uptake of methane utilisation and methanol
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formation indicating that the stoichiometry was not consistent with a reaction
catalysed by a monooxygenase. However, it was suggested that the stoichiometry
would be consistent if methane caused redirection of the electron flow from
oxygenation to the methane oxygenase system (Higgins et al., 1976).
1.8.1 Location of the methane monooxygenase
Early reports suggested that the methane mono oxygenase could exist in different
intracellular locations in the cells from various methanotrophs. Stirling and Dalton
(1979) obtained a soluble version ofMMO from Methylosinus trichosporium OB3b,
which was previously thought to be located in the particulate fraction, and was found
to be similar to the enzyme from Methylococcus capsulatus (Bath). The soluble
MMO from Methylosinus trichosporium OB3b was found to exist under defined
growth conditions i.e. under methane or nitrate-limited growth conditions (Scott et
al., 1981a and b). During oxygen-limiting conditions the presence of intracytoplasmic
membranes and the particulate form of the enzyme were observed. However, when
oxygen limitation conditions were used by Stirling and Dalton (1979) only the soluble
MMO was observed suggesting that regulation of the intracellular location of the
MMO was due to some other factor.
Dalton et al. (1984) noted that soluble extracts from Methylococcus capsulatus
(Bath) cells that had been cultured in small shake flask cultures, did not have MMO
activity. However, when these cells were transferred into a lOO-litre fermenter for
growth, the resulting MMO activity was again detected in the soluble fraction. On
further examination, it was discovered that at biomass concentrations of <O.8g/l,
MMOactivity was entirely located in the particulate fraction. Above this biomass
concentration, MMO activity was increasingly located in the soluble fraction until at
1.6gll, when the MMO was located entirely in the soluble fraction. This demonstrated
that the intracellular switch for MMO location is related to biomass concentrations of
the cell culture. In addition to this, when the copper concentrations were increased
from O.2mg/ml to 1.2mg/ml in a I5-litre batch culture MMO activity was again
observed in the particulate fraction of the cell extracts at low biomass concentrations.
The soluble MMO activity was not detected until the biomass concentration reached
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1.4g/1 dry weight. This led to the proposal that the cellular location of MMO was
dependent on the concentration of copper in the growth medium. This was confirmed
by the observation that in steady state cultures grown under low copper: biomass
conditions, the soluble form (sMMO) was expressed and at high copper: biomass
conditions, the particulate or membrane-associated form (pMMO) was expressed
(Stanley et al., 1983, Prior and Dalton, 1985).
1.9 Regulation of MMO gene expression .
In methanotrophs which possess both pMMO and sMMO enzyme systems, e.g.
Methylococcus capsulatus (Bath) and Methylosinus trichosporium OB3b, copper is
believed to regulate MMO expression by a unique 'copper switch'. The exact
mechanism of this switch is' not known, although recent advances in the molecular
biology of both methane monooxygenases have given us a clearer insight into the
regulation ofMMO expression by copper ions.
1.9.1 Molecular biology of soluble MMO (sMMO)
The genes encoding the soluble MMO have been cloned and sequenced from several
methanotrophs including Methylococcus capsulatus (Bath) (Murrell, 1993 and 1994).
Northern blotting and primer extension analysis using Methylococcus capsulatus
(Bath) showed that the six open reading frames (ORFs) of the sMMO gene cluster
are organised as an operon. The sMMO gene cluster (Figure 1.5) consists of the
mmoX, mmoY and mmoZ genes, which encode the a, p and y subunits of the
hydroxylase respectively. An open reading, frame (ORF) orf Y; separates mmo Y and
mmoZ and has no known function. The mmoB and mmoC genes encode protein B
and C respectively. Transcription of the sMMO genes was only observed under low
copper : biomass conditions (Neilsen et al., 1996a). Primer extension analysis
identified a cr54_like promoter immediately upstream of the mmoX transcription start
site inMethylosinus trichosporium OB3b.
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Figure 1.5 Schematic diagram depicting the soluble methane
monooxygenase gene cluster and the corresponding expression of the
sMMO subunits, Protein A (a,f3,y), Band C.
1.9.2 Molecular biology of pMMO
The pmoA and pmoB genes, which encode the f3 (27kDa) and a (46kDa)
'switchover' polypeptides of pMMO subunits respectively, were sequenced and
cloned from Methylococcus capsulatus (Bath) (Semrau et al., 1995a). An
oligonucleotide probe, designed from the N-terminal ,sequencing of the putative
46kDa polypeptide of pMMO, was hybridised to the chromosomal DNA digest from
Methylococcus capsulatus (Bath). A 2.1kb region of DNA was identified and was
found to contain both the pmoA and the pmoB genes. A third open reading frame,
designated pmoC which encodes the y (25kDa) protein of pMMO was also sequenced
(Costello et. al., 1995; Stolyar et al., 1999). There are two virtually identical copies
of the genes encoding pMMO (pmoCAB) in the chromosome of Methylosinus
capsulatus (Bath) and a third, separate copy of pmoC has also been identified
(Semrau et al., 1995a; Costello et. al., 1995; Stolyar et al., 1999).
The open reading frames for the pmoCAB genes are contiguous on the chromosome
of Methylococcus capsulatus (Bath) (Figure 1.6) and are transcribed into the same
mRNA. Smaller transcripts of individual genes have also been detected and gene
specific probing indicated the presence of a transcript encoding pmoCA (Nielsen et
al., 1996b). The pmo genes have also been cloned and sequenced from Methylosinus
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trichosporium, OB3b and Methylocystis sp. strain M (Finch, 1997 and Gilbert et al.,
2000).
I I I
Figure 1.6 Schematic diagram of the pmo gene cluster from
Methy/ococcus capsu/atus (8ath) and the corresponding pMMO
hydroxylase subunits (a, f3 and y) expressed. P = Putative promoters.
The presence of multiple gene copies has also been observed encoding the analogous
enzyme, ammonia mono oxygenase (AMO) (Sayavedra-Soto et al., 1996). A
comparative study was carried out on pmo and, amo genes from various
methanotrophs and nitrifiers from a,f3,y subdivisions of Proteobacteria. Degenerate
oligonucleotide primers, designed from homologous regions of pmoA and amoA
sequences were used to amplify pmo and amo gene sequences. Analysis revealed
strong conservation between the sequences. The amoA from Nitrosococcus oceanus
showed higher identity to pmoA sequences from other y-Proteobacteria than
sequences of amoA. This provided evidence that pMMO and AMO are evolutionarily
related despite their different roles in methanotrophs and ammonia-oxidising bacteria
(Holmes et al., 1995; Murrell and Holmes, 1996).
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1.9.3 Models of the 'copper switch' mechanism
Neilsen et al. (1996) identified a 5.5kb transcript in copper-depleted Methylococcus
capsulatus (Bath) cultures, which was thought to encode the entire sMMO operon.
Fifteen minutes after the addition of copper sulphate to these steady-state
Methylococcus capsulatus (Bath) cultures, this transcript could no longer be
detected. Since the growth of cells was unaffected it was thought that copper might
be repressing the transcription of the sMMO operon. Similar results were seen with
Methylosinus trichosporium OB3b where the repression of the sMMO transcription
was concomitant with the appearance of pmo transcripts.
The exact mechanism for the reciprocal regulation of the sMMO and pMMO operons
by copper ions is not fully understood. Neilsen et al. (1996a) proposed a hypothetical
classic repressor model for the possible role of copper in the transcriptional regulation
of the smmo gene cluster (Figure 1.7). At high copper growth conditions, the
transcriptional regulator protein binds Cu2+ ions causing a conformational change and
allowing it to bind to the operator regions on the promoter, which in turn blocks the
transcription of the smmo genes.
Murrell et al. (2000) proposed a number of models for reciprocal regulation of the
pmo and smmo operons. One probable model involves the positive control of sMMO
gene regulation, where Cu2+ binds and inactivates an 'activator protein'. This model is
preferred as there is evidence to suggest that all known (}'54 promoters rely on
activator proteins for transcription (Westen, 1998).
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regulator
b) Transcriptional
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Figure 1.7 Model proposed for reciprocal transcription of the smmo
operon. (Adapted from Charlton, 1997). In the absence of copper the
transcriptional regulator is not able to bind to the operator sequence (0) of
the (J54 promoter and the RNA polymerase transcribes the smmo operon. In
the presence of copper, the transcriptional regulator binds to the operator
sequence of the promoter and the transcription of smmo genes is repressed.
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1.10 Isolation of the particulate methane monooxygenase
The purification of the particulate methane mono oxygenase (pMMO) has been
hindered by the lack of activity of the enzyme in vitro. Recently, however there has
been significant progress made in this field.
An active pMMO complex from Methylosinus trichosporium OB3b was isolated
using the solubilising agent phospholipase D (Tonge et al., 1975 and 1977). The
complex could use various electron donors apart from NADH (in particular
ascorbate) via a soluble CO-binding cytochrome-c, which was essential for pMMO
activity. The mono oxygenase unit was shown to consist of two proteins of molecular
weight 46 and 9.4kDa. The cytochrome (12.5kDa) was proposed to be the in vivo
..
electron donor. They also found that methanol could serve as the electron donor to
the pMMO. From their findings, Tonge et al. (1977) proposed a mechanism (Figure
1.8) by which electrons derived from methanol and formaldehyde oxidation, were
recycled back to the monooxygenase. Attempts to reproduce this work were
unsuccessful by other groups and, after a while, the authors themselves could not
repeat this work (Higgins et aI, 1981b).
NAD+ NADH + H+
o, J20 ~
CI\ \. ~CH30H---.HCHO---. HCOOII\.. r~ CO2
Methane Methanol Formaldehyde Formate
~~ ..
Pteridine
rAscorb~te
'------Cytochrome Ceo .i
.. ~XH2
O2 ._ NADH .......1-----'....
Figure 1.8 Tentative mechanism for methane oxidation adapted from
Tonge et al. (1975). Electrons derived from methanol and formaldehyde
oxidation are recycled in to the methane oxygenation reaction via the
immediate physiological electron donor, the CO-binding cytochrome-c,
which is reduced in turn by methanol dehydrogenase.
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Gvozdevand coworkers (1984) solubilised a pMMO complex from Methylococcus
capsulatus (Strain M) using the detergent sodium deoxycholate. They proposed that
upon solubilisation an inhibitor was released, which could inactivate the enzyme. This
could be overcome if the solubilisation was carried out in the presence of
hydroxyapatite since the inhibitor preferentially reacted with the adsorbent. They then
went on to purify a complex by ion exchange chromatography (Akent'eva and
Gvozdev, 1988). The complex was found to be composed of a mono oxygenase
component and an NADH oxidoreductase and had a specific activity of
3600nmoles/min/mg based on the disappearance of methane.
Smith and Dalton (1989) were the first to attempt a detailed purification of the
-
pMMO from Methylococcus capsulatus (Bath). In their studies they used the non-
ionic detergent dodecyl-J3-D-maltoside to solubilise the enzyme system at a detergent:
protein ratio of 0.5. No activity was detectable in the directly solubilised fraction
using a variety of electron donors including NADH and ascorbate. However, removal
of the detergent using Bio-Beads SM2 and addition of the egg or soya bean lecithin
restored enzyme activity. Attempts to further purify the solubilised MMO were
unsuccessful and resulted in inactivation of the enzyme. The enzyme was found to
consist of the polypeptides 49, 23 and 22kDa. The" loss of enzyme activity on
solubilisation was proposed to be due to the detergent-induced disruption of the
electron transport chain from NADH to the pMMO.
Shiemke et al. (1995) published details of a reproducible method for the solubilisation
of pMMO from Methylococcus capsulatus (Bath) based on the earlier work of Smith
and Dalton (1989). In this study, a variety of reduct ants were tested for their ability to
donate electrons to solubilised pMMO. Various quinols, in particular the plastoquinol
analogues, duroquinol and decyl-plastoquinol (Figure 1.9) were found to be most
effective, whereas ubiquinone analogues were ineffective as electron donors to
pMMO. They found that a detergent : protein ratio of 1.7 was optimal for
solubilisation of an active pMMO.
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Figure 1.9 Structures of the plastoquinol analogues duroquinol and
decyl-plastoquinol
The ability of plastoquinol analogues to serve as reductants for pMMO electrons was
proposed to be due to their similarity in structure and redox potential to the in vivo
electron donor, which was not identified in their study. In whole cells of
Nitrosomonas europaea (Shears and Wood, 1986) quinols could act as reductants to
the analogous enzyme, ammonia monooxygenase. The rate of reduction of the
endogenous quinone pool was inversely proportional to the redox potential of the
exogenous quinol. No such correlation was observed with pMMO indicating that it
was unlikely that the quinols were interacting with pMMO via an endogenous
quinone pool, which would have been depleted in solubilised extracts anyway.
Shiemke and coworkers (1995) proposed that the quinol was interacting directly with
the pMMO or a pMMO reductase closely associated with pMMO.
Shiemkeand co-workers (Cook and Shiemke, 1997) also observed that the addition
of catalytic amounts of exogenous quinones in solubilised extracts could restore the
role of NADH as a reductant to pMMO. This indicated that an NADH:quinone
oxidoreductase might be involved in the reduction ofpMMO by NADH in vivo. They
also claimed to have purified small amounts of a NADH:quinone oxidoreductase
(36kDa) which was thought to mediate this reaction, although there have been no
subsequent reports on the isolation of this enzyme.
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The pMMO from Methylococcus capsulatus (Bath) was purified usmg aruon
exchange and hydrophobic interaction chromatography columns under anaerobic
conditions (Zahn and DiSpirito, 1996). The anaerobic conditions were necessary to
maintain enzyme activity. Methylococcus capsulatus (Bath) were grown with high
copper and high iron concentrations in the growth medium to achieve optimal cell-
free pMMO activity. The pMMO was solubilised using dodecyl-If-Dcmaltoside and
duroquinol was used as the reductant in propylene oxidising activity assays.
The enzyme consisted of three polypeptides of molecular masses 46, 27 and 25kDa
and contained 14.5 copper and 2.5 iron atoms per 99kDa of enzyme. The enzyme had
a specific activity of approximately 11 nrnoles/rnin/mg. The 47 and 27kDa switchover
-
polypeptides were isolated after Triton X-lOO or CHAPS solubilisation, using a
sucrose gradient and were found to contain one nonhaem atom, one copper atom and
one acid-labile sulphur. Two contaminating polypeptides (37 and 20kDa) that co-
purified with the pMMO were identified as cytochrome b-559/569. Efforts to remove
these polypeptides resulted in a total loss of activity. They also observed copper
binding cofactors (CBCs) of molecular mass 618Da, associated with the pMMO,
which were believed to have a role in sequestering copper. A model was proposed
based on these findings (Figure 1.10).
A 8
Figure 1.10 Proposed mechanism of methane oxidation by pMMO.
Using duroquinol as a reductant with (A) cytochrome b-559/569 as the initial
electron donor and with (8) duroquinol oxidised directly by the pMMO.
(adapted from Zahn and DiSpirito, 1996)
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Recently, Nguyen et al. (1998) published protocols to purify the pMMO hydroxylase
from Methylococcus capsulatus (Bath) using either ion exchange or affinity
chromatography under anaerobic and partially anaerobic conditions. Cultivation of
Methylococcus capsulatus (Bath) cells was optimised to obtain maximal pMMO
activities. The enzyme was solubilised using dodecyl-B-Dcmaltoside and NADH was
used as the reductant in activity assays. The purified enzyme had specific activities of
2-5 nmoles propylene oxide produced/minlmg. The hydroxylase was composed of
subunits of molecular mass 46, 26 and 23kDa, designated a, P and y respectively. In
addition to this they also found a proteolytically-cleaved version of the enzyme a',
with a molecular mass of 35kDa. Metal analysis of the pMMO showed it had
approximately 12-15 copper ions per 94kDa monomeric unit but no iron was detected
in these preparations.
Nguyen et al. (1998) proposed that a pMMO reductase must exist since NADH is a
two electron donor and each copper is a one electron acceptor. Therefore a mediator
would be required to pass electrons one at a time to the recipient pMMO. They also
claim to have purified an NADH-oxidoreductase, which can be added back to the
purified pMMO to enhance NADH-linked activity (Nguyen et al., 1998). As yet,
details for the purification of the NADH-oxidoreductase have not been published.
The purification of the pMMO from Methylococcus trichosporium OB3b was carried
out by -Takeguchi et al. (1997 and 1998a). Dodecyl-B-Dcmaltoside was used to
solubilise the enzyme which was then.purified by chromatographic methods. The
molecular weight of the enzyme was estimated to be 326kDa by gel filtration, and
was comprised of two subunits with molecular masses 25 and 41kDa, with a trace of
a contaminating polypeptide (26kDa). The enzyme was found to contain 0.9 iron
atoms and 12.8 copper atoms per molecule.
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1.11 Properties of the pMMO
1.11.1 Substrate analysis of the pMMO
Smith and Dalton (1989) performed substrate analysis studies on pMMO-containing
membranes and solubilised pMMO from Methylococcus capsulatus (Bath). They
found that n-alkanes up to and including butane were oxidised efficiently with a
preference for hydroxylation at the C-2 position.
The epoxidation of substrates, such as propylene and butene, was also observed.
Epoxidation of propylene gave only propylene oxide as a product and this reaction is
currently used as a standard activity assay for MMO. The epoxidation and oxidation
of l-butene was observed, resulting in the formation of 3-buten-2-ol. Both but-2-ene
-
isomers were oxidised by the pMMO. The cis-but-2-ene underwent an epoxidation
reaction whereas the trans-but-2-ene underwent an epoxidation reaction as well as
terminal oxidation yielding a crotyl alcohol. This is in contrast to the findings of
Nguyen et al. (l996a) where only the epoxidation reaction was observed for both the
but-2-ene isomers in pMMO-containing membranes from Methylococcus capsulatus
(Bath). Nguyen et al., (1996a) also found that propane was only oxidised to propan-
2-01, which is in contrast to the findings of Smith and Dalton (1989) where both the
propan-l-ol and propan-2-ol were produced.
Using stereochemical analysis, Nguyen et al., (l996a) found that substrates of three
carbons or higher were generally oxidised to (R)-2-alcohols with virtually no
detectable primary alcohol product. This chiral distribution of products demonstrated
that the pMMO exhibited regioselectivity,
1.11.2 Metal components associated with of pMMO
Electron paramagnetic resonance (EPR) investigations have been carried out on
particulate MMO from various methanotrophs and are discussed here briefly and in
more detail in Chapter 5 of this thesis. EPR spectroscopy is a useful technique for
investigating the ligand environment of metals in a metalloprotein.
The most controversial EPR studies on pMMO were carried out by Chan and co-
workers on pMMO-containing membranes and the purified enzyme (Chan et al.,
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1993; Nguyen et al., 1994, 1996a, 1996b, 1998). Although they observed a type-2
copper EPR signal in their pMMO samples, when pMMO was oxidised with
ferricyanide, this signal gave rise to a broad isotropic signal which was proposed to be
due to a trinuclear copper cluster. Subsequent analysis of the enzyme showed that the
pMMO contained 15-21 copper ions arranged in 5-7 mixed-valence trinuclear copper
clusters. They postulated that these trinuclear copper clusters could be classified into
groups according to their role in catalysis (C-clusters) and electron transfer (E-
clusters). The 2-3 C-clusters were proposed to fuaction as the catalytic core of the
enzyme and the 3-4 E-clusters were presumed to be the source of endogenous
reducing equivalents (Nguyen et al., 1996b).
Zahn and DiSpirito (1996) presented an alternative model in which the enzyme
involves both iron and copper. Their EPR spectra were consistent for a type 2 copper
centre but also gave a weak high spin iron signal (g=6.0) and a broad low field signal
at g=12.5. The low-field signal is typical for a protein containing a diferric cluster e.g.
soluble methane mono oxygenase although DiSpirito and coworkers dispute this. Zahn
and DiSpirito (1996) also suggest that the loosely bound copper ions associated with
copper binding cofactors (CBCs) may be responsible for the broad isotropic signal
observed by Chan and coworkers.
Similar findings of a trinuclear copper cluster model for pMMO has only been
reported for the enzyme from Methylosinus trichosporium OB3b (Takeguchi et al.,
1997 and 1999). Takeguchi and coworkers (1997, 1998 and 1999) also suggested the
existence of two classes of trinuclear copper clusters with similar roles as previously
proposed by Chan and coworkers. However, a high spin iron signal was also
observed, which was proposed to originate from the active site ofpMMO, since when
duroquinol or acetylene were added to the pMMO sample, the high spin iron signal
decreased.
Antholine and coworkers (Yuan et al., 1997, 1998a and b, 1999; Lemos et al., 2000)
carried out X-band and S-band EPR studies on whole cells and membranes from
Methylococcus capsulatus (Bath) and Methylomicrobium albus B08, which were
grown in media enriched with 63CUand 15N. They concluded that their S-band EPR
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spectra unambiguously established that there was one cupric ion co-ordinated to four
nitrogen donor atoms i.e. a type 2 copper.
1.11.3 Active site of pMMO
The 47kDa and 27kDa polypeptides are believed to be the polypeptides expressed
when the cells switch from soluble MMO expression to particulate MMO and are
known as the 'switchover polypeptides'. Studies have been carried out on the pMMO
from Methylococcus capsulatus (Bath) using radio-labelled acetylene, which is a
suicide substrate of pMMO as it binds irreversibly to the active site of pMMO thus
inactivating it (Prior and Dalton, 1985b). The resultant banding patterns were
analysed by SDS-PAGE and fluorography and showed that the 14C-acetylene bound
"
irreversibly to the 26kDa polypeptide of pMMO, which was therefore proposed to
contain the active site. This phenomenon has been observed in both soluble and
particulate MMO from other methanotrophs (DiSpirito et al., 1992) and ammonia
monooxygenase (AMO) from nitrifiers e.g. Nitrosomonas europaea (Hynes and
Knowles, 1982). However, recent studies by Zahn and DiSpirito (1996) demonstrated
that the 47kDa subunit of pMMO from Methylococcus capsulatus (Bath) was also
labelled by 14C-acetylene and was thought to be due to the increased sensitivity of the
phosphorescence image technique over fluorograms. Similar findings were also
observed in ammonia mono oxygenase of the Nitrosomonas europaea (Hyman and
Arp,1992)
The 47kDa a subunit and 27kDa ~ subunit contain six and five histidine residues
respectively in their protein sequences (Semrau et al., 1995). Seven of these
histidines are conserved when compared to the protein sequence of ammonia
monooxygenase from Nitrosomonas europaea (Bergmann and Hooper, 1994;
McTavish et al., 1993). This indicates that they may have an important role i.e. in
copper ligation. This is in agreement with the findings of Elliot et al. (1998), who
performed pulsed EPR studies on pMMO membrane samples from Methylococcus
capsulatus (Bath). Their data supported histidine ligation to EPR-detectable copper
and the copper sites were proposed to be in the 27kDa ~ subunit involving the His38,
His40 and/or His 168 at the membrane-periplasmic interface.
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However, Yuan et al. (1999) proposed that the a subunit of pMMO contained a
potential type 2 site for Cu2+ as it had a conserved histidine (His33) as the amino-
terminal residue after the putative leader sequence. Therefore, they used a synthetic
amino acid fragment designed from the first twenty amino acids of the amino terminal
of the a subunit of pMMO from Methylococcus capsulatus (Bath). When copper ions
were added to the synthetic peptide, EPR signals similar to those usually associated
with the pMMO were observed. They suggested that the amino-terminal end in the a
subunit would be a good bidentate chelator, as depicted in Figure 1.11, and if the
47kDa subunit existed as a dimer, the cupric ion could stabilise the dimer by
coordination with four approximately equivalent nitrogen donor atoms.
Figure 1.11 Schematic diagram for the binding of cupric ion to the
amino-terminal sequence for which histidine is the first amino acid
(adapted from Yuan et al., 1999). Nitrogen donor atoms from the imidazole
of histidines provide the third and fourth nitrogen donor atoms. Alternatively,
another bidentate amino-terminal histidine of another a subunit could
complete the square planar configuration resulting in the formation of cis
and trans dimers.
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1.12 Scope of this thesis
Although there has been significant progress in the elucidation of the particulate
methane mono oxygenase (pMMO) from Methylococcus capsulatus (Bath) the recent
reports by Zahn and DiSpirito (1996) and Nguyen et al. (1998) have given rise to
some confusion in this field. Therefore, the aims of this PhD project were:
1) To develop a reproducible method for the isolation of the pMMO to obtain a high
specific activity enzyme.
2) To undertake basic characterisation of the pMMO.
3) To conclusively establish the nature of the metals associated to the pMMO.
4) To investigate the structure of the membrane-bound and purified pMMO
complex.
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2. Materials and Methods
2.1 Chemicals and Biochemicals
All chemicals were of analytical grade and obtained from BDH Chemicals Ltd.,
Dorset, UK; Boehringer Mannheim UK (Diagnostics and Biochemicals) Ltd., East
Sussex, UK; Sigma-Aldrich Chemical Company Ltd., Dorset, UK. Dodecyl-p-D-
maltoside was of UItrol grade and was purchased from Calbiochem (California,
USA). Argon, hydrogen, methane/carbon dioxide and nitrogen were of technical
grade and obtained from Linde Gas Ltd., Stoke on Trent, UK.
2.2 Methanotroph
Methanotroph strains Class
Methylomicrobium album BG8 Type I
Methylosinus trichosporium OB3b Type II
Methylococcus capsulatus (Bath) Type X
All methanotrophs were obtained from the University of Warwick culture collection.
2.3 Growth and maintenance of micro-organisms
All media were made using distilled water and autoclaved for 20 minutes at 121DC
and 15 1b/in2• Volumes greater than 5 litres were sterilised by autoclaving for 60
minutes at 121DC and 151b/in'and were allowed to cool overnight. Heat labile
solutions were sterilised using 0.2J.tm, pore-size disposable sterile filter units
(Millipore, Watford, UK).
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2.3.1 Culturing Methanotrophs
Methanotrophs were grown in Nitrate Minimal Salts (NMS) medium (Whittenbury et
al., 1970). The constituents of the stock solutions are given in Table 2.1
NMS MgS04 1 g r'
KN03 1g r'
*Trace element solution
.'
0.2 g r'
1m1 r'
0.5 mg rl
3.8 mg r'
NaMo04.2H20
FeEDTA
CuEDT A can also been used to replace FeEDT A
*Trace element
FeS04.5H2O 0.5 g rl
ZnS04.7H2O 0.4 g rl
H3B03 0.015 g r'
CoCb.6H2O 0.05 g r'
Na2EDTA 0.25 g r'
MnCb.4H2O 0.02 g r'
NiCh.6H2O 0.01 g r'
CuS04.5H2O 0.5/1.5 g r'
Phosphate buffer KH2P04 26 g litre"
NaHP04.I2H2O 71.6 g litre"
Table 2.1 Constituents of the stock solutions of NMS media.
The higher concentration of copper sulphate (1.5grl) was used in the trace elements
solution when particulate methane monooxygenase expressing cells were grown. This
was added to the media after autoclaving. For preparation of sterile solid NMS, 2 %
(w/v) Bacto-agar (Difco) was added to the basic NMS medium prior to sterilisation.
With both types of media, phosphate was autoclaved separately to avoid precipitation
and added to the NMS media after cooling.
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2.3.2 Maintenance of Methanotrophs
Cultures of methanotrophs were maintained on NMS agar plates as described by
Whittenbury and Dalton (1981). Culture plates were placed in plastic Tupperware™
boxes, gassed with methane/carbon dioxide mixture, sealed and incubated at 30°C for
Methylosinus trichosporium, OB3b or 45°C for e.g. Methylococcus capsulatus (Bath)
for 3-5 days.
Small-scale growth of methanotrophs was carried out in 250ml 'Quickfit flasks'
(Fisher Scientific UK Ltd) containing 50ml of NMS medium. Flasks were inoculated
with a single colony of the methanotroph of choice and aseptically sealed with rubber
suber-seals (W.H. Freeman, Barnsley, UK). 60ml of air was removed from the flask
and 60ml of methane/Co, mixture (95% and 5%, v/v, respectively) was injected.
Cultures were incubated for 3-5 days, shaking at 200rpm, at 30°C or 45°C.
2.3.2.1 Continuous fermentation of methanotrophs
500ml of a starting culture was used to inoculate the fermenter (LH 2000 or LH 210
series fermenter, L.H. Engineering). When the culture had reached an OD55o of 6, a
steady state was maintained by automatic addition of media and simultaneous
overflow of cultures into a 20 litre vessel. Working volumes of between 2-4 litres of
media with a dilution rate of 0.05 hr" were used. Methane (20 %, v/v, in air) was
supplied as the sole carbon source. The culture was grown at the appropriate
temperature and maintained at a neutral pH.
Cells were harvested from the 20 litre overflow vessel by centrifugation at 3000 x g in
a Westfalia continuous centrifuge (Westfalia Separator Ltd, Milton Keynes, UK).
Harvested cells were resuspended in the appropriate buffer.
2.3.2.2 8atch growth of Methy/ococcus capsu/atus (8ath)
Large-scale batch growth of Methylococcus capsulatus (Bath) was performed in a
lOO litres fermenter (LH Engineering Ltd, UK). NMS medium was supplemented
with an additional 1.0 g litre" KN03 to prevent cells from becoming nitrate limited
during the later stages of growth (Charlton, 1997). The fermenter was inoculated
with 10 litres of a continuous culture overflow. Methane was provided as a
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methane/air mixture (20%, v/v, in air). Cells were harvested after an OD550 of 7 was
obtained (for pMMO expressing cells) by centrifugation at 3000 x g in a Westfalia
continuous centrifuge (Westfalia Separator Ltd, Milton Keynes, UK). Harvested cells
were resuspended in the appropriate buffer.
2.3.2.3 Analysis of culture purity
Cultures of methanotrophs were routinely checked for purity by streaking on to
nutrient agar (NA) plates (Sambrook et al., 1989). ~lates were incubated aerobically
at 30°C for a couple of days. Growth of colonies on NA plates indicated
contamination. Contamination was verified by phase contrast microscopy.
2.4. Preparation of c~1I free extracts
Particulate extracts were initially prepared as described by Charlton (1997). Modified
procedures used in this study are described below and in Chapter 3.
2.4.1 Preparation of sMMO extracts
sMMO whole cells were harvested at 10,000 x g for 15min at 4°C. The cells were re-
suspended in of 25 mM 3-[N-morpholino ]propanesulfonic acid, sodium salt (MOPS)
buffer pH7 containing 1mM benzamidine, 5mM D, L-dithiothreitol (DTT) and 5mM
sodium thioglycollate. A few crystals of Deoxyribonuclease I (DNAse I) were added
to the cells before passing them two times through a pre-cooled cell disrupter
(Constant Systems Ltd., UK) at a pressure of 172 MPa. The resulting cell suspension
was centrifuged at 38,000 x g for 45 minutes at 4°C. The supernatant was drop frozen
and could then be stored at -80°C until further use.
2.4.2 pMMO extracts
Cells expressing pMMO were harvested by centrifugation at 10,000 x g for 15
minutes at 4°C and resuspended in 25mM Piperazine-N, N'-bis[2-ethanesulfonic acid,
disodium salt] PIPES buffer, pH7.25. A few crystals of DNAse I and 1mM
benzarnidine were added to the cell suspension and the cells were then broken by two
to three passes through a Constant cell disrupter at 172 MPa until a smooth paste was
obtained. Unbroken cells and cell debris were removed by centrifugation at 10,000g
for 30 minutes.
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2.5 Isolation of intracytoplasmic membrane (ICMs)
Intracytoplasmic membranes (ICMs) were collected by centrifugation at 150,000 x g
for 60-90 minutes (depending on volume) at 4°C and the pellet containing the ICMs
was resuspended in 25mM Pipes, pH7.25, 0.5M NaCI and ImM benzamidine. This
process was repeated at least twice to remove soluble proteins until the supernatant
was clear, before finally resuspending the pellet in 25mM Pipes pH7.25, 0.5M NaCI
and 1mM benzamidine. The membrane-bound pMMO extract (pMMOm) was assayed
for activity (Section 2.9.2) could then be drop frozen, in liquid nitrogen and stored at
-80°C until further use.
2.5.1 Sucrose gradient sedimentation
A 20-60% sucrose step gradient was prepared by making up the appropriate %
solutions of sucrose in 10mM Pipes, pH7.25 (using a refractometer for accuracy).
The solutions were then slowly layered into Beckman SW41Ti centrifuge tubes
starting with a 60% sucrose cushion. lrnl of membrane sample (50mg/ml) was applied
to the top of the gradient. The tubes were centrifuged for 14 hours at 38,000rpm at
4°C in a Beckman ultracentrifuge. Membrane fractions (gelatinous masses) were
decanted slowly and assayed separately for enzyme activity using gas phase activity
assays.
2.5.2 Triton separation of ICMs
For preferential solubilisation of inner membranes triton X-lOO and X-114 (Sigma)
were used (Fjellbirkeland et al., 1997). This was carried out by resuspending the
particulate extract (Section 2.4.2) in a ~orking buffer containing 2% (v/v) Triton.
The resulting suspension was stirred at room temperature for 1 hour, centrifuged at
100,000 x g for 1 hour and the soluble fraction containing ICMs was collected,
assayed for activity and analysed by SDS-PAGE.
2.6 Solubilisation of ICMs
The particulate extract was thawed and assayed for activity. Extracts with high
specific activities (>75nmoles of propylene oxide produced/minlmg of protein) and
consisting of at least 60% of the polypeptides associated with pMMO (as analysed by
SDS-PAGE) were used for the solubilisation stage. The extract was centrifuged at
150,000 x g for 30 minutes at 4°C. The pellet was resuspended in a freshly made
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buffer of 2SmM Pipes pH7.2S, O.SM NaCI and ImM benzamidine. Copper sulphate
was added to give a final concentration of 40f.lM.
Solubilisation was performed by adding the dissolved anionic detergent dodecyl-Bvlz-
maltoside to give a detergent:protein ratio of 1.5, to the particulate extract. The
detergent was added drop-wise, whilst stirring constantly on ice. The particulate
extract was then left for l hour on ice with continuous but gentle stirring. After this
time the extract was then centrifuged at IS0,000 x g for 90 minutes. The solubilised
extract was assayed for propylene oxidising activity using duroquinol as the reductant
and analysed by SDS-PAGE. Solubilised pMMO (pMMOS) extracts were drop-frozen
in liquid nitrogen and stored at -80°C until further use.
2.7 Purificationmethods
Fast Protein Liquid Chromatography (FPLC) equipment, columns and accessories
used in this study were obtained from Amersham Pharmacia Biotech (St Albans, UK).
Chromatographic procedures for protein purification were performed on a Pharmacia
'FPLC Basic' system, complete with two P-SOOpumps, an LCC SOOprogrammable
pump controller, a monitor UV-M detector system, and a FRAC-I00 fraction
collector. The media were packed into the Pharmacia XK columns. All FPLC
columns were washed with two column volumes of degassed distilled water before
equilibrating with the appropriate buffer before each purification run. Purification
procedures were carried out as described by Zahn and DiSpirito (1996), Charlton,
(1997) and Nguyen et al., (1998) under anaerobic and aerobic conditions. When
.,
isolation was performed under anaerobic conditions the working buffers were firstly
degassed, either SmM dithionite or ascorbate was added and then the buffer was kept
deoxygenated by constantly bubbling argon through the buffer. The buffers were
tested for 'anaerobicity' using a solution of the indicator methyl viologen (Sigma).
The anion exchange chromatography media used was DEAE-Cellulose, DES2 and
DEAE-Sepharose, CL-6B (Whatman). The hydrophobic interaction chromatography
(HIC) media used in this study was Phenyl Sepharose High Performance or Phenyl
Sepharose CL-4B (Amersham Pharmacia Biotech). Procedures were carried out as
described by Zahn and DiSpirito (1996), Charlton (1997) and Nguyen et al. (1998). A
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working buffer of 10mM Pipes, pH 7.25 was used with an increasing salt or detergent
gradient to elute bound proteins from the column.
Lysine-Agarose (Sigma) affinity columns were used in this study in a procedure
similar to that described by Nguyen et al. (1998). A salt gradient was used to elute
bound proteins from the column.
Superdex 200 preparative grade (Amersham Pharmacia Biotech), either XK 26/600.
(2.6 x 68cm) and XK 16/200 (1.5 x 68cm), depending on the concentration of protein
was used during purification. Calibration of the Superdex 200 for molecular weight
estimation was carried out by equilibrating the column with 10mM Pipes, pH7.25
containing 0.01% dodecyl-f-Demaltoside. The molecular weight determination of
pMMO was made by comparing the ratio ofVeNo ofpMMO with the ratio ofVeNo
of five proteins of known molecular mass (BIORAD calibration kit), where Ve is the
elution volume and Vo is the void volume of the column. The void volume was taken
as the elution volume required for the elution of Blue Dextran (M, 2000kDa) from the
column. A calibration curve was prepared by plotting the logarithms of the known
molecular weights of the protein standards against their VeNo values. The
corresponding molecular mass could then deduced from the calibration curve by using
the experimental VeNo ofpMMO.
Protein samples were desalted using disposable PD 10 or 025 columns desalting
media (Amersham Pharmacia Biotech) under gravity feed. Elution volumes shown in
typical FPLC traces are measured after the void volume of the column.
2.8 Isolation of the pMMO complex
Solubilised pMMO was concentrated using an Amicon stirred cell with XM50 filter
(Amicon Corporation, Danvas, M.A.) to 20mg/ml (further concentration at this stage
can lead to precipitation). The concentrated extract was then filtered through a
0.2JlM Whatman syringe filter and applied to a pre-cooled (4°C) Superdex 200
column (1.5 x 68 cm) which was equilibrated in 25mM Pipes buffer, pH7.25
supplemented with 0.03% dodecyl-Bvd-maltoside and 1mM benzamidine. The column
was run at a flow rate of l.5ml/min.
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Fractions containing pMMOH were pooled from numerous S200 runs and finally
concentrated using an Arnicon stirred cell concentrator with an XM50 filter
membrane to give >50mg/ml of protein. The protein was then re-applied to the S200
column. Fractions containing the pMMO were collected and concentrated using an
Arnicon stirred cell with a XM50 ultrafiltration. The sample could then be drop frozen
in liquid nitrogen and stored at -80°C until further use. The sample could then be
analysed by electron microscopy to ensure complex homogeneity .
.'
2.8.1 Separation of components of the pMMO complex
A DEAE-cellulose, DE52 (Whatman) ion exchange column (1.5 x 15cm) was used to
separate the components of the pMMO complex. Concentrated pMMO complex
obtained from the S200 column (> 15mg/ml) was then filtered through a 0.2 JlM
syringe filter and applied to a cooled (4°C) DE52 column which was equilibrated in
10mM Pipes buffer, pH7.25 supplemented with 0.01% dodecyl- ~-D-maltoside and
1mM benzamidine. The flow rate of the column was 2ml1min. An increasing salt
gradient was applied to elute bound proteins. Fractions corresponding to the
hydroxylase and the reductase were collected and concentrated using an Arnicon
stirred cell with a PM1 0 ultrafiltration membrane
2.9 Enzyme activity assays
Methane mono oxygenase (MMO) activity was assayed by following the oxidation of
propylene to propylene oxide. The data in this study are the mean and standard error
(as calculated using the package Microcal Origin, version 4.10) from at least two
assays unless otherwise stated. Propylene oxide was measured using a Pye Unicam
Series 104 gas chromatograph (Pye Unicam, Cambridge, UK) fitted with a Porapak Q
column (4mm x 1m, Waters Associates, Milford. Massachusetts, USA). Nitrogen was
the carrier gas with a flow rate - 30mllmin and oven temperatures of 150-200°C. This
system was linked to a Hewlett-Packard 3390A integrator (Hewlett-Packard,
Avondale, Pennsylvania, USA).
A 2mM standard of the appropriate product was used to calibrate the column. Either
a 5JlI liquid or 0.5ml of gas sample was injected into the gas chromatograph
depending on which phase was being used in the experiment.
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2.9.1 Whole cell MMO activity
Assays for whole cell activity were performed in 5ml flasks containing lrnl of an
ODsso 20 cell suspension. The flask was sealed, 3ml of air was extracted and replaced
with 4ml of propylene. The flask was then incubated in a 45°C water bath for I
minute before 100mM sodium formate was added. The sample was injected onto the
column at 3 minute intervals.
2.9.2 Cell-free extract MMO assays
MMO activity in cell-free extracts was determined using NADH (or occasionally
duroquinol for particulate extracts) as the electron donor. Samples (lOmg/ml) were
placed in a 2ml vial containing the appropriate buffer (25mM MOPS buffer, pH7 for
sMMO extracts and 10mM-PIPES buffer, pH7.25 for the pMMO) in a final volume
of 100ml. The flask was sealed and 0.5ml of air was replaced with 0.6ml of
propylene. The flask was then incubated in a 45°C water bath for I minute before
NADH was added to give a final concentration of 5mM. The 0.5ml of gas phase
sample was injected onto the column.
2.9.3 Activity assays for pMMO· and pMMOc assays
The electron donor used in these assays was 5-25mM, duroquinol. Duroquinol was
dried onto the base of a 2ml vial. The protein sample and 10mM PIPES buffer, pH
7.25 was added to give a final volume in the vial was 100f.!l. 0.6ml of air was
extracted from the vial and Iml of propylene was injected into the vial. The reactions
were supplemented with 50f.!M copper sulphate to give optimal activity. During
kinetic analysis of pMMO appropriate volumes of methane were injected into the
sample vial to obtain the desired final concentration of methane in the assay. A 0.5f.!1
liquid phase sample was then injected onto the column and methanol production was
measured. 0.5f.!1ofa 2mM methanol standard was used for calibration.
2.9.4 Test for sMMO activity in whole cells
Whole cell activity of sMMO for batch and continuous fermentation cultures was
assessed by following the oxidation of naphthalene. This assay was used routinely to
determine whether Methylococcus capsulatus (Bath) cells were expressing sMMO or
pMMO. lrnl of culture was incubated in 1.5ml Eppendorftubes in the presence of a
34
small naphthalene crystal and agitated for 30 minutes at 30°C. 100 III of a fresh 0.2 %
(w/v) solution of tetrazotised-c-dianisidine (TOD) was added to the sample.
Formation of a purple diazo dye indicated the presence of naphthols, which indicated
the presence of sMMO activity, since pMMO is unable to oxidise naphthalene.
2.9.5 Assay for methanol dehydrogenase
Methanol dehydrogenase (MDH) activity was measured spectrophotometrically at
45°C with phenazine ethosulphate (PES) and 2,6-dic!llorophenolindophenol (DCPIP)
as electron acceptors. The reaction mixture (total volume 500111) contained 50 mM
Tris-HCl buffer (pH 9.0), O.lmM DCPIP, 15mM ~Cl, 10mM methanol, 5mM
KCN and 500llg MDH. The reaction was started by the addition of 1.0 mM PES, and
the decrease in absorbance 'of DCPIP at 600nm (6= 1.91 MI cm") was measured.
One unit of MDH activity was defined as lumol DCPIP reduced per min per mg
protein.
2.10 Analytical determinations
2.10.1 Estimation of protein concentration
Protein concentrations were estimated using a modified dye-binding method of
Bradford (1976) using bovine serum albumin (BSA) as a standard. An alternative
assay modified from that described by Lowry, 1977 was used which was more
suitable for detergent containing samples. Both procedures were carried out using the
BioRad Reagent and the Detergent compatible (De) Reagent (BioRad Ltd, Watford,
Hertfordshire, and UK).
2.10.2 Estimation of metal content
Copper and iron metal content of samples were estimated using Inductively Coupled
Plasma Emission Spectroscopy by Dr. Karen Sanders at the Warwick analytical
centre, University of Warwick. Samples were prepared by acid washing in Nitric acid
(Primar grade) as described by the Warwick analytical centre guidelines. A control
sample of buffer alone was also prepared in the same way and values obtained for this
control were subtracted for the experimental protein sample values.
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2.10.3 Sedimentation equilibrium experiments
Sedimentation equilibrium experiments were carried out in collaboration with Dr. K.
Jumel at NCMH, University of Nottingham. The pMMO complex and pMMO
hydroxylase were analysed at a concentration of 5mg/ml in 20mM Pipes buffer, pH
7.2. Measurements were made using a Beckman Optima XL-A analytical ultra-
centrifuge (Beckman Instruments Inc., Palo Alto, CA, USA) at a temperature of 4°C.
Protein was prepared as described in Section 2.6.
Buffers containing D20IH20 ratios between 0 and 50% were prepared, the protein
was added to the appropriate buffer and samples were concentrated to give a final
volume of 200J.l1. Buffer and detergent densities were measured at 4°C using a
Precision Density Meter (Model 02C, Anton Paar, Graz, Austria).
Samples and their appropriate buffers were loaded into their respective channels in
12mm multichannel cells. Equilibrium runs were carried out on a Beckman XL-A
analytical ultracentrifuge (Beckman, Palo Alto, CA) at a temperature of 4°C and
speeds of 3,000, 6,000, and 9,000rpm for the pMMO complex and 10,000, 12,000
and 15,000rpm for the hydroxylase sample until equilibrium was achieved at each
speed. Samples were pre speeded at 45,000rpm to obtain the baseline absorbance for
each sample. Molecular weights for the proteins at each D20!H20 ratio were obtained
using the manufacturers software package (Beckman Instruments, Inc. Fullerton, CA
1993).
2.10.4 Electron microscopy
Electron microscopy studies were carried out in collaboration with Dr. A. Kitmitto
and Dr. R. Ford at the University of Manchester, Institute of Science and Technology
(UMIST). The pMMOm samples were pelleted and resuspended in 25mM Pipes
buffer, pH 7.25 containing 100mM NaCI and lOmM EDTA. Membranes were diluted
to protein concentrations of 100-150J.lg/ml. Samples were mounted onto colloidion-
carbon coated 3000 mesh/inch copper grids and negatively stained using 4% uranyl
acetate as described before and examined in a Phillips 400 transmission electron
microscope operated at an accelerating voltage of 100keV. Micrographs were
recorded at a calibrated magnification x 43,600 on Kodak electron microscope film
36
(EST AR thick base 4489*). Electron micrographs were digitised (Zeiss SCAl
scanner) resulting in a pixel size of6.4A at the specimen level.
SPIDER and WEB image processing packages were employed on an indigo-silicon
graphics workstation. The image was first band pass-filtered. Particles were selected
interactively using the program WEB, using reference-free alignment algorithm the
particles were rotationally and translationally aligned. An average image was
calculated from a sum of the aligned particles ... Correspondence analysis and
hierarchical ascendant classification using complete linkage as a merging criterion was
performed to separate out and average particles within in each group. The threshold
level was determined by visual inspection of particles randomly selected from each
group to check for agreement of particle orientation shape and size.
2.10.5 Electron Paramagnetic Resonance Spectroscopy
Electron paramagnetic resonance (EPR) spectroscopy studies were carried out in
collaboration with Dr. B. Katterle and Professor K.Andersson at the University of
Oslo, Norway. EPR spectra were recorded on a Bruker ESP300 instrument equipped
with an helitram liquid helium set-up. Samples were prepared at the University of
Warwick as described in Section 2.6. Samples were measured at approximately 10K
for copper signal analysis and 4K for iron signal analysis. Protein concentration of
extracts used in EPR experiments varied. Final sample volumes of 200J.!1were used
and were frozen slowly in EPR tubes at -80°C.
The appropriate chemical solution e.g. ammonia, potassium cyanide etc., was added
to protein samples to give a final concentration of 500J.!M, unless stated otherwise.
Excess chemicals were removed by applying treated protein samples to G25-packed
disposable columns and centrifuging them for 3 minutes at 3,000rpm. Ascorbate and
dithionite reduction experiments were performed in an anaerobic chamber while
flushing with argon/nitrogen. ImM of the reductants were added to the sample while
using phenyl methyl sulphate (PMS) as the mediator of the reaction.
During the copper titration experiment, samples were washed twice with 10mM
Pipes, pH 7.25, 0.03% dodecyl-f-Demaltoside, 10mM EDTA before washing with
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10mM Pipes, pH 7.25, 0.03% dodecyl-f-Dcmaltoside alone. Sample washing took
place using a PM10 centricon (Amicon Corporation, Danvas, M.A.) which were
centrifuged at 3000rpm, 4°C. Increasing concentrations of copper were added.
2.10.6 Spectrophotomeric procedure
Routine UV/vis spectrophotometry were carried out on a UV/vis HP8452A Diode
Array Spectrophotometer.
2.11 Other procedures
2.11.1 Polyacrylamide gel electrophoresis (PAGE)
Sodium dodecyl sulphate (SDS) PAGE was performed (adapted from Laemmli,
1970) using a Mini PROTEAN II system (BIO-RAD, Hemel Hempstead, UK) or a
Hoefer SE 600 series standard dual cooled units using a BIO-RAD PowerPac 300
and a BIO-RAD PowerPac 1000 power supply.
The gel were prepared using a discontinuous buffer system containing 0.375M Tris-
HCI (pH 8.8) in the upper (resolving) gel, and 0.125 M Tris-HCI (pH 6.8) in the
lower (stacking) gel. Samples were diluted with an equal volume of SDS sample
buffer (100mM Tris-HCI , pH 6.8; 200mM DTT; 4 '% ,w/v, SDS; 0.2 %, w/v,
Bromophenol Blue; and 20 %, v/v, glycerol) and boiled (lOO°C) for 1 minute. The
samples were then loaded onto 12 % (wt/vol) homogenous acrylamide gels with a
4 % stacking gel. The reservoir buffer was a 25mM Tris-glycine (pH 8.3) reservoir
buffer; all buffers used in SDS-PAGE were supplemented with 0.1% SDS. The
proteins were visualised on the gel by a >30 minute incubation with Coomassie
Brilliant Blue stain (0.1 % Coomassie Blue R-250 in a solution of methanol: glacial
acetic acid: water, 3:1:6 by volume). The gel was then de-stained by a >30 minute
incubation in a solution of methanol: glacial acetic acid: water (4: 1:5 by volume).
SDS-PAGE gels were calibrated using Dalton Mark VII-L markers (Sigma Chemical
Company Ltd) bovine albumin, 66 kDa; egg albumin, 45 kDa; glyceraldehyde-3-P-
dehydrogenase, 36 kDa; bovine carbonic anhydrase, 29 kDa; bovine pancreas
trypsinogen, 24 kDa, soybean trypsin inhibitor, 20 kDa; and bovine milk a-
lactalbumin, 14.2 kDa.
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2.11.2 Production of anti-sera to the pMMO
A band containing the 47 kDa polypeptide ofpMMO was cut out from a 12% SDS
PAGE gel and electro-eluted for 4 hours. Anti-sera were raised in Dwarf-lop rabbits
by the subcutaneous injection of 0.5-1.0mg aliquots of purified protein homogenised
with Moris's modification of Freund's adjuvant (V. Cooper, University of Warwick,
UK). Bleeds were taken at lmonth intervals and stored at 4°C for 16 hours. The
coagulated blood proteins were discarded carefully and the clear supernatant was
removed carefully and stored on ice. An optimal volume of 50!J.Iantiserum was found
to give an effective reaction to the 47 kDa polypeptide of pMMO as visualised by
Western blot analysis (Section 2.9.4). The antiserum was stored in 50!J.Ialiquots at
-20°C until further use.
2.11.3 Protein electro-elution
Protein samples were excised from SDS-PAGE gels and electro-eluted under
conditions as described in the instructions for the BIO-RAD Model 422 Electro-
eluter.
2.11.4 Western blots analysis
Protein samples (1-5!J.g) were run on SDS-PAGE gel and the marker lane cut off and
stained with Coomassie Brilliant Blue. The remaining part of the gel was soaked in
transfer buffer (20 mM Tris-HCI, pH 8.0, 150 mM glycine, 20 % (v/v) methanol) for
30 minutes at room temperature. Proteins from the gel were electro blotted onto
hybond-C nitrocellulose membrane (Amersham life sciences Limited,
Buckinghamshire, UK) in an X-Cell blot module (Novex) at 25V constant potential
difference for 2 hours.
Non-specific protein-binding sites on the membrane were blocked by soaking in 2%
(wt/vol) skimmed milk powder in 20ml TBST (50mM Tris-HCI, pH 8.0; 150mM
NaCl; 0.1 % (v/v) Tween 20) for 1 hour at room temperature or overnight at 4°C.
The membrane was then soaked in 20ml TBST containing 2 % (wt/vol) skimmed milk
powder and 50/-l1of primary antiserum with gentle shaking for 90 minutes. The blot
was washed in three rinses with TBST (10 minutes per wash). The membrane was
then soaked in TBST containing 2% Marvel skimmed milk powder and secondary
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antibody (SOIlI anti-rabbit, anti-goat IgG-peroxidase conjugate, Sigma) for 90
minutes. Unbound secondary antibody was removed by three washes in TBST and
two washes in TBS (TBST without Tween 20) for 10 minutes each. The bound
antibody-peroxidase conjugate was visualised staining the membrane for peroxidase
with stain solution for S-10 minutes at room temperature.
The stain solution was freshly prepared as follows:
Solution A: l.Sg NaCl and Iml of 1M Tris-HCl, pH 7.S were dissolved in SOml
distilled water.
Solution B: 30mg chloronaphthol dissolved in 10ml methanol and diluted to SOml
with distilled water.
SOIlI of 8M hydrogen peroxide was added to solution B, which was then combined
with solution A immediately before use.
The blot was rinsed in water and dried on tissue paper after it had been developed to
the desired extent.
2.11.5 Western blotting for N-terminal sequencing
Protein samples were run on SDS-PAGE gel alongside Dalton Mark VII-L markers
(Sigma) leaving an empty lane between the markers and samples. The stacking gel
and unused lanes were cut off and the remainder of the gel soaked in transfer buffer
(2S0ml solution containing 10mM 3-[cyc1ohexamino j-l-propanesulphonic acid
(CAPS) buffer and 2Sml methanol) for S minutes at room temperature. A piece of
polyvinylidine difluoride (PVDF) membrane (Amersham Pharmacia Biotech, UK), cut
to size Imm larger than the gel in both directions, was soaked briefly in methanol
before transferring to transfer buffer for a few minutes. Protein from the gel was
electro blotted onto the PVDF membrane in an X-Cell blot module (Novex) at 2SV
constant potential difference for 2 hours.
The PVDF membrane was prepared for staining by rinsing with water followed by
methanol before staining with Coomassie Brilliant Blue solution (0.1% Coomassie
Brilliant Blue R-2S0, water:methanol:acetic acid (S:4:1) for 1 minute. The membrane
was subsequently de-stained in three changes of SO% methanol for 1-2 minutes each
by which time the protein bands were visible on the blot. The blot was dried overnight
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at room temperature on a sheet of blotting paper before sending it to Dr. Arthur
Moir, Department of Biological Sciences, University of Sheffield, for sequencing.
2.11.6 Quinol Preparation
Quinones e.g. duro quinone (tetramethyl-p-benzoquinone) were obtained from Sigma
and were reduced to the corresponding quinol using sodium borohydride (Shiemke et
al., 1995). Acidified ethanol solution (3mM Hel) of the quinone was made anaerobic
by adding excess sodium dithionite (20mg/ml) and gassing the solution with argon.
"
The quinone was reduced by the addition of a 1.5 fold molar excess of solid sodium
borohydride. The yellow solution was gassed with argon until it became colourless.
Approximately 200ml of 3mM Hel solution was added to precipitate the dissolved
quinol. The precipitate was collected by filtration and washed three to five times with
3mM Hel. The dried precipitate was dissolved in acidified ethanol and stored in
crimp capped 2ml vials under an atmosphere of argon at -20oe until required. The
concentration of the duroquinol was calculated from the absorbance of the solution
based on its extinction coefficient of2140M1cm-1 at 283nm.
41
3. Purificationof the pMMOcomplex
3.1 Introduction
There have been published protocols for the isolation of pMMO from various
methanotrophs. Early reports by Tonge et al. (1975 and 1977) describe the purification
of a pMMO complex from Methylosinus trichosporium OB3b using phospholipase D as
the solubilising agent with ascorbate as well as NADH as electron donors. The methane-
oxidising complex consisted of three components, two proteins consisting of molecular
weight 46kDa and 9.4kDa and a CO-binding cytochrome-c. The complex was purified
by using ultrafiltration techniques and ion-exchange (DEAE-cellulose), gel filtration
(Sephadex G 150 and G50) and an hydroxyapatite chromatography.
Akent'eva and Gvozdev (1988) published details of the purification of an NADH-
utilising pMMO from Methylococcus capsulatus (Strain M). The purification involved
salt-washing and fractionation of the membrane using 0-20% sodium sulphate. The
enzyme was solubilised using 1% sodium deoxycholate followed by 5% sodium
deoxycholate. An ion exchange chromatography column (DEAE-cellulose DE32) was
then used to purify the pMMO to homogeneity. The enzyme was found to consist of two
subunits, a monooxygenase component and an NADH reductase, The purified enzyme
had a specific activity of 3600nmoles/minimg based on the disappearance of methane.
This organism is unavailable to other labs so this work has not been reproduced
elsewhere.
A reproducible procedure for the solubilisation of the pMMO from Methylococcus
capsulatus (Bath) was published by Smith and Dalton (1989) using the non-ionic
detergent dodecyl-B-Dvmaltoside. All NADH-dependent activity was lost upon
solubilisation although activity could be restored if the solubilised pMMO was
reconstituted with egg or soya bean lecithins. Further purification of the pMMO resulted
in total loss of activity. The major polypeptides thought to be associated with the
pMMO were of molecular weights 49,23 and 22kDa.
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Zahn and DiSpirito (1996) published details on the purification of the pMMO from
Methylococcus capsulatus (Bath). Here, the non-ionic detergent dodecyl-f-Demaltoside
was again used to solubilise the pMMO. The enzyme was then isolated using ion-
exchange (DEAE-cellulose) and hydrophobic interaction chromatography (Phenyl
Sepharose) while maintaining anaerobic conditions. The pMMO did not bind to the ion
exchange column but was present in the flow through fractions. These were combined
and loaded onto the hydrophobic interaction column from which the pMMO-containing
fractions were eluted with an increasing detergent concentration gradient (0.01-0.9%).
Contaminating polypeptides were also observed (37kDa and 20kDa) and were identified
as the cytochrome b-559/569. Removal of these polypeptides resulted in enzyme
inactivation.
In order to purify pMMO from Methylococcus capsulatus (Bath), Charlton (1997)
investigated various purification techniques including sucrose gradient sedimentation,
immobilised metal ion affinity chromatography (lMAC), gel filtration and ion exchange
chromatography among others. These protocols were performed under aerobic
conditions but were not successful in producing purified pMMO with good activity and
the specific activities of partially purified extracts decreased during the purification
process.
Nguyen et al. (1998) used methane-limiting conditions during the growth of
Methylococcus capsulatus (Bath) cells to obtain membranes highly enriched in pMMO.
Purified active pMMO was obtained by solubilisation with dodecyl-f3-D-maltoside and
subsequent isolation with affmity (Lysine Agarose) or ion exchange (DEAE sepharose
Fast Flow) chromatography. An excess of reduct ants (dithionite or ascorbate) was used
to maintain anaerobic conditions and enzyme activity during solubilisation and
purification. NADH was used as the reductant with the purified pMMO. A
proteolytically processed version of the enzyme was found with a modified a subunit of
35kDa (a' subunit). The normal sized a subunit had a molecular weight of
approximately 47kDa. Minor protein and haem contaminants were also observed.
43
3.2 Investigating published protocols
Historically, pMMO has proved notoriously difficult to purify in a reproducible manner,
which has hindered any subsequent characterisation of the enzyme. The aims in this part
of the study were concerned with fmding a reproducible procedure to isolate the pMMO
so a detailed characterisation of the pMMO enzyme could be undertaken.
The published methods of both Zahn and DiSpirito .(1996) and Nguyen et al. (1998)
were individually repeated under both anaerobic and aerobic conditions. Following
Zahn's procedure, the dodecyl-Bvlr-maltoside solubilised pMMO extract (60mg) was
applied to a pre-cooled (4°C) DEAE-cellulose column (4.5 x 10cm) equilibrated with
25mM Pipes, pH 7 and 0.01% dodecyl-f-Dsmaltoside. The pMMO did not bind to the
column and was eluted in the flow-through fraction. This fraction was applied to a pre-
cooled (4°C) Phenyl Sepharose HP column (4.5 x 10cm) equilibrated with 25mM Pipes,
pH 7 and 0.01% dodecyl-p-D-maltoside with or without excess reductants depending on
whether anaerobic or aerobic conditions were being used. The pMMO bound to the
column and was eluted using an increasing dodecyl-f-Dvmaltoside concentration
(0.01%-0.9%). This fraction was concentrated using a PM30 cut-off membrane Amicon
concentrator and applied to a SDS- PAGE gel to assess purity (Figure 3.1) and measured
for activity using the standard propylene to propylene oxide detection assay with 25mM
duroquinol as the reductant (Table 3.1).
Following Nguyen's protocol, the solubilised pMMO extract (60mg) was either applied
"
to a Lysine Agarose or a DEAE Sepharose column which was cooled to 4°C and
equilibrated with 50mM Pipes, pH 7.25 containing 0.05% dodecyl-ji-Dvmaltoside,
200mM copper sulphate and 5mM ascorbate. Excess reductants were omitted when
protocols were performed under aerobic conditions. Three fractions were eluted from
the Lysine Agarose column, the pMMO was eluted in the second slow-moving fraction.
When using DEAE Sepharose, the pMMO fraction was eluted from the column using
~ 1OOmMNaCl. Fractions containing pMMO were concentrated using a PM30 cut-off
membrane Amicon concentrator and applied to an SDS-PAGE gel to assess purity
(Figure 3.1).
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. .
66kDa
45kDa ... 49
36kDa
29kDa
~ 2724kDa 23
20kDa
14kDa
Figure 3.1 12% 50S-PAGE gel of proteins eluted during different stages
of the purification protocols
Lane 1 Sigma Dalton-VII molecular weights
Lane 2 Starting preparation of solubilised pMMOs extract
Lane 3 Flow through fraction containing pMMO, from DEAE cellulose column for
application to Phenyl Sepharose HP column using (Zahn's protocol)
Lane 4 Fraction eluted from Phenyl Sepharose HP column using an increasing
dodecyl-p-D-maltoside concentration (0.01-0.9%) (Zahn's protocol)
Lane 5 Slow moving fraction containing pMMO from Lysine-Agarose affinity
(Nguyen's protocol)
Lane 6 Bound fraction of pMMO eluted from DEAE Sepharose column at
100mM NaCI (Nguyen's protocol)
Proteins were visualised by staining with Coomassie brilliant blue R-250.
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The pMMO samples were measured for activity using the standard propylene to
propylene oxide detection assay with 25mM duroquinol as the reductant (Table 3.1). In
contrast to Nguyen's findings (Nguyen et al., 1998) NADH was not able to support
activity in solubilised or purified pMMO samples.
Anaerobic Procedure Aerobic procedure
Specific Activity of Specific Activity of
pMMO (nmoles of pMMO (nmoles of
propylene oxide propylene oxide
producedlminlmg) produced lminlmg)
Solubilised pMMO . 10 20
Flowthrough fraction from 3 12
*DEAE cellulose
pMMO fraction from Phenyl 0 0
*Sepharose
Slow moving pMMO fraction 8 15
from Lysine Agarose +
pMMO fraction eluted from 3 10
DEAE sepharose with
lOOmMNaCt
Table 3.1 Purification of pMMO, using either anaerobic or aerobic
conditions. Each fraction was concentrated and assessed for pMMO activity
using the standard propylene to propylene oxide production assay with 25mM
duroquinol as the reductant described in (Chapter 2, Section 2.9.3)
*-Protocol carried out as described in Zahn and DiSpirito (1996)
+-Protocols carried out as described in Nguyen et al. (1998)
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Although, all activity was lost at the Phenyl Sepharose step in Zahn and DiSpirito's
protocol (Table 3.1) the polypeptides of the pMMO hydroxylase (pMMOH) were
present (Lane 4 of Figure 3.1). These results are in contrast to those seen by Zahn and
DiSpirito (1996) where a specific activity of 11.08 nmoles of propylene oxide
produced/min/mg was obtained at this stage. This protocol was believed to be unsuitable
as the pMMO was inactive and the high concentration of expensive detergent required
.'was not cost-effective. It is not clear how Zahn and DiSpirito (1996) obtained active
pMMO using this protocol but they did observe major contaminating polypeptides
(identified as the cytochrome-b 556/569) which were not detected in this study.
Using the protocol of Nguyen et al. (1998), under either anaerobic or aerobic conditions,
resulted in active pMMO preparations (Table 3.1). These activities of 3-15 nmoles
propylene oxide produced/min/mg were generally higher than those activities obtained
by Nguyen and co-workers (1998). However, the degree of purification in this study is
lower, as analysed by SDS-PAGE (Figure 3.1).
In general, the purification procedures carried out under aerobic methods gave more
than 50% higher activities than those carried out under anaerobic procedures (Table
3.1). The polypeptide profiles were identical whether aerobic or anaerobic protocols
were used.
3.2.1 Anaerobic versus aerobic methods
In this study and that of Charlton (1997), aerobic conditions were found to be sufficient
to maintain activity of solubilised pMMO. This is in direct contrast to the findings of
Zahn and DiSpirito (1996) and Nguyen et al. (1998), where anaerobic conditions were
necessary to maintain the activity of the pMMO. In this part of the study, the solubilised
extracts were initially from the same batch of cells, maintained under either anaerobic or
aerobic conditions, and had the same starting specific activity. It was found that the use
of ascorbate in the protocols as described by Nguyen et al. (1998) masked protein
absorption at A280nmand was therefore routinely omitted during the aerobic procedure so
that protein elution could be monitored by A28onm.It is unclear how Nguyen and co-
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workers monitored protein elution in the presence of ascorbate. Since starting and
resultant enzyme activities during the anaerobic procedure were so much lower than
using aerobic conditions, the anaerobic conditions were abandoned during subsequent
procedures.
3.2.2 Summary
In this study, the procedure using Lysine Agarose as described by Nguyen et al. (1998)
yielded higher specific activities when compared to those obtained by the method of
Zahn and DiSpirito (1996) where no activity was seen in the fmal preparation. However,
the extent of purification, as analysed by SDS-PAGE, was limited as protein
contaminants were observed (Figure 3.1).
Attempts to purify an active pMMO using gel filtration, metal chelating and
chromatographic methods described by Charlton (1997) were unsuccessful. Electron
microscopy analysis indicated that particulate extracts prepared by protocols described
by Zahn and DiSpirito (1996) and Charlton (1997) were heavily contaminated with
soluble proteins namely high molecular weight and sMMO polypeptides (confirmed
using antibodies raised to the hydroxylase of sMMO, data not included). The
consequences of this contamination could result in misleading information being
obtained i.e. specific activity and metal analysis, when using these published protocols.
This observation was also made by Nguyen et al. (1998).
In light of the failure to obtain active purified pMMO using protocols previously
described and working from possibly contaminated sources, it was decided that the
knowledge gained from previous literature could be used as a foundation in order to
develop a more successful approach.
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3.3 Optimisation of intracytoplasmic membrane (ICM) isolation
The growth of intracytoplasmic membranes (ICMs) has been correlated with the
presence of pMMO in Methylococcus capsulatus (Bath), (Prior and Dalton, 1985).
Investigations were carried out in order to optimise the isolation of the ICMs, thereby
reducing contamination of possible soluble or outer membrane proteins and increasing
the abundance of pMMO in the starting preparations.
ICMs were subjected to a discontinuous sucrose (60-20%) gradient, (Chapter 2, section
2.5.1) in an attempt to separate inner and outer membranes, therefore reducing
contamination sources. Good separation was achieved and the small amounts of ICM
with pMMO activity were isolated as shown in Figure 3.2 and Table 3.2. However,
attempts to then solubilise an active pMMO were unsuccessful. The sucrose in the
sample was thought to be affecting solubilisation as there was a low yield of solubilised
proteins and no activity in the supernatant. Attempts at dialysing out the sucrose before
solubilisation resulted in a decrease in activity and subsequent solubilisation of these
dialysed membranes resulted in no enzyme activity as shown in Table 3.2.
Triton X-lOO and Triton X-114 were used as detergentsin an attempt to solubilise the
cytoplasmic membranes in preference to outer membranes as previously carried out by
Fjellbirkeland et al. (1997). This was performed by resuspending the particulate extract
(Chapter 2, section 2.5.2) in a working buffer containing 2% (v/v) Triton. The resulting
suspension was stirred at room temperature for 1 hour, centrifuged at 100,000xg for 1
hour and the soluble fraction containing ICMs was collected, assayed for activity and
analysed by SDS-PAGE. The polypeptides thought to correspond to the pMMO
hydroxylase were observed (Figure 3.2) however, no propylene oxidising activity was
detected in the fraction possibly because of inactivation of the enzyme by the detergent.
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Both methods were unsuccessful in isolating high activity, membrane bound pMMO
(pMMOm). However, a successful method was developed which combined extra
ultracentrifugation steps and ionic washes to remove outer membranes and soluble or
periplasmic proteins. This washing technique is described in more detail in Chapter 2,
section 2.5. Briefly, cells were broken, whole cells debris was removed by
centrifugation and the supernatant was centrifuged at. 150,000 x g for 90 minutes. The
resulting pellet was then resuspended in excess working buffer and centrifuged at
150,000 x g for 60 minutes at least twice until the supernatant became clear. The pellet
was finally resuspended in minimal working buffer. Membrane samples (pMMOm) were
tested for activity (Table 3.2jby measuring the epoxidation of propylene with NADH as
the reductant, as described in Chapter 2, section 2.9.2. The pMMOm sample was
estimated to contain ~60% of the polypeptides associated with pMMO. The stringent
washing protocol removed high molecular weight and soluble proteins as observed by
electron microscopy (Chapter 6, Figure 6.6).
Specific Activity
Method oflCM isolation (nmoles of
propylene oxide
produced lminlmg)
Sucrose gradient 52
Sucrose gradient and dialysis 16
Sucrose gradient and dodecyl-j3-D- 0
maltoside solubilisation
ICM preferential solubilisation 0
by Triton
Stringent washing technique 75
Table 3.2 Specific activities of intracytoplasmic membranes after
specified isolation procedure. Activities of isolated ICMs (10mg/ml) were
measured using the detection of propylene oxide produced from propylene with
NADH as a reductant as described in Chapter 2, section 2.9.2.
50
66kDa
... 4745kDa
36kDa
29kDa
... 27
24kDa ... 23
20kDa
14kDa
1 2 3 4
Figure 3.2 12%SOS PAGEgel of intracytoplasmic membranes isolated
by different procedures.
Lane 1 Dalton VII molecular weight markers
Lane 2 leMs isolated using Triton X-100 preferential solubilisation
Lane 3 leMs isolated using a discontinuous sucrose gradient (60-20%)
Lane 4 leMs isolated using the stringent washing technique. The membrane
pellet was resuspended in excess working buffer and washed at least twice by
centrifugation at 150,000g for 60minutes.
Proteins were visualised by staining with Coomassie brilliant blue R-250.
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3.3.1 Useful observations
Several observations were made during the course of this study that may be useful as a
guide for obtaining high activity membrane preparations.
1) Batch cultures (lOOL) appeared to produce high specific activity pMMO
preparations (75-200 nmoles/minlmg) particularly if sMMO cultures were used as
the starting inoculant. Rigorous checks were made to see that no subsequent sMMO
contamination was introduced i.e. stringent washing of soluble proteins, electron
microscopy analysis of cultures (Chapter 2, section 2.10.5), Western Blotting
analysis (Chapter 2, section 2.11.4) with antibodies raised to the sMMO
polypeptides, napthaleneassay (Chapter 2, section 2.9.4) to verify the authenticity of
the preparations.
2) Initial fast growing cultures gave nse to high specific activity (75-200
nmoles/minlmg) and stable pMMO and were used in preference to slower growing
cultures, which gave low specific activities (30-50 nmoles/minlmg) of a more
unstable nature.
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3.4 Solubilisation of the pMMO complex
An intrinsic difficulty in the purification of membrane protein complexes is their
tendency to dissociate in detergent solutions. Previous studies with various detergents
(Smith and Dalton, 1989; Charlton, 1997) concluded that dodecyl-f-Dvmaltoside is the
only detergent to yield an active pMMO enzyme. This is because non-ionic detergents
such as decyl and dodecyl maltosides are generally milder than other detergents,
therefore preserving intact complexes. Dodecyl-j=lf-maltoside was the choice of
detergent in this study. An active pMMO was solubilised using a 1.5mg dodecyl-~-D-
maltoside /mg protein and 40f.!M copper sulphate in a manner similar to that described
by Charlton (1997) (Chapter 2, section 2.6). However, this detergent to protein ratio was
only effective when the membrane pellet was repeatedly resuspended in buffer
containing 0.5M NaCI prior to solubilisation. This yielded enzyme activities in the range
of 15-30 nmoles of propylene oxide produced /min/mg protein (Table 3.3).
Concentration Specific activity of pMMO after solubilisation
ofNaCI in (nmoles of propylene
resuspension buffer oxide/min/mg)
(M) No copper ' 40f.!Mof copper
sulphate added sulphate added
0 0 0
0.5 0 30
1.0 0 19
Table 3.3 Effect of NaCI concentration in resuspension buffer on
resultant activities of pMMO during solubilisation with dodecyl-~-D-
maltoside. Prior to solubilisation with dodecyl-p-Drnaltoside, the membrane
pellet was resuspended in minimal volumes of Pipes, pH7 buffer containing
either 0.5 or 1.0M NaCI, with or without the addition of 40f.!M copper sulphate.
Solubilised samples were assayed by measuring the production of propylene
oxide from propylene using 2SmM duroquinol as described in Chapter 2,
Section 2.9.3.
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It is not known why the addition of salt in the resuspension buffer allows the
solubilisation of an active enzyme. However, salt can stabilise interactions within
protein complexes and it is possible that this then allows an intact and therefore active
protein complex to be solubilised.
The effectiveness of solubilisation was hard to decipher since membrane-associated
protein preparations are often difficult to visualise on gels as membrane-bound proteins
can be retarded in the gel because of the associated lipids, leading to smearing. In
addition to this, complete solubilisation of the membrane preparation in sample buffer is
often hard to do and therefore, the visual representation is often not an accurate
depiction of the total membrane protein population in the preparation. However, the
solubilised extracts were estimated to contain ~75% of the polypeptides associated with
the pMMOH as analysed by SDS-PAGE (Figure 3.3). Other bands in the solubilised
extract could not be identified but were proposed to be involved in membrane electron
transport e.g. cytochromes etc.
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1 32
66kDa +--63..
45kDa +--47
36kDa
29kDa
24kDa +--27
+-23
20kDa
14kDa
Figure 3.3 12%SDS PAGEgel of dodecyl-D-D-maltoside solubilised ICM
from Methylococcus capsulatus (Bath).
Lane 1 Sigma Dalton-VII molecular weight markers
Lane 2 Intracytoplasmic membrane from Methy/ococcus capsu/atus (Bath) prior
to solubilisation. (SJ.!gapplied to gel)
Lane 3 Dodecyl-p-D-maltoside solubilised pMMO extract (SJ.!gapplied to gel)
Proteins were visualised by staining with Coomassie brilliant blue R-2S0.
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3.6 Purification of the pMMO complex
Having obtained active solubilised pMMO (pMMOS) extract it was then necessary to
devise a reproducible method of isolating an active pMMO. The procedure described
below was effective at achieving this.
Solubilised pMMO was concentrated, using an Amicon stirred cell concentrator with an
XM50 filter, to 20mg/ml (attempts to achieve higher concentration at this stage led to
precipitation of the protein). The concentrated protein was then filtered through a 0.2f.!m
Whatman syringe filter and· applied to a cooled (4°C) Superdex 200 (S200) column
which was equilibrated in 25mM Pipes buffer, pH7.25 containing 0.03% dodecyl-Bvd-
maltoside and 1mM benzamidine.
Three main peaks were obtained as seen in a typical FPLC trace (Figure 3.4a). Fractions
corresponding to the peak 2 were found to contain -90% of the polypeptides associated
with the pMMO hydroxylase (pMMOH) as analysed by SDS-PAGE (Figure 3.5).
Fractions containing the pMMOH polypeptides (47, 27,and 24kDa) were pooled from
numerous S200 runs and finally concentrated using an Amicon stirred cell concentrator
with an XM50 filter to give >50mg/ml of protein. The protein was then re-applied to the
S200 column as previously described. Only one main peak (2), which contained
pMMOH, was obtained (Figure 3.4b). These fractions (peak 2) were collected,
concentrated and drop frozen in liquid nitrogen and stored at -80°C until further use,
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Figure 3.4 A typical FPLC trace showing the elution of proteins of
Methy/ococcus capsu/atus (Bath) from a) first and b) second Sephadex
200 column. 20-S0mg pMMOs was loaded onto a pre-cooled S200 column. The
column was run at a flow rate of 1.Smllmin with an elution buffer of 2SmM Pipes
buffer, pH7.2S containing 0.03% dodecyl-p-D-maltoside and 1mM benzamidine.
Eluted fractions corresponding to protein peaks were collected and
concentrated. Peak 2 corresponds to the pMMO complex (pMMOC).
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Figure 3.S 12% 50S-PAGE gel depicting the polypeptide profiles of the
peaks collected from the size-exclusion Superdex 200 column.
Lane 1 Sigma Dalton-VII molecular weight markers
Lane 2 pMMOs applied to Superdex 200 column (5~g applied to gel)
Lane 3 Peak 1 from Superdex 200 column (1~g applied to gel)
Lane 4 Peak 2 from Superdex 200 column (5~g applied to gel)
Lane 5 Peak 3 from Superdex 200 column (5~g applied to gel)
Proteins were visualised by staining with Coomassie brilliant blue R-250.
1
66kDa +-63
45kDa
36kDa
29kDa
24kDa - t=2623
20kDa
14kDa
~
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Additional polypeptides of approximate molecular weights 63 and 8kDa (often runs
with dye-front) were observed in the pMMO sample obtained from the S200 column
(figure 3.5). However, electron microscopy analysis indicated that there was complex
homogeneity in the sample (Chapter 2, section 2.8.4; Chapter 6, section 6.6). From this
it could be inferred that the 63kDa and 8kDa polypeptides were associated with the
pMMOH in a complex and will now be referred to as the pMMO complex or pMMOc.
The pMMOc sample was assayed for activity usmg duroquinol as the reductant.
Activities obtained at different stages of purification are shown in Table 3.4 and were
found to be in an approximate range of 30-75 nmoles/minlmg.
Total Total activity Specific activity Yield
protein (nmoles of with duroquinol (%)
(mg) propylene oxide (nmoles of propylene
Protein produced/min) oxide produced
Sample lminlmg)
pMMOm 300 5700 19 100
pMMOs 150 4550 30 79
pMMOc 70 3150 53 55
Table 3.4. Purification of the pMMO complex from Methy/ococcus
capsu/atus (Bath). Activity measurements were made using the standard
propylene to propylene oxide detection assay as described in Section 2.9.3. The
activity measurement of pMMOc was assayed using the optimised conditions
stated in Chapter 4, Section 4.2.
The degree of purification was high and specific activities increased by ~3-fold during
the purification process suggesting that a duroquinol-driven pMMO complex was being
purified. This was the first time a complex containing the pMMOH and the 63 and 8
kDa polypeptides had been observed. Therefore, it was necessary to assess whether the
63 and 8 kDa polypeptides had any role in pMMO activity or were adventitiously bound
to the pMMOH.
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3.7Separation of the components of the pMMOc
Although, the complex is known to comprise of a hydroxylase component, other
component(s) in pMMOc have not been identified. In order to verify the importance of
the 63 and 8kDa polypeptides in the 'pMMO complex' it was necessary to firstly isolate
the individual components separately.
This was achieved by using an anion exchange column (DEAE-cellulose, DE52). The
concentrated pMMOc sample obtained off the S200 column (> 15mg/mI) was filtered
through a 0.2J.lm syringe filter and applied to a cooled DEAE cellulose column which
was equilibrated in 10mM Pipes buffer, pH7.25, 0.01% dodecyl-p-D-maltoside, ImM
benzamidine. Three peaks were obtained as seen in the typical FPLC trace (Figure 3.6).
Two peaks were obtained in the void volume. Fractions corresponding to the different
peaks were collected, concentrated using a PMIO cut off membrane in an Amicon
-A-NaCI (M) -.-A 280 nmconcentrator.
1.40 -
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e. 1.00 -
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E
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0
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0 20 40 60 80
Elution volume (ml)
100 120
Figure 3.6 A typical FPLC trace showing the elution of proteins of
Methy/ococcus capsu/atus (Bath) anion exchange DEAEcellulose column.
The column was equilibrated with 25mM Pipes buffer, pH7.25 containing 0.03%
dodecyl-p-D-maltoside and 1mM benzamidine. The column was run at a flow
rate of 2ml/min. Peak 3 was eluted with an increasing NaCI gradient.
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The first peak (Figure 3.6) was found to contain polypeptides (63kDa and 8kDa) as
analysed by SDS-PAGE (Figure 3.7). Their co-purification indicates that they may exist
together as a component of unknown function. Fractions corresponding to the second
peak contained only the polypeptides associated with the pMMOH. A fmal peak was
eluted at O.3M NaCI using an increasing salt gradient and contained the undissociated
pMMO complex.
66kDa '-63
45kDa '-47
36kDa
29kDa
.-27
24kDa '-23
20kDa
14kDa
'-8
Figure 3.7 12% 50S-PAGE gel showing peaks collected from anion-
exchangeOEAEcellulose column.
Lane 1 Sigma Dalton-II molecular weight markers
Lane 2 pMMOc applied to DEAE cellulose column (5!-!g)
Lane 3 Fast moving proteins (Peak 1) from DEAE cellulose column (5!-!g )
Lane 4 Slow moving proteins (Peak 2) from DEAE cellulose column (5!-!g)
Proteins were visualised by staining with Coomassie brilliant blue R-250.
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The results presented in Figure 3.6 and 3.7 indicate that the pMMOc can be dissociated
into its two components under gentle conditions (during the washing step). This may
suggest that after isolation, the complex constituents are naturally dissociating and
associating at a low rate, as the majority of protein still exists in the complex form.
Concentrations of pure components obtained usmg DEAE-cellulose FPLC were
typically low at <5mg/ml.
The fractions from Peak 1 and Peak 2 were assayed for propylene oxidising activity as
previously described in Chapter 2, section 2.9.3. The results of the activity assays are
detailed in section 3.8.
3.8 Reconstitution of the pMMO complex components
The existence of the pMMOH has been established although it has been suggested that
there may be extra component(s) i.e. a reductase, necessary to maintain pMMO activity.
This suggestion is also upheld by the observation of low specific activities of the
purified pMMO of approximately 10 and 2.6-5 nmoles/minlmg obtained by Zahn and
DiSpirito (1996) and Nguyen et al. (1998) respectively. The natural dissociation of the
63kDa and 8kDa component with the pMMOH may point to fortuitous binding of the
proteins however, this could only be determined by assessing if the unknown component
had any role in supporting pMMO activity. The 63 and 8kDa component has been
designated as the putative reductase (pMMOR) for the purposes of this study.
62
Total Mean activity Specific Activity %
protein (runoles of (runoles of Activity
(mg) propylene oxide propylene oxide
produced/min) produced/nrumJmg)
pMMOc 0.5 13.75 ± 0.25 27.5 100
pMMOc+ pMMOH 0.6 17.15 ±0.45· 28.6 105
pMMOc + pMMOR 0.6 16 ± 5 26.6 100
pMMOH + pMMOR 0.5 1.3 ± 0.6 2.6 9.5
pMMOc + pMMOH 0.7 19 ±3 27.1 95..
+pMMOR
pMMOH 0.5 0 0 0
pMMOR 0.5 0 0 0
Table 3.5 Specific activities of reconstituted proteins. MMO assays were
carried out using the detection of propylene oxide production using 10mM
Pipes, pH7.2S, 2SmMduroquinol and O.OSmMcopper sulphate as described in
detail in chapter 2, section 2.9.3 Results are an average of at least two
experiments
The results presented in Table 3.5 indicate that when isolated components (pMMOH
and pMMOR) are added back to the purified pMMO complex the activity is increased
but the specific activity (28 runoles of propylene oxide produced/min/mg) remains
approximately the same. Neither the hydroxylase nor the reductase can support activity
alone suggesting both are necessary for propylene oxidising activity. The reconstitution
procedure (hydroxylase and the reductase in the absence of complex) was not effective,
yielding only 10% of the activity of the as-isolated pMMO complex. This could be due
to a missing component necessary for activity e.g. haem, or the loss of major structural
integrity of the complex.
These findings indicate that the 63kDa and 8kDa (pMMOR) component is a vital
constituent of the pMMO complex.
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3.9 Discussion
In the preliminary study, the lysine agarose protocol described by Nguyen et al. (1998)
yielded higher specific activities (~8-15 nmoles/minlmg) than that of Zahn and
DiSpirito (1996) where no activity was seen in the fmal preparation. However, major
contaminating polypeptides of unknown function, were observed in the samples
prepared by the one-step protocols of Nguyen et al. (1998), as analysed by SDS PAGE
(Figure 3.1). The observations presented in this study appear to be in contrast to the
results presented in the original publications where Zahn and DiSpirito (1996) obtained
impure preparations of high activity (11.08 nmoles/minlmg) and Nguyen et al. (1998)
obtained purer preparations of low activity (2.6-5.1 nmoles/minlmg).
These differences may be explained by the fact that the starting preparations used in the
unmodified protocol were purer than those used by Zahn and DiSpirito (1996) but were
not as pure as those used by Nguyen et al. (1998). Only minor haem and protein
contaminants were present in the purified pMMO samples of Nguyen et al. (1998).
Professor S.1. Chan, (pers. com.) suggests that further purification of the pMMO
hydroxylase (pMMOH) should be avoided as it results in the inactivation of the enzyme.
The success of the purification protocol hinges on the fact that initial membrane
preparations are enriched with pMMO i.e. ~60% of the total proteins were identified as
the polypeptides associated with the pMMO hydroxylase (pMMOH). Solubilisation of
the membranes with dodecyl-~-D-maltoside. further serves to act as a purification
procedure resulting in ~75% of the total' proteins being identified as the polypeptides
associated with the (pMMOH)
The essential difference in the pMMO preparations obtained in this study and those
obtained by other groups is the presence of the putative reductase (pMMOR). The
findings have shown that pMMOR can naturally dissociate from the pMMOH but that it
is also essential for maintaining an efficient and functional duroquinol-driven pMMO
complex. The protocols developed in this study may serve to stabilise the interactions
between the pMMOR and the pMMOH, perhaps because of the addition of salt to
64
resuspension buffer. The preparations in this study were highly stable, with respect to
activity after prolonged storage, and have the highest recorded activities in this field to
date (Table 3.6).
The isolation of a pMMO reductase is not unprecedented as it has been suggested that
high pMMO activities can be obtained when a purified NADH reductase is added back
to the activity assay (Nguyen et al., 1998; Chan, S.l. {pers. com.}). As yet there has
been no published procedure to confrrm the existence and subsequent isolation of an
NADH reductase, so this could not be followed up.
The findings in this study are in contrast to previous studies carried out by Charlton,
(1997), Zahn and DiSpirito (1996) and Nguyen et. al. (1998)
Summary of major findings
1) Charlton (1997) found that a breakage buffer CHAPS was essential for maintenance
of activity in particulate extracts. This result is in contrast with the findings from this
study and other published protocols. (Smith and Dalton, 1986; Prior and Dalton, 1985;
Zahn and DiSpirito, 1996 and Nguyen et al., 1998.)
2) Soluble proteins are expected to be a major source of contamination in preparations
described by Zahn and DiSpirito (1996) and Charlton (1997) since some appear to
associate quite strongly with the membrane. These can be removed while still
maintaining high levels of pMMO activity (-75nmoles of propylene oxide
produced/min/mg) using the stringent washing protocol that has been described in this
study. This step is essential prior to solubilisation since failure to remove contamination
can lead to misleading results particularly where the polypeptides of the soluble methane
monooxygenase (sMMO) are present, as they may give a positive result in the MMO
assay if propylene is used as the substrate.
3) In contrast to the observations of Zahn and DiSpirito (1996) and Nguyen et. al.
(1998), anaerobic conditions were not found to be necessary during solubilisation and
purification of the pMMO in this study. Indeed, such conditions were found to be
detrimental to enzyme activity (Table 3.1). This is consistent with previous studies
carried out in our laboratory group where aerobic conditions were also used during
65
solubilisation and purification of the enzyme (Prior and Dalton, 1985; Smith and Dalton,
1986 and Charlton, 1997).
Following these general principles, pMMO extracts were produced which had varying
but high specific activities (50-200 nmoles/mg/min) and were stable in storage at -80°C
for 1year. The activities ofpMMO obtained in different studies are summarised in Table
3.6. The specific activities observed in this study were similar to those activities
observed in previous studies in our laboratory (Smith and Dalton 1986, and Prior and
Dalton, 1985) and are generally higher than those obtained by any other group.
.,
pMMO specific activity
Reference pMMO sample (nmoles/minfmgprotein)
NADHas Duroquinol as
Reductant reductant
This study pMMOm 50-200 19
Purified pMMO - 50-75
Nguyen et al (1998) pMMOm 9.66-12.5 -
Purified pMMO 2.6-5.1 -
Charlton (1997) pMMOm 60-90 -
pMMOs - 30
Zahn and DiSpirito pMMOm - lOA
(1996) Purified pMMO - 11.08
,
Cook and Shiemke (1996) pMMOs - 8.0
Shiemke et al. (1995) pMMOs - 6.2
Semrau et al. (1995b) pMMOm 23.0 -
Chan et al. (1993) pMMOm 20-30
Smith and Dalton (1989) pMMOm 172.0 -
Prior and Dalton (1985) pMMOm 114
Table 3.6 - A comparison of activity of pMMO preparations in
Methy/ococcus capsu/atus (Bath) by different research groups.
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The results indicate that both the pMMOH and the putative duroquinol-dependent
pMMO reductase (pMMOR) are necessary for maintaining pMMO activity and are
referred to as the pMMO complex or pMMOc for the remainder of this study. A series of
experiments were undertaken to characterise the pMMOc and its components.
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4 Characterisationof the pMMOcomplex
4.1 Introduction
The three polypeptides (47, 27 and 23kDa) of pMMO hydroxylase (pMMOH) have
been purified to homogeneity from Methylococcus capsulatus (Bath) (Zahn and
DiSpirito, 1996; Nguyen et al., 1998). However, subsequent characterisation of the
purified pMMO at a chemical and physical level has been slow in coming, largely due to
the decrease in specific activity on solubilisation and isolation of the pMMOH. This
indicates either the presence of an inhibitory substance in the preparation, denaturation
of proteins or the loss of a component vital for methane monooxygenase activity. The
results presented in the Chapter 3 suggested that the latter suggestion is true.
The aims of this part of the study were to undertake characterisation of the pMMO using
the high specific activity pMMO complex purified as described in the previous chapter.
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4.2 Optimisation of the pMMO assay
Before characterisation of the purified pMMO complex could be undertaken, it was
necessary to ensure that the maximum activity of the enzyme was obtained. The
following experiment was carried out to optimise the concentrations of duroquinol and
copper ions used in the activity assay.
4.2.1 Optimisation of duroquinol concentration
The optimal concentration of duroquinol to attain maximal activity of pMMO samples
was determined by using 40~M of CUS04 in the reaction mixture. Increasing
concentrations of duroquinol (prepared as described in Chapter 2, section 2.11.6) were
used for the propylene oxidising activity assay (Chapter 2, section 2.9.3). The pMMOs
and pMMOc samples were prepared as previously described in Chapter 3, section 3.6.
Specific Activity
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Figure 4.1 The effect of duroquinol concentration on the specific activity
of solubilised pMMO extract (pMMOS) and purified pMMO complex
(pMMOC). Results were an average of at least two assays. Assays were
supplemented with 40~M copper sulphate and carried out as described in
Chapter 2, section 2.7. The pMMOs and pMMOc samples were prepared as
described in Chapter 3, section 3.6 and were used at a final concentration of
1mg/ml in the assay.
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The results from Figure 4.1 indicate that a duroquinol concentration of 5mM gave
maximal pMMOc activity of ~83nmoles/minlmg, which is in contrast to pMMOs which
required an optimal concentration of 20mM duroquinol (~17nmoles/minlmg). Having
ascertained the optimal concentration of duroquinol for pMMOc activity, the following
experiment was carried out to determine the optimal concentration of copper sulphate
needed for activity ofpMMO.
4.2.2. Optimisation of copper sulphate concentration
The optimal concentrations of copper sulphate for obtaining maximal activities of
pMMOs and pMMOc samples were determined by using concentrations of 20mM and
5mM of duroquinol respectively. Increasing concentrations of copper sulphate were
added in a manner similar to that described previously in section 4.2.1.
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Figure 4.2 The effect of copper ions on the specific activity of
solubilised pMMO extract (pMMOS) and purified pMMO complex (pMMOC)
using 20mM and SmM duroquinol respectively. Results were an average of
at least two assays. The pMMOs and pMMOc samples were prepared as
described in Chapter 3, section 3.6 and were used at a final concentration of
1mg/ml in the assay.
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Maximal enzyme activity was obtained at a copper sulphate concentration of 0.05mM
for the pMMO complex (~56nmoles/minlmg), in contrast to 0.15mM for solubilised
pMMO, which gave ~19nmoles/minlmg. The higher concentration of copper needed by
pMMOs may be due to the association of copper by other proteins in the impure sample.
Higher concentrations of both duroquinol and copper ions were found to inhibit pMMOc
activity. This may be because the excess co-substrates are binding to their binding sites
causing saturation of these sites and preventing enzyme turnover. 5mM duroquinol and
0.05mM copper sulphate were used in all subsequent assays to give maximal pMMOc
activity.
4.3 N-terminal sequencing of the putative reductase
N-terminal sequence analysis was carried out on the putative pMMO reductase,
pMMOR (purified as described Chapter 3, Section 3.6) in order to determine if the
pMMOR had any sequence homology to any other protein in the NCB! database
(http://www.ncbi.nlm.nih.govlblast/psiblast.cgi)usingaBLASTsimilaritysearch.It
was expected that proteins with similar sequences would help to determine the possible
identity of the pMMOR. The N-terminal sequencing analysis was performed by Dr.
Arthur Moir at the University of Sheffield (Chapter 2, section 2.11.5).
A comparison of the N-terminal sequence of pMMOR and the N-terminal sequence of
formaldehyde dehydrogenase from Methylococcus capsulatus (Bath) (Tate and Dalton,
1996) revealed a 60% sequence similarity (Table 4.2). However, recent reports from the
Dalton group have indicated that the formerly known formaldehyde dehydrogenase is
actually a methanol dehydrogenase (Adeosun, 2000) and a comparison of the N-terminal
sequence of pMMOR and the N-terminal sequence of the methanol dehydrogenase
revealed a 70% sequence similarity.
A higher percentage sequence similarity (-95%) of the N-terminal sequences would be
required to conclusively confirm the identity of the pMMOR as the methanol
dehydrogenase from Methylococcus capsulatus (Bath). However, these fmdings in
conjunction with the uncanny similarity between the estimated sizes of the subunits of
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the pMMOR (~63kDa and 8kDa) and the methanol dehydrogenase (~63.615 and
8.211kDa, Adeosun, 2000) led us to conclude that the putative reductase (pMMOR) of
the pMMO complex is also a methanol dehydrogenase from Methylococcus capsulatus
(Bath).
1) Putative reductase (pMMOR)
(This study)
NGELDRNSKG
2) Formaldehyde dehydrogenase
(Tate and Dalton, 1996)
NSELDRLXKF
3) Methanol dehydrogenase
(Adeosun, 2000)
NSELDRLSKD
Table 4.1 A comparison of N-terminal sequence of putative reductase
from the pMMO complex with the N-terminal sequences of formaldehyde
and methanol dehydrogenase from Methy/ococcus capsu/atus (Bath).
Differences in sequence 1) and 3) are designated in red. Differences in
sequence 1) and 2) are designated in blue.
Since, the pMMOR is an essential component of the pMMO complex as determined by
activity assays in Chapter 3, section 3.8, it can be inferred that the methanol
dehydrogenase interacts with the pMMO hydroxylase to form an efficiently functioning
pMMO complex in vitro. The significance of this phenomenon compels us to
reinvestigate proposals by Tonge and coworkers (1975 and 1977) that the in vivo
electron transfer to the pMMO might occur via a mechanism in which methanol
dehydrogenase (MDH) recycles electrons generated from methanol oxidation back to
thepMMO.
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4.4 Electron donor specificity of the pMMO complex
4.4.1 In vivo electron donors for pMMO
Although NADH can support crude extracts of pMMO activity in vitro, it has been
postulated that in vivo electron transfer might occur via a mechanism in which methanol
dehydrogenase (MDH) recycles electrons generated from methanol oxidation back to
the pMMO without the involvement of NADH (Tonge et. al., 1977). Although, it has
not been possible for other groups to reproduce their work, there have been subsequent
reports that support this theory. Methanol, ethanol and higher primary alcohols, which
are incapable of directly reducing NAD(P), could act as electron donors in pMMO-
expressing Methylococcus capsulatus (Bath) cell suspensions although the ability was
lost in sMMO-expressing cells (Leak and Dalton, 1983; Stanley et al., 1983). Ethanol
was also shown to act as an in vivo electron donor for pMMO in Methylomonas
methanica (Ferenci et al., 1975; Leak and Dalton, 1983). Since these reports indicate
that methanol can provide electrons for methane oxidation in pMMO-expressing cells
and as primary alcohols are oxidised by methanol dehydrogenase in methanotrophs, it
can be inferred from this that electrons derived from methanol oxidation can be recycled
into the methane oxidation reaction by methanol dehydrogenase, as previously proposed
by Tonge et al. (1977).
To determine the validity of this proposal, various reductants were used to test their
ability to donate electrons to the membrane associated and purified pMMO. Samples of
pMMOm and pMMOc were prepared as described in Chapter 3 and used at final
concentrations of 5mg/ml and lmg/ml respectively in the reaction mixture. Activity
assays were performed as outlined in Chapter 2, section 2.9.2 and 2.9.3, with the
addition of 50J,lM CUS04 and the various electron donors. Reaction mixtures were
incubated for 1 minute before initiation of the reaction by the addition of propylene.
This method was used in preference to the initiating the reaction with the addition of
reductants, for comparative assays, since plastoquinols are dried to the bottom of the
assay vial and therefore present at the start of the reaction. Control experiments were
carried out in the absence of reductant.
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Reductant
(mM)
120
Formaldehyde
Methanol
Decylplastoquinol
Duroquinol + NADH
Duroquinol
Control
Figure 4.3 Relative propylene oxidising activities of pMMOm with
different reductants. The final concentration of the particulate extract in the
assay was Smg/ml. Final concentrations of reductants in the reaction mixture
were SmM for NAD, NADH, methanol and formaldehyde and 1mM for
duroquinol, decyl-plastoquinol unless otherwise stated. NAD was added at a
final concentration of SmM. Average NADH-linked activity was 30 nmoles of
propylene oxide produced/min/mg and was taken as 100% activity.
o 20 40 60 80 100
% Activity
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Figure 4.4 Relative propylene oxidising activities of the pMMO complex
with different reductants. The pMMO complex (1mg/ml.) was purified as
described in Chapter 3, section 3.6. Final concentrations of reductants in the
assay were 5mM for NADH, methanol and formaldehyde and 1mM for
duroquinol, plastoquinol and POO (pyrroloquinoline quinone) unless otherwise
stated. NAD was added at a final concentration of 5mM. Average duroquinol-
linked activity was 50 nmoles of propylene oxide produced Imin/mg and was
taken as 100% activity.
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The results shown in Figure 4.3 indicate that NADH (30 nmoles/minlmg) is by far the
best reductant for the pMMOmextracts with duroquinol as second best with only 19% of
the NADH-driven activity. The fmding that methanol can act as a reductant to the
pMMO, albeit poorly at 4% of NADH-driven activity, is in agreement with previous
proposals that primary alcohols can serve as electron donors to pMMO. Methanol-
driven activity is increased in the presence of NAD in pMMOm to give a tenth of
NADH-driven pMMO activity and 50% of the activity when duroquinol is used as the
electron donor. The enhancement of methanol-driven activity with NAD may be
explained by the fact that the addition of NAD shifts the equilibrium of the
formaldehyde oxidation reaction to the left, causing an increase in the rate of the NAD-
linked formaldehyde oxidation in order to try and restore equilibrium. This in turn
increases the rate ofthe methanol oxidation reaction, subsequently enhancing the rate of
pMMO activity. Formaldehyde can also act as a poor reductant to pMMOm (5% of
NADH-driven activity) which may indicate that the methanol dehydrogenase is
recycling electrons derived from formaldehyde oxidation back to the pMMO.
Alternatively it may suggest that the NADH produced during the formaldehyde
oxidation reaction is one of the sources of reducing power for the pMMO.
Figure 4.4 indicates that various plastoquinol analogues, m particular duroquinol
(50nmoles/minlmg) are effective at donating electrons directly to the purified pMMO
complex. It is not known whether this is due to the fortuitous homology of the
plastoquinol analogues to the direct in vivo electron donor for pMMO. NADH-,
methanol- and formaldehyde-linked activity is lost in pMMOc samples. This may
indicate that the methanol dehydrogenase is not fully functioning in the pMMO complex
or an unknown electron transport component necessary for coupling reducing
equivalents fromMDH or NADH to the pMMO has been removed during purification.
The methanol dehydrogenase co-factor, pyrroloquinoline quinonone, PQQ (in the
reduced form, PQQH) does not act as a reductant to pMMOc and may reflect the need to
obtain a fully functional PQQH. Addition ofPQQH (lmM) actually inhibits duroquinol-
driven activity of pMMOc although NAD appears to slightly lessen the effect of
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inhibition. A higher concentration of PQQH (2mM) causes total inhibition of activity.
This indicates that there may be competition for binding to a quinone-binding site in the
complex.
In contrast to the fmdings of Tonge et al. (1975) and Nguyen et al. (1998), both
ascorbate and dithionite 'were unable to donate electrons to pMMO but this result is
perhaps unsurprising as they have previously been shown to inhibit pMMO activity in
this study (Chapter 3, Table 3.1).
4.4.2 In vitro Electron Donors for pMMO
The results of the previous section indicate that NADH is a highly efficient electron
donor to the pMMO when it is present in the membrane but once pMMO is purified,
NADH ceases to act as a reductant. However, plastoquinol analogues, in particular
decylplastoquinol and duroquinol were shown to be capable of providing reducing
power to the pMMOc which is in agreement with the fmdings of Shiemke et al., 1995.
The findings indicate that NADH may not be the direct electron donor to pMMO in vivo
but is probably the ultimate source of reducing power via an electron transport chain.
Preliminary electron transport inhibitor studies were performed using the particulate
system from Methylosinus trichosporium OB3b by Tonge and coworkers (1975).
Amytal was found to inhibit the transport of electrons to pMMO from NADH but not
from ascorbate, indicating that NADH is not the direct in vitro electron donor of
pMMO. Prior and Dalton (1985) proposed that the inhibition of NADH-driven pMMO
activity in intracytoplasmic membranes from Methylococcus capsulatus (Bath) by
potassium cyanide and sodium azide was due to the fact that NADH was not the direct
electron donor to pMMO in vitro. This proposal was upheld by the findings of Charlton
(1997) on the effect of electron transport inhibitors on pMMOm and pMMOs samples
from Methylococcus capsulatus (Bath) using the electron inhibitors antimycin A,
oligomycin, rotenone, 2,4-DNP and HOQNO. The different electron transport inhibitor
profiles obtained for NADH- and duroquinol-driven pMMO activity indicated that these
reductants transfer electrons to the pMMO via two different systems.
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The rationale behind the following series of experiments was to ascertain whether
specific electron transport proteins playa role in NADH- or duroquinol-driven pMMO
activity in the membranes or the purified complex from Methylococcus capsulatus
(Bath).
Electron transport inhibitors (detailed in Table 4.2) were made up in lOmM Pipes,
pH7.25 by ultrasonic dispersion in a manner similar to that described by Colby and
Dalton (1976) at final concentrations stated in this study. The pMMOmand pMMOc
samples were prepared as described in Chapter 3 and were used at fmal concentrations
of lOmg/ml and lmg/ml respectively, in the reaction. pMMO samples were
preincubated for 1 minute Withthe inhibitor prior to the addition of propylene to start
the reaction. MMO activity was determined by measuring the epoxidation of propylene
by gas chromatography. Control reactions were carried out with the absence of the
electron transport inhibitor for each series of experiment.
Inhibitors Mode of action
Antimycin A Inhibits electron flow between flavoproteins and cytochrome
b. Inhibits electron flow between b and Cl.
Oligomycin Prevents the final ATP formation.
Rotenone Inhibits the transfer of electrons fromNADH to flavoproteins.
2,4-DNP An uncoupling agent that allows electron flow but not
phosphorylation.
"
HOQNO Inhibits electron transport between cytochromes b and c or
flavoprotein and cytochrome b.
KCN Inhibition of terminal oxidase- may act to bind to the terminal
oxidase, where it reacts with the ferric form of haem a3 to
block the electron flow in cytochrome oxidase.
Table 4.2 The electron transport inhibitors used in this study and their
modes of inhibition. Abbreviations are: 2,4-DNP=2,4 dinitrophenol,
HOQNO=2-N-heptyl-4-hydroxyquinoline-N-oxide, KCN=Potassium cyanide.
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Figure 4.5 indicates that HOQNO (1O-3M) causes inhibition, giving 40% of pMMO
activity in the membrane-associated system when NADH was used as a reductant. This
is in contrast to the results observed by Charlton (l997) who observed total inhibition of
NADH-driven pMMOm activity at this concentration of HOQNO. Although, total
inhibition could be obtained at higher concentrations of HOQNO (> 10-2M). The
discrepancy was thought to be due to the limited solubility of the HOQNO. This result,
in conjunction with the observation that rotenone (a flavoprotein inhibitor) only causes
5% inhibition of NADH-driven pMMOm indicates that b- and c- type cytochromes are
involved. HOQNO had no effect in the duroquinol-driven systems (Figure 4.6 and 4.7)
at any concentration indicating that cytochromes b and c do not playa role in electron
transfer between duroquinol and pMMO. Cyanide (l0-3M) inhibited NADH-driven
pMMOm activity giving 80% of the original activity, total inhibition of pMMO activity
was achieved at higher concentrations of cyanide (10-2M). This suggests that NADH is
not the direct in vitro electron donor to pMMOm and could indicate the possible
involvement of a KCN-sensitiveprotein possibly a cytochrome, in the transfer of
electrons to the pMMO. The other electron transport inhibitors did not affect NADH-
linked pMMO activity in membranes indicating that there was unlikely to be any other
electron transport protein involved in the transfer of electrons from NADH to pMMO.
An interesting result shown in Figure 4.6, is that the duroquinol-driven pMMOm activity
was inhibited by 2,4 dinitrophenol (2,4-DNP, 1O-2M),which gave 70% of pMMOm
activity in the presence of duroquinol. It is possible that the 2,4-DNP may be inhibiting
a pump necessary for maintaining a proton motive force (pmj) or for transporting the
reductant to a binding site, across the membrane since the pMMO complex is restricted
in one main orientation in the membrane. This may then explain the lesser effect of 2,4-
DNP in the purified pMMO as either the pmf would be dissipated or the reductant
binding site may be more accessible. Duroquinol-driven pMMOm activity is also
inhibited by cyanide (l0-3M), which gave 57% of original pMMO activity (total
inhibition at 10-2Mcyanide) indicating the presence of a cyanide sensitive protein in the
transfer of electrons from duroquinol to pMMO. The rest of the electron inhibitors have
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much less of an effect in the duroquinol-driven pMMOm indicating that there are no
other electron proteins involved in electron transfer from duroquinol to pMMO.
Inhibitors
(M)
2,4-DNP (10-2)
Rotenone (10-3)
Oligomycin (10-3)
Antim ycin (10-3)
Control
pMMOm and NADH
,--------------..,
o 20 10040 60 120 14080
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Figure 4.5 Relative pMMO activities of particulate extracts after
incubation with various electron transport inhibitors using 5mM NADH as
the reductant. The protein concentration for each assay was 5mg/ml. Assays
were carried out as described in Chapter 2, Section 2.9.2. Inhibitors were
dissolved at the appropriate concentration in 10mM PIPES buffer, pH 7.25.
Particulate extract was preincubated for 1 minute with inhibitor prior to the
assay. The control assay did not contain any inhibitor. Average NADH-linked
activity was 70 nmoles of propylene oxide produced/min/mg of protein and was
used as 100% pMMO activity.
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pMMOm and duroquinolInhibitors
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2,4-DNP (10-2)
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Figure 4.6 Relative pMMO activities of particulate extracts after
incubation with various electron transport inhibitors using 5mM
duroquinol as the reductant. The protein concentration for each assay was
5mg/ml. Assays were carried out as described in Chapter 2, section 2.9.2.
Inhibitors were dissolved at the appropriate concentration in 10mM PIPES
buffer, pH 7.25. Particulate extract was preincubated for 1 minute with inhibitor
prior to the assay. The control assay did not contain any inhibitor. Average
duroquinol-linked activity was 20 nmoles of propylene oxide produced/min/mg of
protein and was taken as 100% pMMO activity.
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Inhibitors
(M)
KeN (10-3)
HOQNO (10-3)
2,4-DNP (10-2)
Rotenone (10-3)
Oligomycin (10-3)
Antimycin (10-3)
Control
D pMMOc and duroquinol
Figure 4.7 Relative activities of pMMO complex after incubation with
various electron transport inhibitors using duroquinol as the reductant.
The protein concentration for each assay was 1mg/mL Assays were carried out
as described in Chapter 2, section 2.9.3. Inhibitors were dissolved at the
appropriate concentration in 10mM PIPES buffer, pH 7.25. The purified pMMO
complex (as described in Section 3.6) was preincubated for 1 minute with
inhibitor prior to the assay. The control assay did not contain any inhibitor.
Average duroquinol-linked activity was 50 nmoles of propylene oxide
produced/min/mg of protein and was taken as 100% activity.
o 20 100 12040 60 80
0/0 Activity
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The purified duroquinol-driven pMMO complex is unaffected by all the electron
transport inhibitors except cyanide (10·3M) which completely inhibits enzyme activity
(Figure 4.7). The inhibition of duroquinol-driven activity in both pMMOm and pMMOc
by cyanide indicates that a cyanide-sensitive electron transport protein e.g. terminal
oxidase may be involved in the mechanism of donating electrons to the pMMO.
However, this is a curious result for the purified pMMO complex since no electron
transport components have been identified. It should be noted that cyanide is known to
be an inhibitor of some methanol dehydrogenases (Anthony, 1986) and the earlier
findings in this chapter, point to the fact that the putative pMMO reductase is a methanol
dehydrogenase. In the light of this, it can be proposed that the complete inhibition of
pMMO by cyanide may be ""dueto the inhibition of the methanol dehydrogenase which
plays a direct role in the transfer of electrons from duroquinol to the pMMO
hydroxylase after the complex is purified.
4.5 Inhibitor profile inhibitors of the pMMO complex
Previous inhibitor studies on membrane-associated and solubilised pMMO have
identified reagents that inhibit the activity of pMMO (Prior and Dalton, 1985, Stirling
and Dalton, H., 1986, Charlton, S., 1997). Chelating or metal-binding agents, in
particular copper chelators such as DDTC, cause inhibition of pMMO activity. This is
reasonable evidence for the involvement of the copper ions in the enzyme. Sulphide
bond modifying agents e.g. dithionite and mercaptoethanol have also been shown to
cause inhibition of pMMO activity. These agents work by reducing disulphide bonds,
disrupting non-covalent interactions and resulting in cleavage of proteins. Therefore
these fmdings indicate the importance of sulphide bonds in the pMMO enzyme,
although the exact significance of this is unclear. Acetylenic compounds are suicide
substrates that bind irreversibly to the active site of the pMMO hydroxylase which then
converts it to the unstable oxirene which is proposed to inactivate the pMMO by
electrophilic attack of nucleophiles in the active site (Prior and Dalton, 1985).
Previous inhibitor studies were carried out on crude extracts of pMMO, which could
lead to ambiguities as any number of proteins, which may be required for a functional
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enzyme, could be inhibited. The following experiment was carried out to assess the
sensitivity of pMMOc to a variety of proposed inhibitors of pMMO. The inhibitors were
made in the 10mM Pipes, pH 7.25 up to the final concentrations detailed in Table 4.3.
The pMMOc sample was used at a fmal concentration of 1mg/ml in the reaction mixture.
pMMOc was preincubated for 1 minute with the inhibitor prior to the addition of
propylene to start the reaction. MMO activity was determined by measuring the
epoxidation of propylene by gas chromatography, A control reaction was carried out in
the absence of the inhibitor and its activity was taken as 100% activity.
Inhibitor Mode Final Specific Activity %
"" Concentration (nmoles of Activity
(mM) propylene oxide
produced/minlmg)
None None 0 56±3 100
Acetylene Suicide substrate Excess 0 0
Dithiothreitol Sulphide bond 0.1 0 0
Modifying agent
Mercapto- Sulphide bond 0.1 0 0
Ethanol Modifying agent
Imidazole Copper chelator 0.1 9±1 16
EDTA Divalent metal 10 28±2 50
chelator
DDTC Copper chelator 0.1 12±3 72
Table4.3 Effect of inhibitors on pMMOc activity at specified
concentrations, using duroquinol as reductant. The results of the single
dose experiment are an average of at least two experiments. A final pMMOc
concentration of 1mg/ml was preincubated for 1 minute with the inhibitor prior to
the addition of propylene to start the reaction. MMO activity was determined by
measuring the epoxidation of propylene by gas chromatography as described in
Section 2.9.3. A control reaction was carried out in the absence of the inhibitor
and its activity was taken as 100% activity.
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The results shown in Table 4.3 are in good agreement with previously published results.
Acetylene caused total inhibition of the pMMO complex indicating that it is a potent
inhibitor ofpMMO activity. This is in agreement with the previous fmdings of Prior and
Dalton (1985).
Both the sulphide bond-modifying agents, dithiothreitol (DTT) and mercaptoethanol
caused total inhibition of pMMO activity. There are only two cysteine residues present
in the published protein sequence of the pMMO hydroxylase (Semrau et al., 1995;
Stolyar et al., 2000) which could form a disulphide link, one which is present inpmoA
(J3 subunit) and the other in the pmoC (y subunit). Clearly the assumed disulphide link
-
formed between these residues is vital for the functioning pMMO complex possibly
because it maintains the structural integrity of the hydroxylase.
The metal binding agents imidazole, EDT A and DDTC caused partial inhibition of the
pMMO which is consistent with the suggestion that certain divalent cations are
necessary for pMMO activity. The exact role of metal ions in the pMMO is discussed in
detail in the next chapter.
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4.6 Kinetics of methane oxidation by the pMMOc
The rationale behind the following experiment was to determine the kinetic constants for
methane oxidation by the pMMOc from Methylococcus capsulatus (Bath). Having
defined these kinetic constants they can then be used to compare the efficiency of
methane oxidation by different enzymes e.g. sMMO or pMMO from different
methanotroph strains. The pMMOc sample was used to generate initial velocity plots at
increasing concentrations of methane. Methane concentrations were calculated using
Henry's constant of 4.3 at 45°C as stated in chemical tables (Chapter 2 section 2.9.3). A
double reciprocal Lineweaver-Burk plot was generated in order to calculate the kinetic
constants Vmax and Km.
The kinetic constants Vmax and Km were calculated from the double Lineweaver-Burk
plot (Figure 4.8).
y-axis intercept
Therefore, Vmax
== I/Vrnax = 0.0075
= 133 nmoles/minlmg
x-axis intercept
Therefore, Km
== -11Km
=0.2mM
= -5
Hence, the kinetic constants Vmax and Km were 133 nmoles/minlmg and 200IlM,
respectively. Low concentrations of methane were difficult to measure manually with
accuracy and may have given rise to some misleading data. Ideally, this experiment
should be carried out using cyc1opropanol, a specific inhibitor of the methanol
dehydrogenase (MDH) which is not available commercially. This would ensure that
methanol production measurements were not being affected by methanol utilisation by
MDH.
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Figure 4.8 A double reciprocal Lineweaver-Burk plot of the pMMO
complex using increasing concentrations of methane. 1mg/ml pMMOc was
used in the assay. The assays were carried out using 10mM Pipes pH7.2S,
SmM duroquinol, 40!-lM copper sulphate and 1 mg/ml of purified pMMO
complex. Assays were taken at 3 and 6 minutes intervals for each methane
concentration. Results are the average of at least two assay.
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The kinetic constants for methane monooxygenase reported by various groups IS
summarised in Table 4.4 below.
Strain Author Km Vmax
(IlMl nmoles/minlmg
pMMOcfrom This study 200 133
Methylococcus capsulatus
(Bath)
sMMO Methylococcus Green and Dalton 3.0 -
..
capsulatus (Bath) (1986)
pMMO-expressing Carlsen et al. 23 457
Methylococcus capsulatus (1991)
(Bath) cells
pMMOcfrom Tonge etal. 66 -
Methylosinus (1977)
trichosporium
Table 4.4 Comparison of kinetic constants Km and Vmax for methane
oxidation by methane monooxygenase by various groups.
The Km value for methane in this study is -3-10 fold higher than the Km values for
pMMO found by other groups (Table 4.4).' The soluble MMO appears generally more
efficient than its counterpart pMMO as it has a much lower Km for methane that pMMO
i.e. lower concentration of methane are required to obtain maximal enzyme activity.
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4.7 UV-visible spectral properties of pMMOc and components
Neither Zahn and DiSpirito (1996) nor Nguyen et al. (1998) observed co-factors
associated with their purified pMMO preparations. Both claim to have some haem
contamination as previously discussed in Chapter 1. Co-factors e.g. haem groups, absorb
at characteristic wavelengths, therefore pMMOc and its individual components were
examined to see if they contained any associated co-factors. The pMMOc, pMMOH and
pMMOR samples were prepared as described in Chapter 3, section 3.10. The UV-visible
spectra were measured on a Hewlett Packard diode array spectrophotometer (Chapter 2,
section 2.10.6)
pMMO complex
Hydroxylase
Reductase
Figure 4.9 Absorption spectra of the pMMO complex, hydroxylase and
reductase. Protein samples were diluted to give final concentrations of
~1Of.lg/ml Peaks were observed at 280nm and 310nm which are characteristic
of protein and haem constituents respectively.
Absorbanc
The absorption spectrum of the pMMO complex in Figure 4.9 depicts an absorption
band at 412nm that is indicative of the presence of haem. On dissociation of the
complex i.e. when the components of the complex are purified, the haem component is
removed. This suggests that the haem is non-covalently associated with the complex and
could indicate the presence of a h-type haem (protohaem IX). The presence of haem is
0.5
300 400
Wavelength (nm)
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consistent with the findings of Nguyen et al. (1998), where minor haem contamination
with a weak absorption band at 410nm were also observed in purified pMMO samples.
Samples were boiled to 100°C for 5 minutes in order to release the methanol
dehydrogenase co-factor PQQ, with a characteristic peak at 345nm and a shoulder at
400nm. Boiling had no significant effect on the spectra observed in Figure 4.9
suggesting that PQQ was not present in these samples. However, PQQ may be present at
such low concentrations in the samples as to make it undetectable.
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4.8 General Discussion and conclusions
In this chapter the putative pMMOR was identified as a probable methanol
dehydrogenase (Section 4.3). This was an important finding which led to the subsequent
reinvestigation of the proposal that in vivo electron transfer might occur via a
mechanism in which methanol dehydrogenase (MDH) recycles electrons generated from
methanol oxidation back to the pMMO without the involvement of NADH (Tonge et.
al., 1977). The fmdings in this study indicated that methanol can provide reducing
power to the pMMOm, albeit poorly at only 5% of NADH linked activity and was
consistent with the earlier finding that primary alcohols could act as electron donors to
Methylococcus capsulatus (Bath) cells (Leak and Dalton, 1983; Stanley et al., 1983).
"
The possibility of methane oxidation without the need for NADH would allow the cell
to conserve energy. This is supported by the fact that cells expressing pMMO are
energetically more efficient (in terms of g cells produced/g methane consumed) than
cells expressing sMMO (Dalton and Leak, 1985).
The ability of methanol to act as reductant to the pMMO was lost upon purification of
the enzyme which probably reflect the need to obtain a fully functioning methanol
dehydrogenase with an intact cofactor, pyrrolo-quinoline quinone (PQQ). This is
supported by the results of the DV-vis spectra (Figure 4.9) that indicate that the PQQ is
not present in the purified MDH (pMMOR).
The findings in section 4.4.2 indicate that PQQ may compete with duroquinol for a
,
quinone-binding site in the pMMO complex. This site could be like the quinone-binding
sites found in the plant alternative oxidase (Moore et al., 1995). Alternatively, the PQQ
is known to exist in a hydrophobic site in the a subunit of the methanol dehydrogenase
(Anthony et al., 1994) and it may be possible that this is where duroquinol interacts with
the MDH.
The electron transport inhibitor studies indicate that NADH provides electrons for the
pMMO via other electron transport proteins possibly b- and c-type cytochromes. The
fact that rotenone, a flavoprotein inhibitor, does not inhibit NADH-driven pMMO
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activity does not rule out the possibility that a rotenone resistant flavoprotein similar to
the type II NADH-quinone oxidoreductase (Yagi et al., 1991) may be involved in
electron transfer.
The electron transport proteins are probably removed during solubilisation and
purification of the pMMO complex, as duroquinol-driven pMMOc activity is only
inhibited by cyanide, which is proposed to inhibit the pMMORlMDH component of the
pMMO complex. In summary, the results from this part of the study indicate that NADH
donates electrons to the pMMO via a series of electron transport proteins and duroquinol
directly provides electrons to the pMMO complex (Figure 4.10).
The inhibitor profile (Section 4.5) generated in this study has similar results as those
found previously for the particulate enzyme (Prior and Dalton, 1985, Stirling and
Dalton, 1986, Charlton, 1997). The sulphide bond modifying agents e.g. DTT have a
profound effect on pMMO activity. This suggests that a covalent sulphide bridge may
have an important role in the pMMOc• The cysteine residue present in the pmoA ((3)
subunit, which is proposed to contain the active site (Semrau et al., 1995), is conserved
in the sequence of ammonia monooxygenase (AMO)' from Nitrosomonas europaea
which suggests that the cysteines may have an important role possibly in the active site
ofpMMO.
Inhibitor profiles of the pMMO complex confirm the importance of copper ions in the
enzyme, possibly in the active site. However, it is as yet unclear what form this copper
takes and whether there are any other metals involved in the active site. The next part of
the study was to clarify the nature of metal ions in the active site ofpMMO.
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NADH
.. Possible routes of electron transfer to pMMO from NADH
• Possible route of electron transfer to pMMO from duroquinol
• I Methane oxidation reaction ' I
Figure 4.10 Proposed mechanism of electron transport routes to pMMO
from NADH and duroquinol.
NAOH transfers electrons to the pMMO via a possible rotenone-insensitive
flavoprotein NAOH oxidoreductase. The electrons could then be passed onto
cytochromes-b and cytochromes-c and finally on to the pMMO. Alternatively,
electrons may be passed from NAOH to an unknown quinone pool and then on
to the cytochromes and finally pMMO.
Duroquinol transfers electrons via the pMMOR/methanol dehydrogenase (MOH)
to the pMMO hydroxylase.
93
5. The nature of the metal ions in the active site of pMMO
5.1 pMMO and electron paramagnetic resonance spectroscopy (EPR)
The role of copper in the enhancement of activity in pMMO has been well established
(Stanley et al., 1983; Prior and Dalton, 1985; Zahn and DiSpirito, 1996; Chan et al.,
1993). This has led to the assumption that pMMO is a metalloprotein containing copper.
Two different laboratories (Zahn and DiSpirito, 1996; Nguyen et al., 1998) have reported
the purification and characterisation of the pMMO enzyme from Methylococcus
capsulatus (Bath). However, depending on the report, the active site was found to contain
both iron and/or copper.
Electron paramagnetic resonance (EPR) is one of the principal methods used to study
metal sites and its ligand environment in a metalloprotein. Metalloproteins like pMMO
with Cu2+ ions (Spin =112) and/or Fe3+ ions (Spin = 5/2, 1/2) etc. have EPR absorbance
peaks. EPR techniques have been used successfully to probe the metal site of the pMMO
complex as described in more detail in Section 5.2.
5.1.1 Introduction to EPR
The following section is a brief introduction to the fundamentals of electron paramagnetic
resonance (EPR) spectroscopy for those unaccustomed to the technique.
Since electrons possess both spin (S) and charge they behave like magnets i.e. exhibit
magnetic moments (paramagnetism). In the presence of an applied magnetic field,
electrons can exist in two different states, either aligned parallel with the field in a ground
state (low energy) or antiparallel to the field in an excited state (high energy). Transition
ofthe electron from a low to a high-energy state is induced when an electromagnetic
radiation of appropriate frequency is applied to make resonance occur (as depicted in
Figure 5.1).
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The resonance condition is defmed as
where
I hv=gPBo
h = Planck constant
v = frequency of applied radiation
g = constant, electronic splitting-factor (free electron=2.0023)
p= magnetic moment of the electron - Bohr magneton (0.92 x 10-23 J.T)
Bo= applied magnetic field .
s = 112
IAbsorptionx
dX/dB I First derivative ~ .8
Figure 5.1 Schematic diagram of resonance (hv) in a two-level system
giving rise to EPR absorption peaks.When the sample is placed in a magnetic
field, B and an electromagnetic radiation of appropriate frequency is applied,
electron transition gives rise to EPR absorption peaks (X) and subsequent
derivative spectra. The two levels are described by the magnetic quantum
number Ms=±1/2.
Figure 5.1 depicts what happens when an experimental sample is placed in a magnetic
field and an electromagnetic radiation of appropriate frequency is applied. The resulting
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electron transition gives rise to EPR absorption peaks. The EPR spectra are displayed as
the first derivative of the absorption spectra and can be characterised by four main
parameters:
Parameter Description
g-value This is a measure of the local magnetic fIeld of an electron
giving information on the nature of bonding and the immediate
environment of the unpaired electron.
Intensity This gives information on the concentration of the radical. The
integrated area under the signal IS proportional to the
concentration of unpaired spins giving rise to the signal.
Multiplet structure Hyperfine splittings (A) are caused by the interaction of the
unpaired electron with adjacent nuclei (I) and give information
on the spatial location of atoms in the molecule
Linewidth Spin-lattice relaxation time (T,) is the measure of the recovery
rate of the spin population after perturbation. The shorter the T,
the broader the line. Homogenous broadening occurs due to
different magnetic fields experienced by each molecule
therefore, spreading the resonance frequency. Usefullinewidths
for observing EPR signals can be obtained by altering the
temperature of the sample.
Table 5.1 Definition of the parameters associated with EPRspectra. The
parameters are listed in the left-hand column and a brief definition of these
parameters is given in the right -hand column.
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5.1.2 Copper and EPR
It is has been established that copper is an integral element at the active site of pMMO.
However, the type of copper in pMMO is still a matter of controversy and is discussed in
brief here and in more detail in section 5.2. The cupric ion, Cu2+ (3d9) is EPR detectable
because of its unpaired electron whereas the cuprous ion, Cu+ is EPR silent. Figure 5.2
depicts the electron configuration of copper and its ions.
3d 4s 4p
Cu 1'.1'.1'.1'.1'.1 [!J
eli 1'.1'.1'.1'.1'.1 []
eu2+ 1'.1'.1'.1'.1+ 1 []
Figure 5.2 Electron configuration of copper and its ions. The 3d, 42 and
4p atomic orbitals are depicted in the schematic diagram.
Copper (II) ions use four bonds in complex formation. A type 2 Cu2+ centre is formed
when the copper is ligated by three ligands, either 3 nitrogen atoms, 2 nitrogen and 1
,
oxygen atom or 2 nitrogens and 1 methionine. The fourth co-ordination site may remain
free in which case the copper usually has a catalytic (C) role. If the fourth coordination
site is taken then only a fifth apical site is free and therefore there is no co-ordination site
available for interaction with oxygen etc. In this instance the copper will usually be
involved in electron transfer (E). A
y
Figure 5.3 Copper (II) ions use four bound in complex formation. The spatial
arrangement of a square planar complex. A=apical site; N=nitrogen; X=nitrogen ,
oxygen or methionine; Y=N or free.
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5.2 Background to EPR studies on pMMO
Chan and coworkers (Chan et al., 1993; Nguyen et al., 1994, 1996a, 1996b, 1998)
suggested that the copper in the active site of pMMO exists as trinuclear copper clusters.
This model was based on correlating spectral (EPR) changes in the membrane fraction
and purified pMMO to methane oxidation activity and to changes in copper composition
of the membrane fraction. Although the as-isolated pMMO samples exhibited EPR
spectrum typical of a type 2 copper signal; when the samples were oxidised with
ferricyanide, a broad isotropic copper EPR signal was observed which was thought to
correspond to spin-coupled copper clusters. An isotropic copper signal is an unusual
signal and is normally see~.when there is a high copper concentration (>1.5mM) in a
sample. This gives rise to spin-spin interactions, resulting in broadening of the EPR
signal and causing the gil features to disappear. The majority of copper was shown to exist
in Cu" form by K-edge X-ray absorption spectra of membranes (Nguyen et al., 1996).
However, this 'broad isotropic copper signal' was not detected in purified preparations of
pMMO by Zahn and DiSpirito (1996) who claimed that this signal originated from
membrane-associated copper-binding cofactors (CBCs). They claimed that this small
(618Da) co-factor could bind to 2 to 3 copper atoms and exhibited a complex EPR
spectrum, which could account for the previously observed copper EPR signals in the
membrane fraction of Nguyen et al. (1996).
The EPR spectrum of the purified enzyme observed by Zahn and DiSpirito (1996)
showed evidence for a type 2 copper centre (gil =2.26 and gj_= 2.06, A{u = 180 G, AN=
15G), a weak high spin iron signal (g=6.0) and a broad low field signal at g=I2.5 which
was lost when the sample was reduced. The active enzyme complex was found to contain
2.5 iron and 14.5 copper atoms per 99kDa.Their results showed that the majority of iron
associated with the membrane fraction was EPR silent and only detectable after
formation of an iron-nitric oxide derivative. They concluded that the non-haem iron
existed as a single ferrous iron centre, an iron-iron centre or an iron-copper. The presence
of iron in the enzyme was also supported by the observation of copper-induced iron
uptake into the membranes, activation of pMMO by ferric ions in purified preparations of
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Methylococcus capsulatus (Bath) and inhibition of the formation of the nitric oxide-
ferrous iron complex by preincubation of membrane samples with nitrapyrin.
There is some confusion over the exact nature of the copper ions and whether iron plays
any role in the active site ofpMMO. Antholine and coworkers (Yuan et al. 1997, 1998,
1999; Lemos et al., 2000) have carried out X band and S band EPR studies on whole
cells from Methylococcus capsulatus (Bath) of Methylomicrobium albus BG8, which
were grown in media enriched with 63CU and 15N. They observed two nearly identical
type 2 copper signals in both Methylococcus capsulatus (Bath) and Methylomicrobium
album BG8 cells. The second signal found in membrane fractions was attributed to the
oxidation of cupric sites. The S-band EPR spectra gave resolved N hyperfines in the gj_
region and established unambiguously that one copper was ligated to 4 nitro gens. They
have not as yet carried out investigations on the purified pMMO enzyme.
The reproducible isolation of a duroquinol-driven pMMO complex has allowed
investigations to be carried out in order to clarify the nature of metal ions in the active
site of the pMMO.
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5.3 EPR spectra of as-isolated protein samples
As previously discussed in this chapter, EPR signals corresponding to a ferric iron and a
type 2 copper ions were observed in purified pMMO samples obtained by Zahn and
DiSpirito (1996) from Methylococcus capsulatus (Bath). These fmdings were disputed by
the Nguyen et al. (1998), who claimed that the iron associated with the pMMO was due
to iron-containing contaminants. In addition to this, they proposed that the copper ions
existed as trinuclear copper clusters (Chan et al., 1993; Nguyen et al., 1994, 1996a,
1996b, 1998). Although, Yuan and co-workers (Yuan et al. 1997, 1998, 1999; Lemos et
al., 2000) found no evidence for iron in pMMO from Methylomicrobium albus B08 cells.
They observed copper signals corresponding to a Cu2+ ion ligated to 4 nitro gens.
The first stage of metal analysis by EPR spectroscopy was to examine as-isolated pMMO
samples for copper and iron signals. Samples of membrane-associated, solubilised and
purified pMMO were prepared Methylococcus capsulatus (Bath) as described in Section
2.7 and Section 3.3. The X-band EPR spectra were recorded on a Bruker ESP 300
spectrometer.
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Figure 5.4 EPR spectra of the membrane fraction and the solubilised
membrane of Methy/ococcus capsu/atus (8ath). 200,..tI of membrane sample
(27mg/ml) and solubilised membrane sample (15mg/ml) were prepared for
analysis as described in Section 2.8. Both spectra (pMMOmand pMMOS) had an
axial copper signal with EPR parameters of gll= 2.24 and g..l= 2.06, Allcu=185G,
AN=15G (see Figure 5.8). Spectra were recorded at a microwave power of
10mW, a temperature of 10K and a modulation amplitude of 5G.
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The EPR spectra of membrane-associated and solubilised pMMO (Figure 5.4) indicate
that the solubilisation of intracytoplasmic membranes does not influence the ligand
environment of the cupric sites. Both samples displayed spectra with an axial copper
signal (gil = 2.24, ~ = 2.06 and AIiCu of 1850) which is indicative of a type two Cu2+
signal with square planar geometry. The g.l region had resolved hyperfme signals (~150),
which were due to interactions with nitrogen ligands (Ie4N) =1).
Other signals were observed at g=6, which was assigned to a high-spin ferric signal
(possibly a cytochrome) and a rhombic ferric signal at g=4.3 which is characteristic of
non-specifically bound Fe3+Ion. A signal at g=2 was also observed which is indicative of
an organic radical, possibly a semiquinone species with an approximate concentration of
< 3JlM as determined by integration of the EPR signal. The majority of the semiquinone
signal (g=2) was lost on solubilisation. The specific activities of pMMOm and pMMOs
were 19 and 30 nmoles of propylene oxide produced/minlmg using duroquinol as a
reductant, suggesting that the solubilisation of the pMMO was efficient.
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Figure 5.5 EPR spectrum of purified pMMO complex from Methy/ococcus
capsu/atus (Bath). 200f.!1 of pMMOc (5mg/ml) was prepared for analysis as
described in Section 2.8. The cupric signal had EPR parameters of gil = 2.24,
gj_=2.06 and AlicU=185G. Spectra were recorded at a microwave power of 10mW,
a temperature of 10K and a modulation amplitude of 5G.
The purified pMMO complex (Figure 5.5) also displayed a type 2 copper EPR signal
(~30-40f.!M Cu2+ions) and a signal at g=4.3 corresponding to 'junk iron' similar to the
signal seen in Figure 5.4. This suggests that the purification process does not affect the
EPR cupric signal. The signals at g=2 and g=6 were not 0bserved suggesting these
signals which may be contaminants (cytochromes and semiquinone species), had been
removed during the purification process. The specific activity of pMMOc using
duroquinol as a reductant was ~50nmoles of propylene oxide producedlmin/mg. The
g=12.5 signal observed by Zahn and DiSpirito (1996), possibly corresponding to a
diferric cluster, was not observed in this study.
The preliminary EPR data of pMMO supports a type 2 copper site and provides no
evidence for a trinuclear copper cluster or an iron in the active site.
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5.4 The nature of copper ions in the active site
The following experiments were carried out to try and conclusively establish whether the
copper ions in the active site of pMMO exist as a type 2 copper or a trinuclear copper
cluster.
5.4.1 Oxidation of pMMOcby K3Fe(CN)6
Chan and coworkers (Chan et al., 1993; Nguyen et al., 1994, 1996a, 1996b, 1998) found
that pMMO preparations oxidised by ferricyanide (Fe[CN]6) gave EPR spectra with an
unusual broad, quasi-isotropic signal which they proposed to originate from spin-coupled
trinuclear copper. The intensity of the EPR signal was found to be consistent with the
.'
oxidation of 15 copper ions. However, treatment of pMMO containing membrane
fractions from Methylomicrobium album BG8 with Fe[CN]6 resulted in an EPR signal
that was attributed to CuFe[CN]6 complex and not an intrinsic trimeric copper cluster
(Yuan et al., 1998). A series of oxidation experiments were carried out on pMMOc, using
ferricyanide (Chapter 2, Section 2.10.5) in an attempt to produce EPR spectra that would
indicate whether a trinuclear copper cluster was present as observed by Chan and
coworkers.
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Figure 5.6: X-band EPR spectra of the purified pMMO complex before and
after oxidation. 170~1 purified pMMO complex was incubated with 1mM
K3Fe[CN]6 as described in Section 2.8. Spectra were recorded at a microwave
power of 1OO~W,a temperature of 9K and a modulation amplitude of 5G.
Neither, the broad, quasi-isotropic EPR signals (Nguyen et al., 1996) nor the
CuFe[CN]i- complex (Yuan et al., 1998~ were observed in the oxidised spectra of
pMMO (Figure 5.6) in this study. Oxidation ofpMMOc resulted in a slight increase in the
intensity of the Cu2+ EPR signal but the concentration did not increase by a factor of 2 to
3 as reported by Chan and coworkers (Nguyen et al., 1996, 1998). The broad peak around
2500G is due to CuFe[CN]62- and prevents an exact determination of the Cu2+
concentration. These results indicate that there are some oxidisable Cu+ ions present in
as-isolated pMMO complex.
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5.4.2 Reduction of pMMOc
An increase in the level of reduction of copper ions (Cu+) was correlated with
improvements in pMMO preparations by Chan and co-workers (Nguyen et al., 1996).
They carried out experiments to fully reduce the membrane-copper ions using dithionite,
which was found to be the best reductant for reducing the copper ions. Their dithionite-
reduced samples did not exhibit any EPR-detectable species, indicating most of the
membrane-bound Cu2+ ions can be reduced to the Cu' form (EPR silent). In conjunction
with the results from copper K-edge X-ray absorption spectroscopy they deduced that 70-
80% of the total copper ions existed in the reduced form in as-isolated samples and any
EPR silent copper was therefore due to Cu+ ions not diamagnetic copper ions e.g.
antiferromagnetically coupled copper ions).
The following reduction experiments were carried out on pMMOc to reproduce the EPR
spectra of Chan and coworkers and therefore supporting the theory that the majority of
copper ions may exist in the Cu+ form. pMMOc was placed in an EPR tube, evacuated
and then flushed with argon several times to obtain anaerobic conditions. Anaerobic
solutions of the reductant and the mediator phenyl methyl sulphate (PMS) were then
added and the sample was incubated for 10 minutes prior to EPR measurements Chapter
2, section 2.10.5).
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Figure 5.7 X band EPR spectra of ferric site of pMMOc after reduction by
dithionite. The anaerobic sample pMMOc was reduced with 1mM sodium
dithionite in presence of the mediator 100~M phenyl-methyl sulphate (PMS). The
spectra were recorded at temperature 4K, modulation frequency 100kHz,
modulation amplitude 5G and power 1mW. The radical signal at g=2 is due to
PMS.
The reduction of pMMOc by dithionitelPMS (figure 5.7) resulted in a decrease in the
Cu2+ EPR signal, but not complete reduction of the Cu2+ ions as observed by Nguyen et
al. (1996). The spectrum of the reduced pMMOc gave an unexpected, dramatic increase
in a symmetrical signal at g=4.3, which is usually characteristic of non-specifically bound
Fe3+ ions. The concentration of Fe3+ ions in pMMOc was estimated to be approximately
33 ~M by integration of the Fe3+ EPR signal.
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However, this is a curious result as the reduction of Fe3+ to Fe2+ (EPR silent) ions by
dithionite, would result in a decrease not an increase of the iron signal (g=4.3). This
effect has also been seen in Methylococcus capsulatus, strain M (Dr B. Katterle.
pers.com.). Therefore, the increase in the Fe3+ signal (g=4.3) was thought to be due to an
iron cluster. The power saturation behaviour of pMMOc at 4.5 and 6.5 K was identical to
that of the protein transferrin (data not included), which has a strongly bound octahedral
iron, i.e. rhombic Fe3+. Since this iron centre has the same magnetic behaviour and g-
value as the iron centre in pMMOc it suggests that the iron in the pMMOc exists in the
same ligating environment. A feasible explanation could be a Cu2+ Fe3+ centre, since
the Cu2+ and Fe3+ are magnetically coupled this copper is EPR silent, when the copper is
reduced the Fe3+ becomes visible.
5.5 EPR spectra of pMMOc isolated from 63CU enriched cells
Methylococcus capsulatus (Bath) and Methylomicrobium album BG8 cells grown on both
63CUand 15Nenriched media, were used to unambiguously identify X band and S band
EPR cupric signals that corresponded to a Cu2+ ion ligated to 4 nitro gens (Yuan et al.,
1996; Lemos et al., 2000)
The following experiment was carried out to try and establish whether the superhyperfrne
splittings (AN) observed in the EPR visible cupric site of pMMO were consistent with
spectrum for a type 2 copper and to identify the ligand environment. The copper isotopes
have a natural abundance of 69% 63CUandS 1% 65CU,both have nuclear spins of 1=3/2
and the ratio of the nuclear moments of 63CUand 65CUis 1.07. Therefore, Methylococcus
capsulatus (Bath) cells were grown in 63CUenriched media to avoid superposition of
signals from 63CUand 65CU.
Methylococcus capsulatus (Bath) cells grown in 63CU enriched media were kindly
donated by Dr S. Charlton (Charlton, 1997) and the pMMOc was isolated as described in
Chapter 3.
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Figure 5.8 X-band EPR spectra of pMMO complex isolated from
Methy/ococcus capsu/atus (Bath) cells grown in 63Cu-enrichedand non-
enriched media. pMMOc samples were purified and prepared for EPR analysis
as described in Section 2.7. Spectra were recorded at a microwave power of 100
~W, a modulation frequency of 100 kHz, a temperature of 10K and a modulation
amplitude of 5 G.
As expected, the N-hyperfines were better resolved in the spectra of pMMOc from
Methylococcus capsulatus (Bath) cells grown in 63Cu enriched media than spectra of
pMMOc from Methylococcus capsulatus (Bath) cells grown in non-enriched copper
media (see Figure 5.8). The N-hyperfines were not as pronounced as expected suggesting
the copper exchange may not be complete. There are some traces of the radical signal
(g=2) in this sample.
109
Bc
2600
Magnetic Field (Gauss)
3400.
Figure 5.9 A comparison of the experimental cupric signal from
Methylococcus capsulatus (Bath) with a simulation consistent of type 2
copper spectrum by Yuan and coworkers (adapted from Yuan et al. 1996).
(A) copper EPR signal (gll=2.24) of pMMOc from Methy/ococcus capsu/atus
(8ath) from this study (B) simulation of type 2 copper signal (gll=2.24) with
simulated free radical at g=2.007 (C) simulation of type 2 copper signal without
simulated free radical.
The experimental spectrum of 63CUlabeled pMMOc were compared to simulations of a
type 2 copper spectrum (Figure 5.9). It could be concluded from this that the seven-line
pattern observed in the gj_ region in EPR spectra of pMMOc is consistent with spectra
arising from an unpaired electron spin on a copper coupled to three or four nitro gens. It is
not reasonable to suggest that the spectra consists of a ten-line pattern arising from three
equivalent 1=3/2 copper nuclei as observed for a trinuclear copper cluster model as
proposed by Chan and coworkers (Chan et al., 1993; Nguyen et al., 1994, 1996 and
1998).
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5.6 Concentration of copper in the pMMO
As previously discussed in this chapter, the unusual isotropic copper signal observed by
Chan and coworkers, were proposed to originate from spin-coupled trinuclear copper
clusters. However, this signal is usually observed where there are high copper
concentrations in the sample. Chan and coworkers (Chan et al., 1993; Nguyen et al.,
1994, 1996) suggested that pMMO membranes contained approximately 20 copper atoms
per pMMO molecule. This was found to be similar to the amount found in the purified
pMMO (Nguyen et al., 1998) which comprised of 15 copper ions arranged into 5
trinuclear copper clusters. The role of these clusters was classified into either having an
electron transfer (E) or a catalytic (C) function. They also proposed that the amount of
adventitiously bound copper, associated with pMMO membranes was minimal.
Inductively coupled plasma-mass spectroscopy (ICP-MS) is a technique used to analyse
the metal concentrations in experimental samples. ICP-MS was used by Nguyen et al.
(1998) to give the total copper content in pMMO samples (as detailed in Table 5.2). Zahn
and DiSpirito (1996) found as-isolated pMMO to contain approximately 14 nmoles of
copper atoms per nmole of purified pMMO. They suggested that the EPR spectra which
-
were proposed to correspond to trinuclear copper (Chan et al., 1993; Nguyen et al., 1994,
1996 and 1998) may be due to the copper ions associated with the copper binding
cofactor (CBC).
_,
The following ICP-MS analysis was carried out to obtain the total concentration of metal
ions in the pMMO complex. ICP-MS was performed by the Warwick analytical service,
University of Warwick. Protein samples were prepared as described in Chapter 2, section
2.10.5 ..
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Copper/ Iron/ Specific Activity
Protein Protein (runoles of
(umoles/mg) (umole s/mg)
propylene oxide
produced/minlmg)
pMMO 0.133-0.141 0 2.6-5.1
Nguyen et al. (1998) (15)
pMMOC(as isolated) * 0.025 (3) 0.011 (1) 30
This study
pMMOc +10mM EDTA 0.010 (1) 0.009 (1) 15
This study
.
Table 5.2 Copper and Iron metal analysis of purified pMMO complex
*Metal ion analysis was performed on buffer alone and deducted from sample
values. Values in parentheses show the approximate number of copper atoms
per protein molecule assuming a molecular mass of 104kDa as estimated from
protein sequences available on the NCBI database (http://www.ncbLnim.nih.gov)
under accession number L40804.
After pMMOc was treated with 10mM EDTA, the ICP-MS measurements (Table 5.2)
shows that the total concentration of copper ions decreased by approximately 2 fold to
O.OIJ-lmoles/mg. The concentration of total iron did not notably decrease after EDTA-
treatment. The specific activity of the pMMOc decreased by 50% suggesting that the
copper ions removed were essential for activity. When the EDTA-treated pMMOc sample
was analysed by EPR (Figure 5.10) there was no drastic change in the cupric signal
although the N-superhyperfmes were slightly better resolved indicating that very little of
the Cu2+. ions were removed. This indicates that the copper ions removed do not
contribute to the cupric signal but are still necessary for the enzyme i.e. EPR silent
copper ions.
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Figure 5.10 Spectra of purified pMMO complex before and after EDTA-
treament. 10mM EDTA was added to 200f.!1 of purified pMMOc and then
removed by washing as described in Section 2.8. The spectra were recorded at
The blue curve is pMMOc washed with EDTA. Recording conditions are:
temperature 10K, modulation frequency of 100kHz, modulation amplitude of 5G,
power 100 f.!W.
Having ascertained that extra coppers were required for enzyme activity, the following
experiment was carried out to investigate the effect of copper addition to the EDTA-
treated pMMOc to see if the added copper ions would undergo magnetic interaction
therefore supporting the trinuclear copper cluster proposal by Chan and coworkers (Chan
et al., 1993; Nguyen et al. 1994, 1996, 1998). The EDTA-treated pMMOc sample was
estimated to have approximately 14f.!MCu2+ ions, by integration of the copper signal and
was the value for [Cu]o in the following copper titration experiment. The addition ofCu2+
ions was correlated with the concentration of Cu2+ ions that could be calculated by
integration of the corresponding signal. Any magnetic interaction of the copper ions
would result in a lower intensity cupric signal than expected for the corresponding
concentration of Cu2+ ions added.
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Figure5.11 Graph of copper titration against concentration of copper
deduced by corresponding signal in pMMO complex. CUS04 was
sequentially added to 200f.l1 of as-isolated pMMOc (Smg/ml), to give the final
concentrations detailed in x-axis above (Chapter 2, Section 2.10.5). Corrected by
[Cu]o = 14f.lM.
Figure 5.11 demonstrates that the addition of copper was reflected by the same increase
in Cu2+ detection. This infers that there is no magnetic interaction between the added
coppers i.e. there was no copper cluster formation, and is evidence (though not
conclusive) that does not support the trinuclear copper cluster hypotheses suggested by
Chan and coworkers (Chan et al., 1993;Nguyen et at, 1994, 1996 and1998).
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Figure 5.12 EPR spectra of the pMMO complex before and after addition of
1571lM copper. The blue curve represents untreated pMMOeand the black curve
represents pMMOe + 157 IlM Cu2+. The spectra were recording using conditions:
temperature 10K, modulation frequency 100 kHz, modulation amplitude 5 G,
power 100 !-LW.
The EPR parameters of the cupric site shifted slightly with the addition of 1571lM copper
and there was no resolution of the N hyperfmes (Figure 5.12). The extra adventitiously
bound copper superimposed the pMMOc cupric site making it difficult to distinguish the
environment of the coppers based on analysis of the copper hyperfmes and g-values.
Interestingly, this spectrum was similar to the oxidised pMMO sample spectra observed
by Chan and co-workers (Nguyen et al., 1996 and 1998). This indicates that the
concentration of copper is unusually high in the sample and may contribute to the broad
isotropic signal thought to correspond to trinuclear copper clusters by Chan and co-
workers. This is in agreement with the proposal by Zahn and DiSpirito (1996) although
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they suggest that the signal may be due to the association of copper ions to copper
binding cofactors (CBCs).
5.7 Probing the active site of pMMO
All fmdings from this EPR study indicate a type 2 copper centre in the pMMO complex
not a trinuclear copper cluster. A confirmation of the importance of this site for pMMO
activity can be carried out using known substrates and inhibitors as probes for the active
site of pMMO as they may perturb the cupric EPR signal. Acetylene was used to
investigate the active site of pMMO by Charlton (1997) although the fmdings were
inconclusive and may be because acetylene is a suicide substrate to the pMMO. This may
result in irreversible inactivation of the enzyme causing the enzyme to degrade releasing
copper, which may lead to ambiguous results.
Ammonia is a substrate of pMMO that has been shown to be a competitive inhibitor of
methane oxidation by the pMMO in Methylococcus capsulatus (Bath) (O'Neill et al.,
1977; Carlsen et al. 1991). Cyanide has also been shown to be an inhibitor of the pMMOc
although its mode of inhibition is still unclear (Prior and Dalton, 1985; This study).
pMMOC samples were treated with ammonia and cyanide to determine whether there
were any changes in the copper superhyperfmes and g-values, due to binding of the
copper active site (Chapter 2, section 2.10.5).
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Figure 5.13 EPRspectrum of pMMOcomplex before and after the addition
of ammonia solution. 500f.!M ammonia solution (adjusted to pH 8 with Hel) was
added to 200f.!1pMMO (5mg/ml) (Final concentration of reaction mixture was pH
7.5) as described in Section 2.8. Spectra were recorded at a microwave power of
5mW, a temperature of 10K and a modulation amplitude of 5G.
~
There is no change in the overall spectra (Figure 5.13) when pMMOc is treated with
ammonia solution but the N superhyperfines of the cupric site have disappeared. This
result indicates that there is some interaction of ammonia with cupric site of pMMO
which is ill agreement with the proposal that ammonia is a competitive inhibitor of
methane oxidation.
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Figure 5.14 EPR spectrum of pMMO complex before and after the addition
of cyanide. SOO!J.M potassium cyanide (KeN) was added to 200!J.1 pMMO
(Smg/ml) as described in Section 2.8. Spectra were recorded at a microwave
power of SmW, a temperature of 100K and a modulation amplitude of SG.
There was no change observed in the overall spectrum and the N hyperfmes (Figure 5.14)
when the pMMOc was treated with KeN indicating that KeN does not bind to the cupric
site of pMMO. There is a slight decrease in the amount of visible copper, which infers
that some Cu2+ ions were reduced to Cu+ ions. The reason for the reduction of eu2+ ions
by KeN is not clearly understood.
118
5.8 Discussion
The evidence from this study indicates that the copper in the pMMO complex exists as a
mononuclear cupric ion in a square planar configuration in which Cu 2+ is bound to three
or four nitrogen donor atoms not a trinuclear copper cluster as proposed by Chan and
coworkers (Chan et al., 1993; Nguyen et al., 1994, 1996, 1998). This is in agreement with
previous proposals by other groups (Zahn and DiSpirito, 1996; Yuan et al. 1997, 1998,
1999; Lemos et al., 2000) that the copper existed as a type 2 copper. The parameters of
the cupric sites of pMMO from various methanotrophs are remarkably similar and are
listed in Table 5.3.
..gu_ _Ku_ AJLLu_(Gl AN(G)
Methylococcus capsulatus (Bath) 2.26 2.06 180 -
(Zahn & DiSpirito, 1996)
Methylosinus trichosporium OB3b 2.24 2.06 184 -
(Takeguchi et al., 1997)
Methylococcus capsulatus (Bath) 2.25 2.06 181 -
(Nguyen et al., 1998)
Methylomicrobium album BG81 2.243 2.067 180 18
Methylomicrobium album BG8 2 2.251 180 18
Methylococcus capsulatus (Bath) 1 2.244 185 19
Methylococcus capsulatus (Bath) 2 2.246 180 19
(Lemos et al., 2000)
Methylococcus capsulatus (Bath) 2.24 2.06 185 15
(This study, 2000) .Table 5.3 EPR parameters for type 2 copper from various
methanotrophs by various groups.
The following evidence indicates that the cupric site of pMMO exists as a type 2 not a
trinuclear cluster copper:-
1)The samples from Methylococcus capsulatus (Bath) cells grown in 63CU enriched
media had EPR parameters (g =2.24) which are consistent with a cupric ion with 3 or 4
equivalent nitrogen donor atoms as determined from Peisach-Blumberg plots simulated
by Yuan et al. (1997). Whether a seven-line or nine-line pattern corresponding to 3
nitro gens or 4 nitro gens respectively was obtained could not be resolved, which is
perhaps unsurprising from natural abundance samples. Lemos et al. (2000) found that the
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resolution of EPR spectra was considerably improved in cells grown in 15N enriched
media. If one delocalised electron over three approximately equivalent coppers a ID-line
pattern with one-third of the coupling expected from monomeric copper should be
observed. This signal was not observed in this study.
2) Ferricyanide-oxidised samples (Figure 5.6) did not produce the unusual isotropic EPR.,
spectrum observed by Chan and coworkers (Nguyen et al., 1996 and 1998). Possible
reasons for their signal have been suggested to be due to copper binding cofactors (Zahn
and DiSpirito, 1996), a CuFe[CN]6 complex (Yuan et al.), or adventitiously bound copper
IOns.
The latter proposal is substantiated by the fact that when 157 f.lMCu2+ ions was added to
pMMOc, the resultant spectrum (figure 5.12) was similar to the oxidised spectra of
pMMO samples observed by Chan and coworkers (Chan et al., 1993; Nguyen et al.,
1994, 1996, 1998). This indicates that the concentration of copper in the pMMO samples
purified by Chan and coworkers was very high. If this is so, the excess coppers may be
kept reduced (Cu+) by the chemicals used to maintain anaerobic conditions e.g.
dithionite, during protein purification and on oxidation may give rise to the broad
isotropic EPR signal observed. Indeed, the copper concentrations of the pMMOc samples
calculated by ICP-MS in this study (0.025f.lmoles/mg of protein) were -5 times lower
than the concentrations observed by Nguyen et al., 1998 (0.141f.lmoles/mg of protein). A
,
control experiment (this study, data not shown) carried out with mixed lipid/detergent
micelles shows that the micelles strongly bind Cu2+ ions.
In the EDT A-treated pMMOc sample, the copper concentration deduced by integration of
the cupric EPR signal (0.003 umoles/mg of protein) was -3 fold lower than the
concentration of copper as calculated by ICP-MS (O.Olf.lmoles/mg of protein). This
indicates that for every EPR detectable Cu2+ there is -3 EPR silent copper ions. These
could exist as Cu+ ions or as a magnetically coupled Cu2+ __Fe3+ centre. This is in
agreement with proposal that there are two or three EPR silent Cu+ ions for every EPR
detectable Cu2+ ion in Methylomicrobium album BG8 (Lemos et al., 1998). They also
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conclude that the enzyme (47, 27 and 25 kDa) comprises of four coppers which is a more
reasonable suggestion than the 15 coppers since they propose that it is difficult to place
even 3-5 copper ions in copper binding sites based on the pMMO amino acid sequences.
There is also mounting evidence that the functioning pMMO complex contains Fe3+,
possibly as a Cu+ Fe3+ cluster. This proposal is supported by the fmdings of magnetic
susceptibility measurements on as-isolated membranes by Nguyen et al. (1994). Their
results indicate notable levels of diamagnetic copper ions, which could arise from
antiferromagnetically-coupled copper ions.
The presence of iron has also been observed in purified pMMO from Methylococcus
capsulatus (Bath) by Zahn and DiSpirito (1996), although it is largely EPR silent and can
only be observed after the formation of a ferrous-nitric oxide derivative (g=4.03). Our
preliminary experiments have not successfully reproduced this iron-NO complex as yet.
Neither has the broad EPR signal at g=12.5 been observed which has been proposed by
Nguyen et al. (1998) to be due to iron-containing contaminants. The presence of iron was
also observed in purified pMMO from Methylosinus trichosporium OB3b (Takeguchi et
al., 1997).
Clearly, the presence of any iron-containing protein, found in pMMOc from this study, is
vital for the efficient functioning of the duroquinol-driven pMMO complex as protein
contamination has been minimised during purification.
When pMMO is treated with ammonia, the N superhyperfmes disappear from the spectra
(Figure 5.13) indicating that ammonia perturbs to the cupric site of pMMO as would be
expected for a competitive inhibitor. However, recent studies by Lemos et al. (2000)
suggest that there is a second type 2 copper signal with unresolved N hyperfmes, which
can not be distinguished from the normal type 2 copper signal in Methylococcus
capsulatus (Bath) cells grown in natural abundance media. If this is the case, the fmdings
may point to the binding of ammonia to the usual cupric site thus giving rise to a clearer
second cupric signal with no N hyperfmes.
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Inhibition profiles have shown KeN to be an inhibitor to pMMOc although the exact
mode of inhibition is unknown. The spectra of KeN-treated pMMO indicates that KeN
does not directly inhibit pMMO by binding to the cupric site. A possible explanation
could be that KeN inhibits the reductase component of the pMMO complex, which may
have an indirect role in the oxidation of copper ions.
5.7 Summary
The results of this study indicate that the copper in the active site of pMMO exists as a
type 2 copper, that is a cupric-ion bound to three or four nitrogen donor atoms, not as
trinuclear copper clusters. In addition to this, there is evidence to suggest that there may
be an iron cluster in the pMMO complex, possibly a eu2+ __Fe3+ centre, which is EPR
silent in as-isolated pMMO samples. The role of this iron centre for pMMO activity is
still unclear.
Having ascertained the nature of metal ions in the active site of pMMO it was thought
necessary to try and elucidate a gross structure for the complex in order to place possible
binding sites for the type 2 eu2+ in pMMO.
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6. Structural determination of the pMMO complex
6. 1 Introduction
The structural information of the pMMO complex has been hindered by the small
amount of purified active protein available. To date, any structural information of the
protein has been deduced from hydrophobicity plots of the pMMOH protein sequences,
as previously discussed in Chapter 1 (Semrau et al., 1995 and Elliott, et al., 1998). X-
ray crystallography is a technique that offers high-resolution structures of proteins but is
often not practical for use on membrane proteins as these preparations usually contain
detergents, which can hinder the crystallisation process. Alternative techniques such as
electron microscopy and electron crystallography combined with particle analysis can be
used to generate low-resolution structural models and are discussed in more detail later
in this chapter.
An early electron microscopy study was carried out by Suzina et al. (1985) to determine
the supramolecular organisation in intracytoplasmic membranes (lCMs) of various
methanotrophs such as Methylomonas methanica, Methylosinus trichosporium,
Methylocystis echinoides and Methylocystis pyreformis. Globular structures were
observed and proposed to consist of seven symmetrically arranged subunits in
hexagonal arrays. Differences in structure were observed between membrane-bound and
membrane- free states of the structures. Low-resolution structural information was
obtained but it is not clear how micrographs were analysed, although it is implied that
observations were made purely 'by eye' alone which made have led to inaccuracies in
interpretation.
The following experiments were carried out in order to generate a structural model of
the pMMO complex using various techniques such as hydropathy plot analysis and
electron microscopy techniques.
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6.2 Molecular mass, purity and subunit association analysis
The pMMO complex from Methylococcus capsulatus (Bath) is proposed to consist of at
least the hydroxylase. The pMMO hydroxylase purified by Zahn and DiSpirito (1996)
was comprised of three subunits of approximate molecular mass 47, 27 and 25 kDa.
Nguyen et al. (1998) proposed the pMMOH to comprise of a, p and y subunits of
approximate molecular mass 47, 26 and 23 kDa. They also observed a modified,
~
proteolytically-cleaved, a subunit (a') of molecular mass of ~ 35kDa.
6.2.1 Molecular mass and polypeptide profile of the pMMOcomplex
66kDa '_63
45kDa
'_47
36kDa
29kDa
'_27
24kDa '_23
20kDa
14kDa '_8-
Figure 6.1 12%SOS PAGEgel of the pMMOcomplex and components
The pMMO components were purified as previously described in Chapter 3,
Section 3.6.
Lane 1- Molecular weiqht markers
Lane 2 - pMMO complex off Superdex 200 column (5119 loaded)
Lane 3 - pMMO Hydroxylase off DEAE cellulose column (5119 loaded)
Lane 4-pMMO Reductase off DEAE cellulose column (5119 loaded)
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The pMMO hydroxylase (Lane 3) is comprised of three subunits (o, p and y) of
approximate molecular mass 47,26 and 23 kDa as estimated by the 12% SDS PAGE gel
of the pMMO complex. (Figure 6.1). These polypeptide masses are comparable to those
associated with the purified pMMO of both Zahn and DiSpirito (1996) and Nguyen et
al. (1998). The putative duroquinol-dependent reductase (Lane 4) consisted of a large
63kDa subunit and a smaller 8kDa subunit, which often ran with the dye-front of the
gel. The pMMO complex consisted of the totalpolypeptides for both the hydroxylase
and the reductase. In addition to this a proteolytically-cleaved a.' subunit was also
identified of molecular mass of around 35kDa as observed by Nguyen et al. (1998).
There are slight discrepancies between the molecular mass determinations of the
pMMOH as estimated by SDS-PAGE analysis by different groups. However, it is clear
that the banding pattern of the polypeptides is similar in all preparations and the
discrepancies are probably due to the different gel and sample conditions that were used
by different groups.
6.2.2 Molecular mass estimation of pMMOc by gel filtration
The molecular mass of the purified pMMO fromMethylosinus trichosporium OB3b has
been estimated to be 326kDa by gel filtration (Takeguchi et al., 1997). The same
approach was used to determine the molecular mass of the pMMO complex from
Methylococcus capsulatus (Bath) using gel filtration as described in detail in Section
2.10. Gel filtration was performed using a Superdex 200 column (15x 984cm,
Pharmacia). The column was equilibrated with 10mM Pipes, pH7.25 containing 0.01%
dodecyl-Bvlf-maltoside.
The molecular mass determination of pMMO was made by comparing the elution
volume of pMMO with that of five proteins of known molecular mass (BIORAD
calibration kit) as described in detail in Chapter 2, Section 2.7. The resultant values were
plotted to generate a calibration curve (Figure 6.2). In this way the molecular weight of
pMMO could be deduced by reading off the calibration curve.
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Figure 6.2 Estimation of molecular mass of pMMO from Methy/ococcus
capsu/atus (8ath) by gel filtration on Superdex 200 column. Column size,
1.5 by 98cm: Flow rate, 2 ml/min. Molecular weight standards. A) aldolase (Mr
158kDa); 8) catalase (Mr 232kDa) ; C) ferritin (Mr 440kDa); D) thyroglobulin (Mr
669kDa);
The approximate molecular mass of the complex was estimated to be 390kDa by this
technique. This method offers a rough molecular mass value and does not account for
the mass of detergent bound to the complex.'
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5.9
6.2.3 Sedimentation equilibrium analysis of pMMO by analytical
ultracentrifugation
The sedimentation rates of molecules can be optically measured by ultracentrifugation
analysis. This allows the behaviour of different protein associations to be assessed in a
solution. These interactions can be distinguished from aggregation by analysis of
residual plots. This method is a valuable tool for the determination of molecular mass,
homogeneity and strength of protein interaction of subunits in a complex.
Where detergents are necessary in buffers i.e. with membrane proteins, the amount of
detergent bound to the protein complex must be calculated first. The detergent binding
constant was calculated in a way similar to that described by Kleinekofort et al. (1992).
Sedimentation equilibrium experiments were performed in a Beckman XL-A analytical
Ultracentrifuge (Chapter 2, section 2.10.3) in collaboration with the Dr. K. Jumel at the
NCMH Business Centre, University of Nottingham.
The molecular weights of pMMOc and pMMOH in different D20IH20 ratios and buffer
density measurements were determined as described in Chapter 2, section 2.10.3. Data
from one speed only (pMMOc=6000rpm) and (pMMOH=10000rpm) were used for
analysis as these proved to be the best conditions. The buoyant molecular weights of
different protein samples were calculated using: -
= M[l-vp]
where default values of partial specific volume, v = 0.73 and density of solution, p
=1.00
The buoyant molecular weights, M, were then plotted against the buffer density
measurements (Figure 6.3 and 6.4).
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Figure 6.3 Determination of molecular weight of the pMMO complex
Buoyant molecular weights, Mb were plotted against the buffer density
measurements.
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Figure 6.4 Determination of molecular weight of the pMMO hydroxylase.
Buoyant molecular weights, Mb were plotted against the buffer density
measurements.
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i) The partial specific volume (v) for the complexes were obtained from the point of
intersection of M, with the abscissa (v = lip) from Figure 6.3 and 6.4.
vpMMO complex = 0.7083 ml/g
vhydroxylase 0.9169 ml/g
ii) The buoyant molecular weight at a density of 1.0000mg/ml was found to be 97,600
Da for the pMMO complex and 78900 Da for the hydroxylase. In order to obtain the
molecular weight for the protein detergent complexes at this density, the v values
calculated above (i) were used giving
Mhydroxylase/detergent
= 334,590 Da
= 949,460 Da
MpNtMO/detergent
iii) Extrapolation of the buoyant molecular weight to the density of the detergent results
directly in the molecular weight of the protein without bound detergent.
pdetergent =1.00106716 g/ml (determined in the same way as other buffer densities)
Mb,pMMO
Mb, hydroxylase
= 97,621Da
= 78,881Da
iv) The molecular weights of the proteins were calculated from the M, values using: -
M=~
I-vp
Therefore, MpMMO=387,100Da and Mhydroxylase= 312,800Da.
The molecular weights of the pMMO complex and the hydroxylase were determined to
be approximately 387,100 Da and 312,800 Da respectively which leaves a component(s)
of molecular weight >- 74kDa unaccounted for. If the pMMOH has a molecular weight
ofM=104, 309 Da as calculated from the published sequences available from the NCB!
database (http://www.ncbi.nim.nih.gov) under accession number L40804, the
hydroxylase may exist as a trimer (n=2.98).
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6.3 Structural prediction of the pMMOH using hydrophobicity plots
Hydropathy plot analysis of amino acid sequences can be used for predicting models of
the folding topology of membrane proteins. This approach has been used for the
pMMOH from Methylococcus capsulatus (Bath) by Semrau et al. (1995). A Kyte-
Doolittle algorithm was used to predict that the pmoB (47kDa) subunit had two potential
membrane-spanning regions and a leader sequence. The hydropathy plot of the pmoA..
(27kDa) subunit predicted four potential membrane-spanning helices with no leader
sequence.
A transmembrane helices model of the pMMO hydroxylase (pMMOH) was proposed
(Figure 6.5) based on predicted hydrophobicity plots using the TMPred package
(http://www.isrec.isb-sib.chlsoftwareITMPredfom.html). The published protein
sequences of the pMMO hydroxylase from Methylococcus capsulatus (Bath) were
available from the NCBI database (http://www.ncbLnim.nih.gov) under accession
number L40804.
Using TMPred prediction package, both the ~ (27kDa) and y (23kDa) subunits of the
pMMOH were predicted to have six potential membrane spanning helices each. A large
portion of the ex. (47kDa) subunit appears to be situated outside the membrane. Histidine
residues, which have been proposed to be responsible for the ligation of coppers in the
active site, are predicted to be located on the periplasmic side of the membranes as
previously proposed by Elliott et al. (1998). This would support the interaction of the
pMMO hydroxylase with a periplasmic protein e.g. methanol dehydrogenase (MDH), as
suggested by earlier fmdings in this study.
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Figure 6.5Transmembrane helices model of a.,f3 and y subunits of the
pMMO Hydroxylase (pMMOH). Based on predicted hydropathy plots of the
pMMOH protein sequences available from the NCBI database
(http://www.ncbi.nim.nih.gov) under accession number L40804.
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6.4 Electron microscopy and Single Particle Analysis of the pMMOc
Electron microscopy has made significant contribution to structural studies of membrane
proteins and is often the only method suitable for use. Improved structural resolutions
can be made by enhancing electron micrographs using image alignment and particle
averaging techniques or single particle analysis (SPA), (Frank et al., 1981). SPA has
the advantage over X-ray crystallography in that the limiting step of crystallisation is
removed. In this technique, single particles are selected, aligned and then the molecule
undergoes multivariate statistical/correspondence analysis (VanHeel and Frank, 1981)
and hierarchical ascendant classification using complete linkage as a merging criterion.
That is selected particles undergo rotational alignment to give a refined image before
being classified into groups depending on their similarities in orientation size and shape.
Electron microscopy and digital image processing were carried out on both membrane-
embedded pMMO and detergent-solubilised pMMO isolated from intracytoplasmic
membranes from Methylococcus capsulatus (Bath). Work was carried out in
collaboration with Dr. A. Kitmitto and Dr. R. Ford at University of Manchester, Institute
of Science and Technology (UMIST), U.K. Electron micrographs of pMMOmand the
,
pMMOc (with average specific activities of 30 and 75 nmoles of propylene oxide
produced/min/mg respectively) were recorded with a Philips CM420 electron
microscope and analysed as described in Materials and Methods (Chapter 2, Section
2.10.4). SPIDER and WEB image processing packages were used for single particle
analysis. Either reference-free or reference-based algorithms were applied to
rotationally and translationally align the particles. During reference-based algorithms a
particle in the data-set is selected as a reference on the basis of its similarity to the
majority of the other particles in the data-set in terms of size and shape.
132
6.4.1 Single particle analysis of membrane-associated pMMO (pMMOm)
Electron microscopy and single particle analysis were carried out on pMMOm and
pMMOc to allow a comparative study to be made between membrane-embedded and
membrane-free pMMO complexes.
pMMO membrane samples (100-150J.lg/ml)were prepared as described in Chapter 2,
section 2.5. Samples were negatively stained' and examined in a Phillips 400
transmission electron microscope as described in Chapter2, section 2.10.4. Micrographs
were originally recorded at a calibrated magnification ofx 43,600. Electron micrographs
were digitised (Zeiss Scanner) resulting in a pixel size of 6.4A at the specimen level.
A typical electron micrograph of negatively stained membrane-embedded pMMO is
presented in Figure 6.6. The membrane appears densely packed with proteins
(white/lighter regions). Since, >75% of the total protein appeared to exist as 'doughnut'
shapes of similar size (as seen in red section, X), they were anticipated to be the pMMO
complex as >60% of the polypeptides m intracytoplasmic membranes (ICMs) are
associated with the pMMO.
Patches of ordered membrane-embedded complexes (green section, Y) and membrane-
associated 2D arrays (blue section, Z) were also observed and are discussed later in
Section 6.5).
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Figure 6.6 Typical electron micrograph of negatively stained
intracytoplasmic membranes (leMs) from Methy/ococcus capsu/atus
(Bath). Micrographs were taken at x43,600 and scanned to 6.4A /pixel. Red
section X depicts an enhanced image of the 'doughnut' shaped proteins.
The red arrows designate typical particles for selection. Green section, Y
and blue section Z are areas of ordered membrane-embedded and
membrane-associated complexes respectively. Enhanced images of
section Y and Z are shown in Figure 6.12 and 6.14, respectively. Scale bar
= O.11lm
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Figure 6.7 Hierarchical ascendant classification of membrane-embedded
pMMO (X). 500 particles of complex X were individually selected using a box
size of 23 x 23 pixels (6.4A1pixel). The vertical axis represents the measure of
the gain in intraclass variance obtained through merging (measure of intraclass
variance). The main classes are shown here with their population numbers in
bold (n=500). '
500 particles of non-ordered, membrane embedded complexes were selected from the
digitised micrograph of the ICMs (Figure 6.6) and subjected to translational and
rotational alignment followed by hierarchical clustering as depicted in Figure 6.7. As
would be expected the data set was very homogenous since the membrane-embedded
complexes are restricted in their orientation with respect to the membrane. A major class
of 440 particles (88%) was identified, Class A and an average projection map was
generated as shown in Figure 6.8.
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Figure 6.8 Average projection map of major class of membrane-
embedded complexes (A). Box size, X = Y = 192 A. The proteins domains are
depicted as the white regions of the map and the black areas are the applied
stain. The dimensions of the complex are approximately 85 x 118A with a
central indentation of about 39 x 47A. The red dashed line indicates possible 2-
fold symmetry.
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The averaged projection map of the major class of membrane-embedded (Class A)
particles (Figure 6.8) depicts a complex where the protein domains surround a large
central indentation. The approximate dimensions of this complex in the projection map
are 85 x 118A with a central indentation of about 39 x 47A. The complex may have 2-
fold rotational symmetry as indicated in Figure 6.8.
6.4.2 Single particle analysis of purified pMMO complex (pMMOC)
Having obtained an average projection map of the membrane-embedded pMMO
complex using electron microscopy in conjunction with single particle analysis, a
comparative study was carried out on pMMOc to generate a projection map of the
solubilised complex. It was expected that after solubilisation from the membrane,
several different views of the pMMO complex would be visible i.e. different
orientations of the complex with respect to the support film, as the complex was no
longer restricted by the membrane in orientation.
The solubilised pMMO complex (PMMOC) was isolated as described in Chapter 2,
section 2.8 and had average specific activities of 50 nmoles of propylene oxide
produced/min/mg. The pMMOc (ug/ml) samples were mounted and negatively stained
for examination using a Phillips 400 transmission electron microscope (as described in
Chapter 2, section 2.10.4). Electron micrographs were digitised (Zeiss Scanner)
resulting in a pixel size of 6.4A at the specimen level.
The particles seen in the typical electron micrograph of negatively stained pMMOc
(Figure 6.9) appeared to be homogenous in terms of size. 1631 particles were selected
for single particle analysis (reference-free) using a box size of 30 x 30 pixels (6.4Ai
pixel).
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Figure 6.9 A typical electron micrograph of negatively stained purified
pMMO complex (pMMOC). Typical particles for selection are designated by the
white arrows. The micrographwas originally taken at a magnificationof x 43,600
and scanned to 6.4A!pixel. Scale bar =50nm
Correspondence analysis and hierarchical ascendant classification was carried out on the
pM:MOc particles in a similar manner to that described previously for the membrane-
embedded complex. Three main classes were identified, class 1 (30%), 2 (27%), 3
(10%). The average projection maps of each of the main groups of particles are shown
in Figure 6.10.
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xFigure 6.10 Average projection maps of three main classes of pMMO
complex. Class 1(n=488), Class 2(n=440) and Class 3(n=163) after
selection of 1631 particles. Particles were selected from digitised micrograph
of pMMOc (figure 6.9) and subjected to correspondence analysis and
hierarchical ascendant classification. Maps were generated for each class and
depicted two protein domains (white areas) surrounded by applied stain (black).
The approximate dimensions of the complex (1) are 136 x 144A. The red
dashed line indicates possible 2-fold mirror symmetry. Box size, X = Y = 192 A.
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489 particles of class 1 were selected and found to have almost identical features to the
membrane-embedded complex depicted in Figure 6.8, if the map was rotated by 900 and
was therefore likely to offer the 'top face' view of the complex'. The complex appears
flattened with possibly 4 protein domains, with approximate dimensions of 136 x 144A.
This membrane-free complex is slightly larger than the membrane-embedded complex,
which is probably due to detergent binding to the complex on solubilisation. The central
cavity was not as well defmed as in the membrane-embedded complexes. This is
perhaps unsurprising, as solubilisation of the complexes may result in some structural
variation. Both class 2 (n=440) and class 3 (n=163) particles present a different view
(Figure 6.10) of the pMMO complex than the class 1 particles. Both the class 2 and 3
average projection maps depict two protein domains (white regions) surrounding a
central indentation, in possible two-fold rotational symmetry. Since both these classes
had complexes with similar dimensions to the class 1 complexes, they were proposed to
be the 'bottom' view of the complex. The slight variation of the class 2 and 3 particles
was thought to be due to slightly different orientations of the complex with respect to
the film support.
,
Other minor groups were also identified after correspondence analysis and hierarchical
ascendant classification and were assigned class 4 (7.5%), 5(5%) and 6(4%). The
average projection maps of the minor classes illustrated a complex with 2 major protein
domains (Figure 6.11). The complexes observed in class 5 (n=85) and 6 (n=66) particles
depicted a complex with dimensions of approximately 130A x 100A. Clearly these three
averaged projection maps are closely related and probably represent the same 'face' of
the complex but at slightly different orientations with respect to the support film. The
complexes were assigned as 'side views' as they appeared to have possible two-fold
symmetry, which would be expected in the side-view of a homopolymeric complex. The
class 4 (n=122) particles were thought to represent an extended side-view of the
complex i.e. tilted top view (seen in class 1 particle). From the dimensions of the class 5
and 6 particles, the length of a membrane spanning helix was estimated at approximately
130A.
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Figure 6.11 Average projection maps of three minor classes of pMMO
complex, Class 4 (n=122) Class 5 (n=85) and Class 6 (n=66). Box size, X = Y
= 192 A. Particles were selected from digitised micrograph of pMMOc (Figure
6.9) and subjected to correspondence analysis and hierarchical ascendant
classification, Maps were generated for each class of particle. Two protein
domains were observed (white areas) surrounded by applied stain (black
areas). The approximate dimension of the complex shown in (4) and (5) are
130A x130A. The red dashed line indicates possible 2-fold mirror symmetry.
There is a clear correlation between the membrane-embedded complexes and the
purified pMMO complexes suggesting they are essentially the same entity. The
solubilisation and purification of the pMMOc has allowed different views of the pMMO
complex to become accessible and the resulting projection maps have portrayed top,
bottom and side views of the complex at low resolution. These projection maps may
serve as blueprints for the eventual generation of an overall model of the pMMO
complex.
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6.5 Electron Crystallography of the pMMO complex
The major obstacle in the advancement of tertiary structure analysis of membrane
proteins has been the difficulty to produce high amounts of pure protein required for
investigations and the presence of detergent during the crystallisation process. Particle
averaging techniques for biomacromolecules arranged in regular arrays (two-
dimensional crystal or helices) were developed by Klug and co-workers (DeRosier and
Klug, 1968). This technique has been proved successful for membrane proteins, as
three-dimensional structures with reproducible resolutions down to approximately
0.7nm have been achieved (Henderson and Unwin, 1975). Higher resolution images can
usually be obtained when using-particle analysis of2D-arrays when compared to particle
analysis of individual molecules. This is largely due to the increased homogeneity of the
data set. Therefore, acquiring 2D arrays of the pMMO complex is a highly desirable step
in obtaining higher resolution structural data.
6.5.1 Membrane-embedded 2D arrays
Intrestingly, the membrane-embedded pMMO complexes spontaneously formed patches
of ordered 2D arrays (green section, Y in figure 6.6). The homogeneity of the complexes
,
in the crystalline areas allowed average projection maps to be generated in a manner
similar to that previously described. Digital image processing of the crystalline areas
was carried out using the PC based CRISP and TRIMERGE image-processing software
packages as described in Chapter 2, section 2.10.4.
The membrane-embedded 2D arrays exhibited hexagonal packing (Figure 6.12).
Approximately 20 molecules were selected from areas of membrane-embedded 2D
arrays from the digitised micrograph of ICMs (Figure 6.6). The resultant average
projection map (Figure 6.13) depicted a complex with the unit cell dimensions of a =
119A, b= 120A. In addition to this, the complex exhibited similar gross features as that
calculated by single particle analysis of non-ordered membrane-embedded pMMO
complexes (Figure 6.8) and purified pMMO (Figure 6.10). That is, the ordered
membrane-embedded pMMO complex is comprised of approximately two distinct
domains surrounding a central cleft.
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Figure 6.12 Typical enhanced section depicting ordered membrane-
embedded complexes. The section was taken from the digitised micrograph
(Figure 6.6) of intracytoplasmic membranes from Methy/ococcus capsu/atus
(Bath). The complexes exhibited hexagonal packing as indicated by green
hexagon.
Figure 6.13 Density map of membrane-embedded complexes. Unit cell
dimensions a=119 A, b=120A. Approximately, 4 protein domains are depicted
by the white regions and surround a central cleft. The orange areas represent
applied stain. Approximately 20 molecules were selected from the digitised
micrograph (Figure 6.6)
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Both the protein domains are similar in shape and size, except that the right hand
domain appears to protrude more from the membrane than the left hand domain
6.5.2 Average projection map of membrane-associated complexes
Crystalline areas were also found associated with, but not embedded in the membrane
(Figure 6.14). The source of these 2D arrays could not be readily identified and
therefore particle analysis was carried out to try" and determined the identity of the
arrays. 15 areas of the membrane-associated 2D arrays were selected and subjected to
translational and rotational alignment.
Digital image processing of 15 crystalline areas generated a projection map of the unit
cell (a=b=12.2±O.2nm;y=900) as depicted in Figure 6.15. The unit cell is composed of
four similar complexes, rotated 90° with respect to each other.
The exact nature of these crystals is still unclear since the average projection map bears
no resemblance to the maps shown previously for the pMMO. Attempts to remove the
arrays from the membrane using salt (2M) or urea (5M) washing were unsuccessful
(data not shown).
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Figure 6.14 Typical enhanced section of electron micrograph (Figure 6.6)
portraying membrane-associated 20 arrays. 15 crystalline areas were
selected for particle analysis.
h
a
Figure 6.15 Final contour projection map of the unit cell of the membrane-
associated 20 arrays.
15 .crystalline areas were selected. The unit cell dimensions are
a=b=12.2±0.2nm; y=900. The unit cell is comprised of four complexes, rotated
90° with respect to each other.
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6.6 Discussion
Preliminary electron microscopy studies indicates that the pMMO complex exists as at
least a dimer, possibly a tetramer. The sedimentation equilibrium analysis confirms that
pMMO exists as an oligomer but the molecular weight of the complex suggests it exists
as a trimer. It should be noted that the techniques are fundamentally different in that the
subunit association takes place in solution during sedimentation equilibrium and out of
solution during electron microscopy. As expected the solubilised complexes are slightly
larger than those from the membrane, which was also seen by Suzina (1985) in various
methanotrophs. This was thought to be due to the structural variation when the complex
is released from the membrane or may be due to detergent binding to the complex.
The membrane-spanning dimension of the complex was calculated to be approximately
130A as inferred from the 'side view' of the complex. If the 'thickness' of a bacterial
membrane is estimated to be approximately 6oA, this suggests that a large portion of the
complex is protruding from the membrane. This result correlates with hydropathy plots
of the pMMOH, which predicts a large portion of the pMMO to be extra-membraneous.
,
The spontaneous formation of the crystalline areas is intriguing. The arrays are
physically attached to the membrane and cannot be removed by salt (2M) or urea (5M)
washing. Trypsin digestion of the membrane samples showed partial digestion of the
crystals, which strongly suggests the crystals are composed of protein. Work is
continuing in the characterisation of these arrays by the Dalton group, in collaboration
with the Dr. A. Kitmitto and Dr. R Ford (UMIST). One line of study involves the use of
gold-conjugated pMMO antibodies in labelling experiments of the arrays.
146
Various projection maps from this study were used to generate a schematic model for
the different views of the pMMO complex (Figure 6.16 a,b and c). The average
projection maps of both the membrane-associated and membrane-free pMMO suggest
the complex is comprised of 2 distinct protein domains (monomers or dimers), which
are related by rotational symmetry when viewed from the top of the complex. These two
distinct protein domains surround a closed cavity as inferred by the assumed 'bottom
views' of the complex (Figure 6. 11). The role of this central depression is not clear but
it may allow hydrophillic substrates accessibility to the active site.
Using electron microscopy ami single particle analysis techniques has given us an
insight into the structure of the pMMO. Higher resolution structures may be obtained
from reconstituting the purified pMMO complex into lipids. If protein:lipid
concentrations are high enough, crystal formation can be induced, which will enhance
the quality 0f subsequent data. This method has been successfully used for other
membrane proteins to obtain reproducible resolutions of down to O.7nm. (Henderson
and Unwin, 1968).
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Figure 6.16b Bottom view of
pMMO model. Model depicts two
associated pMMO monomers.
White line represents
two-fold symmetry
Figure 6.16a Top view of pMMO model
Model-depicts two pMMO monomers
surrounding a central cavity.
White line represents two-fold symmetry
Figure 6.16c Side view of pMMO model
Model depicts the side view of two pMMO
monomers. White line represents mirror
symmetry
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7. General Discussion
A high specific activity pMMO complex was purified from Methylococcus capsulatus
(Bath) during this study and was found to have 5-10 times the activity of previously
reported purified pMMO (Zahn and DiSpirito, 1996; Nguyen et al., 1998). The key to
obtaining a pMMO complex with good specific activity, lies in precept that only
intracytoplasmic membranes highly-enriched with pMMO (60-80% of the total
membrane-bound proteins) with high specific activities (~50-75 nmoles of propylene
oxide produced/minlmg) are used for solubilisation and further purification. One of the
major discrepancies between this study and published reports on the purification of
pMMO from Methylococcus capsulatus (Bath) by other groups is the use of anaerobic
conditions to maintain activity. Protein preparations maintained aerobically during this
study were of high specific activity and good stability when compared with other
groups. These findings are similar to results previously obtained by the Dalton group,
University of Warwick. It is still unclear why our preparations differ from other groups
and may be due to the extensive experience of handling the methanotroph in the Dalton
group.
In this study, the purified pMMO complex consisted of a hydroxylase component
(pMMOH), which required a putative pMMO reductase (pMMOR), to couple it to the
electron donor, duroquinol. The pMMOR has been proposed to be the methanol
dehydrogenase (MDH) from Methylococcus capsulatus (Bath) based on the similarity of
their N-terminal sequences and polypeptideprofiles (Adeosun, 2000). Further work on
the characterisation of the pMMOR is required to conclusively establish the putative
pMMOR is an MDH. The levels of the purified pMMOH and pMMOR components
were low which restricted subsequent characterisation so the purification procedure will
require optimisation in order to provide large-scale purification of the individual
components.
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The results from this study indicate that the methanol dehydrogenase (MDH) may be at
least partially membrane-bound as has been suggested previously (Patel and Felix, 1976;
Grosse, et al., 1997 Anthony, 1986). It is unclear how MDH associates and interacts
with pMMO hydroxylase in the membrane, although it is thought that the ionic washes
used in the isolation procedure stabilise interactions between the two. MDH remains
associated with the membrane despite washing and sonication, and can only be removed
with harsh conditions i.e. urea, which causes complete denaturation of the enzyme
complex. The pMMO samples prepared by Zahn and DiSpirito (1996) and Nguyen et al.
(1998) do not contain significant amounts of MDH and this may be reflected in the low
activities they obtain.
7.1 Properties of the pMMO
The EPR analysis of the pMMO complex indicates that the copper in the active site of
pMMO exits as a type 2 copper not a trinuc1ear copper cluster as proposed by Chan and
coworkers (Chan et al., 1993; Nguyen et al., 1994, 1996, 1998). This fmding is in
agreement with other groups who also found that the copper in pMMO existed as a
cupric ion ligated to three or four nitro gens atoms (Zahn and DiSpirito, 1996; Yuan et
al. 1997, 1998, 1999; Lemos et al., 2000). However, it is not clear whether the copper
ion is ligated to three or four nitro gens atoms. This could only be conclusively
established by EPR analysis of the pMMO complex and its individual components from
Methylococcus capsulatus (Bath) cells grown in either 15Nenriched media as carried out
from Methylomicrobium albus BG8 cells by Lemos et al. (2000).
There is also mounting evidence that the functioning pMMO complex contain some iron
atoms as proposed by Zahn and DiSpirito (1996). The exact nature of these iron atoms
ions is not known although the majority of iron is EPR silent and could be part of a
Cu+---Fe3+ centre. The presence of iron in three preparations of purified pMMO (Zahn
and DiSpirito, 1996; Takeguchi et al., 1997; This study) does suggest there must be
some iron component in pMMO which is contradictory to the fmdings of Nguyen et al.,
(1998). Future EPR analysis will be required to further elucidate the nature and role of
the iron centre in pMMO.
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The results of this study offer the first real structural insight into the pMMO. The
complex was found to be comprised of 2 distinct protein domains (where one domain
=monomer or dimer) surrounding a closed cavity of unknown function, although it may
allow hydrophillic substrates accessibility to the active site. Whether the complex exists
as a dimer or a tetramer requires investigation which will be considerably aided by mass
spectrometry analysis to fmd out the accurate molecular mass of the complex and its
components. The individual components could not be assigned in this study and may be
identified using antibody labelling techniques with antibodies raised to the pMMO.
Higher resolution structures may be obtained by using cryo-conditions where samples
are embedded in vitreous ice and can be sectionalised to collate data to generate 3-D
models. However, this is technically far more difficult.
The apparent spontaneous formation of the membrane-attached 2D crystals is an
intriguing phenomenon. It is possible that the arrays are formed from membrane-
dissociated subunits ofpMMO e.g. the large 47kDa subunit (a) which is proposed to be
mainly extramembraneous. Alternatively, the 2D arrays could offer an insight into
membrane protein processing, where the crystals are the ~orage form of pMMO before
the complex has completely inserted itself into the membrane. A concerted effort to
characterise these crystals is still underway by the Dalton group (University of
Warwick) in collaboration with the E.M group (UMIST). It is hoped that these
experiments will help to elucidate the nature of these 2D crystals.
The results of the kinetic analysis of the pMMO complex indicate that the complex has a
low affmity for methane when compared to sMMO values. This fmding is not in
accordance with previous observations that pMMO-expressing cells have a greater
affmity for methane than sMMO-expressing cells (Leak, 1992; Leak and Dalton, 1986a
and b; Leak et al., 1985) and may be due to the absence of the in vivo electron donor of
pMMO.
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7.2 In vivo electron donors for the pMMO complex
It is now becoming apparent that the in vivo mechanism for methane oxidation is a
complex and ingenious system. The possible role of the methanol dehydrogenase
(MDH) in donating electrons generated from methanol oxidation back to the pMMO
independent ofNADH, as previously suggested by Tonge and co-workers (1977), now
seems plausible with the demonstration of methanol as a reductant to the membrane-
bound pMMO in this study. This would suggest an energy efficient mechanism of
methane oxidation in pMMO expressing methanotrophs which is supported by the fact
that cells expressing pMMO are energetically more efficient (in terms of g cells/g
methane consumed) than cellsexpressing sMMO (Dalton and Leak, 1985).
However, the subsequent loss of the ability for methanol to act as a reductant for the
purified pMMO complex may be due to a couple of factors. It may reflect the need to
obtain a fully functional MDH cofactor PQQH2 or it may indicate that the physiological
electron acceptor for MDH, the cytochrome CL, which may be associated to the MDH in
membrane samples but removed during the purification process, is necessary to maintain
methanol-linked pMMO activity. If this is the case, it mar be inferred that cytochrome
CL is the true in vivo electron donor for pMMO and this is supported by electron
transport inhibitor studies that indicate that a cytochrome c is involved in electron
transfer to the pMMO.
However, it can be postulated that in the absence of a functional PQQH and its true
physiological electron acceptor, MDH may aid an efficient transfer of electrons from
duroquinol to the pMMO, possibly due to it locational attributes. That is for rapid
electron transfer to take place between duroquinol and the active site of the pMMO they
need to be as close together as possible. This proposal is supported by the findings that
the pyrrolo-quinoline quinol and duroquinol could be competing for a binding site in the
pMMO complex, possibly in the reductaselMDH component i.e. the vacation of the
PQQH from its binding site (as indicated from uv/vis spectrophotometry) may allow
duroquinol to bind. It may also explain the fmdings of other groups (Shiemke et ai,
1985; Zahn and DiSpirito, 1996) where the presence of the reductaselMDH has not been
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noted but minimal pMMO activity is obtained using duroquinol as an electron donor,
due to inefficient electron transfer from duroquinol to pMMO.
7.3 The pMMO complex, an oxygenase and an oxidase?
There have been reports that pMMO samples with no MMO activity e.g. by acetylene
inhibition, have stable rates of oxygen consumption, indicating that the oxygen reducing
activity may be due to a terminal oxidase. (Dalton and Whittenbury, 1976; Stirling and
Dalton, 1979; Prior and Dalton, 1985a; DiSpirito et al., 1994).
A terminal oxidase was purified from Methylococcus capsulatus (Bath) (Zahn et al.,
1994) and could be purified with or without a cytochrome c-557 (now referred to as the
cytochrome c peroxidase, Zahn et al., 1997) which was proposed to be the probable
initial electron donor to the oxidase. Interestingly, this enzyme was found to consist of
7-10 copper atoms (an unusually high level for an oxidase) and iron atoms and had a
polypeptide profile (~46, 28 and 20kDa) which is remarkably similar to that of the
pMMO hydroxylase (47, 27 and 23kDa). These fmdings led Nguyen et al., (1998) to
propose that the oxidase preparation was heavily contaminated with the pMMO
polypeptides although no other polypeptides (except for the accounted for cytochrome
c-557 polypeptide) were apparent in the cytochrome preparation. The explanation does
not account for the terminal oxidase activity detected in preparations lacking pMMO
activity
Therefore, a proposal has been suggested based on a number of observations made in
this study and previous literature. Electron transport inhibitor studies on the pMMO
from Methylococcus capsulatus (Bath) (Prior and Dalton, 1985, Charlton, 1997 and this
study) led to the proposal that NADH passes electrons to pMMO via a chain of electron
transfer proteins, involving a possible NADH oxireductase and/or quinol pool,
cytochrome b and cytochrome c, in a manner similar to the mitochondrial electron
transport chain. Whether ATP is generated is not clear, as 2,4-DNP (uncoupling agent)
and oligomycin (prevents fmal step in ATP formation) have little effect on NADH-
mediated pMMOm activity. The role of fmal electron acceptor in an electron transport
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chain with subsequent reduction of 02 to H20, by pMMO, is also reminiscent of a
terminal oxidase. Therefore it is tentatively proposed that the native membrane-bound
pMMO complex i.e. with haem components present, is also the terminal oxidase
responsible for the oxidase activity observed in membrane and solubilised preparations
in the absence of pMMO activity. If this is true, a number of conclusions can be
inferred.
The cytochrome CL is known to interact with cytochrome aas (Nunn and Anthony, 1988)
which supports the earlier proposal that cytochrome CL is the true in vivo electron donor
to pMMO. This logistically facilitates and optimises any electron transfer from methanol
dehydrogenase to pMMO via the cytochrome CL. This is in agreement with the fmdings
of a CO-binding cytochrome Ceo, which was identified as the immediate donor to
pMMO from Methylosinus trichosporium OB3b (Tonge et al., 1975). Complete
cyanide-inhibition of activity in the pMMO is consistent with the proposal of a terminal
oxidase being involved.
From these conclusions, a mechanism of in vivo pMMO electron transfer could be
proposed based on the same principles as those proposed by Tonge et al., 1995 and
1977). If the model (Figure 7.1) is correct then there would probably be two ranks of
cytochromes in the electron transfer pathway since NADH is a two-electron donor and
each cytochrome can only carry one electron. Therefore, electron transfer would be
more efficient (logistically-speaking) if the final electron acceptor (pMMO) was present
in at least two copies as well. This would be consistent with the structural model of the
pMMO complex which exists as, at least a dimer. The presence of multiple copies of the
pmo hydroxylase genes (Semrau et al., 1995; Costello et al., 1995; Stolyar et al., 1999)
a phenomenon rarely found in prokaryotes, lends credence to the fact that the pMMO
may exist in a polymeric state or even in different forms.
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•• NADH+W NAD
NADH
pMMO
complex
Figure 7.1 Schematic diagram for the tentative mechanism of in vivo
electron transfer to pMMO. Electrons are recycled back to the
monooxygenase from the methanol oxidation reaction by methanol
dehydrogenase, via cytochrome CL. NADH generated by the oxidation of
formaldehyde and formate (not shown here) could be channelled back into the
electron transport system.
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The aims of this study were to fmd a reproducible method of purification of the pMMO
and to subsequently characterise the enzyme. During this study a duroquinol-driven
particulate methane oxidising complex was isolated reproducibly from Methylococcus
capsulatus (Bath), with good specific activity. Various methods were used to give the
first real insight into the metal centre and structural integrity of an efficiently functioning
pMMO complex. The study also suggests a mechanism by which the pMMO complex
may interact with electron transport proteins and other components of the methane
oxidation pathway.
The original aims of the study have been in part, fulfilled. It is appreciated that there is
much work to be done to further clarify the mechanism and characteristics of this
pMMO complex. However, because of the promising combination of conceptual
innovation and modem high technology, we stand on the brink of an exciting new phase,
in the elucidation of the enigmatic particulate methane monooxygenase.
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